URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Submission: On February 08 via manual from IN — Scanned from DE

Summary

This website contacted 89 IPs in 12 countries across 67 domains to perform 233 HTTP transactions. The main IP is 104.18.14.141, located in and belongs to CLOUDFLARENET, US. The main domain is www.fiercepharma.com. The Cisco Umbrella rank of the primary domain is 116131.
TLS certificate: Issued by Cloudflare Inc ECC CA-3 on July 14th 2021. Valid for: a year.
This is the only time www.fiercepharma.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

IP Address AS Autonomous System
12 104.18.14.141 13335 (CLOUDFLAR...)
1 2a00:1450:400... 15169 (GOOGLE)
1 65.9.63.73 16509 (AMAZON-02)
1 104.16.92.165 13335 (CLOUDFLAR...)
3 45.133.44.3 39572 (ADVANCEDH...)
6 142.250.184.226 15169 (GOOGLE)
3 2606:4700:10:... 13335 (CLOUDFLAR...)
1 2a00:1450:400... 15169 (GOOGLE)
1 104.16.94.80 13335 (CLOUDFLAR...)
2 2a00:1450:400... 15169 (GOOGLE)
2 2a00:1450:400... 15169 (GOOGLE)
1 54.72.7.92 16509 (AMAZON-02)
2 4 66.155.71.150 13768 (COGECO-PEER1)
1 10 204.180.130.190 53866 (QTS-AS)
1 65.9.58.62 16509 (AMAZON-02)
4 45.133.44.4 39572 (ADVANCEDH...)
5 2a00:1450:400... 15169 (GOOGLE)
4 2606:4700::68... 13335 (CLOUDFLAR...)
2 104.111.234.67 16625 (AKAMAI-AS)
1 143.204.215.21 16509 (AMAZON-02)
1 2606:4700::68... 13335 (CLOUDFLAR...)
13 204.180.130.159 53866 (QTS-AS)
1 65.9.61.60 16509 (AMAZON-02)
2 11 37.252.172.37 29990 (ASN-APPNEX)
3 3.226.203.17 14618 (AMAZON-AES)
2 52.208.138.90 16509 (AMAZON-02)
1 192.28.147.68 15224 (OMNITURE)
10 2a0c:5c81:514... 55081 (24SHELLS)
1 2a00:1450:400... 15169 (GOOGLE)
1 34.194.161.83 14618 (AMAZON-AES)
1 99.86.3.25 16509 (AMAZON-02)
1 18.66.248.91 16509 (AMAZON-02)
1 34.200.182.42 14618 (AMAZON-AES)
2 169.197.150.8 398989 (DEEPINTENT)
1 37.252.161.190 29990 (ASN-APPNEX)
11 18.156.195.47 16509 (AMAZON-02)
8 2602:803:c003... 26667 (RUBICONPR...)
1 178.162.133.150 60781 (LEASEWEB-...)
1 8.2.111.126 46636 (NATCOWEB)
2 185.64.189.112 62713 (AS-PUBMATIC)
1 34.251.249.129 16509 (AMAZON-02)
1 5.178.65.246 50673 (SERVERIUS-AS)
1 185.184.10.30 203690 (RTB-HOUSE...)
1 213.19.147.42 26120 (RHYTHMONE)
1 216.52.2.48 29791 (VOXEL-DOT...)
1 198.148.27.133 19189 (PULSEPOINT)
1 23.37.38.181 16625 (AKAMAI-AS)
2 35.244.159.8 15169 (GOOGLE)
1 146.0.227.109 20773 (GODADDY)
2 147.75.38.124 54825 (PACKET)
11 51.38.120.206 16276 (OVH)
1 88.212.252.22 7979 (SERVERS-COM)
6 178.250.0.165 44788 (ASN-CRITE...)
1 34.107.148.139 15169 (GOOGLE)
1 63.32.247.12 16509 (AMAZON-02)
1 2a00:1450:400... 15169 (GOOGLE)
2 2a00:1450:400... 15169 (GOOGLE)
1 2a00:1450:400... 15169 (GOOGLE)
1 34.249.212.247 16509 (AMAZON-02)
5 185.184.8.65 204995 (RTB-HOUSE...)
1 54.149.174.3 16509 (AMAZON-02)
1 2606:4700:303... 13335 (CLOUDFLAR...)
2 99.86.3.109 16509 (AMAZON-02)
1 1 62.149.0.72 15497 (COLOCALL ...)
1 193.200.65.5 6681 (GIVEME-CLOUD)
1 37.18.16.16 205675 (HYBRID-AS)
5 54.144.118.149 14618 (AMAZON-AES)
5 205.162.42.5 53866 (QTS-AS)
2 3 142.250.185.66 15169 (GOOGLE)
1 35.244.174.68 15169 (GOOGLE)
1 3 2606:4700:20:... 13335 (CLOUDFLAR...)
2 204.180.130.165 53866 (QTS-AS)
2 2a00:1450:400... 15169 (GOOGLE)
1 52.35.70.100 16509 (AMAZON-02)
1 44.230.193.23 16509 (AMAZON-02)
1 2 185.33.221.91 29990 (ASN-APPNEX)
2 9 52.43.149.174 16509 (AMAZON-02)
2 2 52.223.40.198 16509 (AMAZON-02)
2 2 185.64.190.80 62713 (AS-PUBMATIC)
2 2 3.251.21.8 16509 (AMAZON-02)
2 2 52.50.101.149 16509 (AMAZON-02)
1 69.173.144.165 26667 (RUBICONPR...)
1 54.185.136.237 16509 (AMAZON-02)
2 99.86.3.4 16509 (AMAZON-02)
2 2a00:1450:400... 15169 (GOOGLE)
1 35.83.23.20 16509 (AMAZON-02)
1 2001:4de0:ac1... 20446 (HIGHWINDS3)
1 2a00:1450:400... 15169 (GOOGLE)
2 2a02:2638::3 44788 (ASN-CRITE...)
1 151.101.1.108 54113 (FASTLY)
1 2 2a02:2638::1c 44788 (ASN-CRITE...)
2 178.250.2.146 44788 (ASN-CRITE...)
1 51.89.7.110 16276 (OVH)
233 89
Apex Domain
Subdomains
Transfer
16 omeda.com
olytics.omeda.com — Cisco Umbrella Rank: 30868
cdn.omeda.com — Cisco Umbrella Rank: 47954
oqs.omeda.com — Cisco Umbrella Rank: 33396
165 KB
15 adnxs.com
ib.adnxs.com — Cisco Umbrella Rank: 241
prebid.adnxs.com — Cisco Umbrella Rank: 1759
secure.adnxs.com — Cisco Umbrella Rank: 404
acdn.adnxs.com — Cisco Umbrella Rank: 565
13 KB
14 dragonforms.com
sample.dragonforms.com — Cisco Umbrella Rank: 122221
hostedcontent.dragonforms.com — Cisco Umbrella Rank: 88834
89 KB
14 fiercepharma.com
www.fiercepharma.com — Cisco Umbrella Rank: 116131
c405.fiercepharma.com — Cisco Umbrella Rank: 406279 Failed
138 KB
12 ad.gt
a.ad.gt — Cisco Umbrella Rank: 5184
p.ad.gt — Cisco Umbrella Rank: 5806
ids.ad.gt — Cisco Umbrella Rank: 4690
pixels.ad.gt — Cisco Umbrella Rank: 5709
17 KB
11 onetag-sys.com
onetag-sys.com — Cisco Umbrella Rank: 1056
6 KB
11 yahoo.com
c2shb.ssp.yahoo.com — Cisco Umbrella Rank: 693
1 KB
10 criteo.com
bidder.criteo.com — Cisco Umbrella Rank: 722
gum.criteo.com — Cisco Umbrella Rank: 369
mug.criteo.com — Cisco Umbrella Rank: 2864
3 KB
10 doubleclick.net
securepubads.g.doubleclick.net — Cisco Umbrella Rank: 184
stats.g.doubleclick.net — Cisco Umbrella Rank: 96
cm.g.doubleclick.net — Cisco Umbrella Rank: 197
153 KB
9 rubiconproject.com
fastlane.rubiconproject.com — Cisco Umbrella Rank: 467
token.rubiconproject.com — Cisco Umbrella Rank: 689
11 KB
8 mediafuse.com
player.mediafuse.com — Cisco Umbrella Rank: 53525
player.hbmp.mediafuse.com — Cisco Umbrella Rank: 36214
ghb.hbmp.mediafuse.com — Cisco Umbrella Rank: 50582
173 KB
7 spotible.com
ads.spotible.com Failed
creative.spotible.com — Cisco Umbrella Rank: 70958
cdn.spotible.com — Cisco Umbrella Rank: 76793
211 KB
7 adtelligent.com
player.adtelligent.com — Cisco Umbrella Rank: 5710
ghb.adtelligent.com — Cisco Umbrella Rank: 5988
sync.adtelligent.com — Cisco Umbrella Rank: 2849
6 KB
7 crazyegg.com
script.crazyegg.com — Cisco Umbrella Rank: 2008
pagestates-tracking.crazyegg.com — Cisco Umbrella Rank: 3843
assets-tracking.crazyegg.com — Cisco Umbrella Rank: 3846
tracking.crazyegg.com — Cisco Umbrella Rank: 3831
29 KB
6 creativecdn.com
prebid-us.creativecdn.com — Cisco Umbrella Rank: 9562
prebid-eu.creativecdn.com — Cisco Umbrella Rank: 5646
1 KB
5 google-analytics.com
www.google-analytics.com — Cisco Umbrella Rank: 42
41 KB
4 b2c.com
api-54-185-136-237.b2c.com
v4-api-54-185-136-237.b2c.com
7 KB
4 pubmatic.com
hbopenbid.pubmatic.com — Cisco Umbrella Rank: 459
image2.pubmatic.com — Cisco Umbrella Rank: 1032
806 B
4 dpmsrv.com
s.dpmsrv.com — Cisco Umbrella Rank: 27632
a.dpmsrv.com — Cisco Umbrella Rank: 23211
42 KB
3 googlesyndication.com
88de716fcdb80ed5cefd22d492c50498.safeframe.googlesyndication.com
pagead2.googlesyndication.com — Cisco Umbrella Rank: 100
4 KB
3 ml314.com
ml314.com — Cisco Umbrella Rank: 1557
in.ml314.com — Cisco Umbrella Rank: 8786
13 KB
3 addtoany.com
static.addtoany.com — Cisco Umbrella Rank: 4404
60 KB
2 criteo.net
static.criteo.net — Cisco Umbrella Rank: 645
56 KB
2 googletagservices.com
www.googletagservices.com — Cisco Umbrella Rank: 165
2 bidr.io
match.prod.bidr.io — Cisco Umbrella Rank: 524
1 KB
2 360yield.com
ad.360yield.com — Cisco Umbrella Rank: 675
684 B
2 adsrvr.org
match.adsrvr.org — Cisco Umbrella Rank: 329
965 B
2 google.com
adservice.google.com — Cisco Umbrella Rank: 80
671 B
2 google.de
adservice.google.de — Cisco Umbrella Rank: 8028
914 B
2 a-mo.net
prebid.a-mo.net — Cisco Umbrella Rank: 1204
557 B
2 openx.net
adtelligent-d.openx.net — Cisco Umbrella Rank: 17971
u.openx.net — Cisco Umbrella Rank: 710
514 B
2 deepintent.com
prebid.deepintent.com — Cisco Umbrella Rank: 5893
235 B
2 nodserving.com
p.nodserving.com — Cisco Umbrella Rank: 23868
14 KB
2 parsely.com
cdn.parsely.com — Cisco Umbrella Rank: 2931
p1.parsely.com — Cisco Umbrella Rank: 2249
18 KB
2 marketo.net
munchkin.marketo.net — Cisco Umbrella Rank: 3672
6 KB
2 sitescout.com
pixel.sitescout.com — Cisco Umbrella Rank: 3536
191 B
2 basis.net
pixel-a.basis.net — Cisco Umbrella Rank: 16750
132 B
2 gstatic.com
fonts.gstatic.com
54 KB
2 googletagmanager.com
www.googletagmanager.com — Cisco Umbrella Rank: 78
93 KB
2 blueconic.net
cdn.blueconic.net — Cisco Umbrella Rank: 7691
questex.blueconic.net — Cisco Umbrella Rank: 164216
42 KB
2 googleapis.com
fonts.googleapis.com — Cisco Umbrella Rank: 47
ajax.googleapis.com — Cisco Umbrella Rank: 293
7 KB
1 id5-sync.com
id5-sync.com — Cisco Umbrella Rank: 596
538 B
1 jquery.com
code.jquery.com — Cisco Umbrella Rank: 584
29 KB
1 aufp.io
aufp.io — Cisco Umbrella Rank: 6490
3 KB
1 rlcdn.com
idsync.rlcdn.com — Cisco Umbrella Rank: 316
66 B
1 hybrid.ai
dm.hybrid.ai — Cisco Umbrella Rank: 6197
238 B
1 trafmag.com
t.trafmag.com — Cisco Umbrella Rank: 6679
351 B
1 fouanalytics.com
api.fouanalytics.com — Cisco Umbrella Rank: 10665
929 B
1 medidexs.com
sync.medidexs.com — Cisco Umbrella Rank: 33627
21 KB
1 servenobid.com
ads.servenobid.com — Cisco Umbrella Rank: 1823
638 B
1 media.net
prebid.media.net — Cisco Umbrella Rank: 1360
869 B
1 betweendigital.com
ads.betweendigital.com — Cisco Umbrella Rank: 1818
916 B
1 admixer.net
inv-nets.admixer.net — Cisco Umbrella Rank: 2627
510 B
1 casalemedia.com
htlb.casalemedia.com — Cisco Umbrella Rank: 461
336 B
1 contextweb.com
bid.contextweb.com — Cisco Umbrella Rank: 2792
572 B
1 lijit.com
ap.lijit.com — Cisco Umbrella Rank: 690
526 B
1 1rx.io
tag.1rx.io — Cisco Umbrella Rank: 1334
176 B
1 e-planning.net
pbjs.e-planning.net — Cisco Umbrella Rank: 7058
162 B
1 yieldmo.com
ads.yieldmo.com — Cisco Umbrella Rank: 670
229 B
1 colossusssp.com
colossusssp.com — Cisco Umbrella Rank: 2462
247 B
1 sonobi.com
apex.go.sonobi.com — Cisco Umbrella Rank: 1699
887 B
1 mktoresp.com
294-mqf-056.mktoresp.com — Cisco Umbrella Rank: 163244
311 B
1 zoominfo.com
ws.zoominfo.com — Cisco Umbrella Rank: 9204
1 KB
1 cloudfront.net
d1z2jf7jlzjs58.cloudfront.net
1 KB
1 marketo.com
app-sj10.marketo.com — Cisco Umbrella Rank: 162030
68 KB
1 qtxasset.com
qtxasset.com — Cisco Umbrella Rank: 90567
111 KB
0 adxpremium.services Failed
rtb.adxpremium.services Failed
233 67
Domain Requested by
13 olytics.omeda.com www.fiercepharma.com
www.googletagmanager.com
olytics.omeda.com
sample.dragonforms.com
12 www.fiercepharma.com www.fiercepharma.com
11 onetag-sys.com player.mediafuse.com
p.nodserving.com
11 c2shb.ssp.yahoo.com player.mediafuse.com
11 ib.adnxs.com 2 redirects player.mediafuse.com
p.nodserving.com
www.fiercepharma.com
10 sample.dragonforms.com 1 redirects www.fiercepharma.com
sample.dragonforms.com
code.jquery.com
9 ids.ad.gt 2 redirects www.fiercepharma.com
8 fastlane.rubiconproject.com player.mediafuse.com
6 bidder.criteo.com player.mediafuse.com
p.nodserving.com
6 securepubads.g.doubleclick.net www.fiercepharma.com
securepubads.g.doubleclick.net
5 creative.spotible.com securepubads.g.doubleclick.net
creative.spotible.com
www.fiercepharma.com
5 prebid-eu.creativecdn.com p.nodserving.com
5 ghb.adtelligent.com p.nodserving.com
player.mediafuse.com
5 ghb.hbmp.mediafuse.com player.hbmp.mediafuse.com
5 www.google-analytics.com www.googletagmanager.com
www.google-analytics.com
4 hostedcontent.dragonforms.com sample.dragonforms.com
hostedcontent.dragonforms.com
4 script.crazyegg.com www.googletagmanager.com
script.crazyegg.com
3 api-54-185-136-237.b2c.com 1 redirects www.fiercepharma.com
3 cm.g.doubleclick.net 2 redirects www.fiercepharma.com
3 a.dpmsrv.com www.fiercepharma.com
s.dpmsrv.com
3 static.addtoany.com www.fiercepharma.com
static.addtoany.com
2 mug.criteo.com www.fiercepharma.com
2 gum.criteo.com 1 redirects
2 static.criteo.net player.mediafuse.com
static.criteo.net
2 www.googletagservices.com olytics.omeda.com
2 cdn.spotible.com www.fiercepharma.com
2 match.prod.bidr.io 2 redirects
2 ad.360yield.com 2 redirects
2 image2.pubmatic.com 2 redirects
2 match.adsrvr.org 2 redirects
2 secure.adnxs.com 1 redirects acdn.adnxs.com
2 pagead2.googlesyndication.com olytics.omeda.com
2 oqs.omeda.com olytics.omeda.com
2 adservice.google.com securepubads.g.doubleclick.net
2 adservice.google.de securepubads.g.doubleclick.net
2 prebid.a-mo.net player.mediafuse.com
2 hbopenbid.pubmatic.com player.mediafuse.com
2 prebid.deepintent.com player.mediafuse.com
2 p.nodserving.com player.mediafuse.com
p.nodserving.com
2 ml314.com www.fiercepharma.com
ml314.com
2 c405.fiercepharma.com cdn.blueconic.net
2 munchkin.marketo.net www.fiercepharma.com
munchkin.marketo.net
2 pixel.sitescout.com www.fiercepharma.com
2 pixel-a.basis.net 2 redirects
2 fonts.gstatic.com fonts.googleapis.com
2 www.googletagmanager.com www.fiercepharma.com
sample.dragonforms.com
2 player.mediafuse.com www.fiercepharma.com
1 id5-sync.com player.mediafuse.com
1 acdn.adnxs.com p.nodserving.com
1 code.jquery.com sample.dragonforms.com
1 u.openx.net www.fiercepharma.com
1 pixels.ad.gt p.ad.gt
1 v4-api-54-185-136-237.b2c.com www.fiercepharma.com
1 token.rubiconproject.com www.fiercepharma.com
1 p.ad.gt a.ad.gt
1 aufp.io a.ad.gt
1 idsync.rlcdn.com www.fiercepharma.com
1 cdn.omeda.com sample.dragonforms.com
1 dm.hybrid.ai www.fiercepharma.com
1 t.trafmag.com www.fiercepharma.com
1 sync.adtelligent.com 1 redirects
1 api.fouanalytics.com player.hbmp.mediafuse.com
1 a.ad.gt player.hbmp.mediafuse.com
1 sync.medidexs.com player.hbmp.mediafuse.com
1 tracking.crazyegg.com script.crazyegg.com
1 88de716fcdb80ed5cefd22d492c50498.safeframe.googlesyndication.com securepubads.g.doubleclick.net
1 ads.servenobid.com player.mediafuse.com
1 prebid.media.net player.mediafuse.com
1 ads.betweendigital.com player.mediafuse.com
1 inv-nets.admixer.net player.mediafuse.com
1 adtelligent-d.openx.net player.mediafuse.com
1 htlb.casalemedia.com player.mediafuse.com
1 bid.contextweb.com player.mediafuse.com
1 ap.lijit.com player.mediafuse.com
1 tag.1rx.io player.mediafuse.com
1 prebid-us.creativecdn.com player.mediafuse.com
1 pbjs.e-planning.net player.mediafuse.com
1 ads.yieldmo.com player.mediafuse.com
1 colossusssp.com player.mediafuse.com
1 apex.go.sonobi.com player.mediafuse.com
1 prebid.adnxs.com player.mediafuse.com
1 in.ml314.com ml314.com
1 assets-tracking.crazyegg.com script.crazyegg.com
1 pagestates-tracking.crazyegg.com script.crazyegg.com
1 p1.parsely.com www.fiercepharma.com
1 player.adtelligent.com player.mediafuse.com
1 stats.g.doubleclick.net www.google-analytics.com
1 294-mqf-056.mktoresp.com munchkin.marketo.net
1 cdn.parsely.com d1z2jf7jlzjs58.cloudfront.net
1 ws.zoominfo.com www.fiercepharma.com
1 s.dpmsrv.com www.fiercepharma.com
1 player.hbmp.mediafuse.com player.mediafuse.com
1 d1z2jf7jlzjs58.cloudfront.net www.fiercepharma.com
1 questex.blueconic.net cdn.blueconic.net
1 app-sj10.marketo.com www.fiercepharma.com
1 ajax.googleapis.com www.fiercepharma.com
1 qtxasset.com www.fiercepharma.com
1 cdn.blueconic.net www.fiercepharma.com
1 fonts.googleapis.com www.fiercepharma.com
0 ads.spotible.com Failed www.fiercepharma.com
0 rtb.adxpremium.services Failed p.nodserving.com
233 101
Subject Issuer Validity Valid
sni.cloudflaressl.com
Cloudflare Inc ECC CA-3
2021-07-14 -
2022-07-13
a year crt.sh
upload.video.google.com
GTS CA 1C3
2022-01-10 -
2022-04-04
3 months crt.sh
*.blueconic.net
Amazon
2021-08-07 -
2022-09-05
a year crt.sh
player.mediafuse.com
R3
2022-01-15 -
2022-04-15
3 months crt.sh
*.g.doubleclick.net
GTS CA 1C3
2022-01-17 -
2022-04-11
3 months crt.sh
app-sj10.marketo.com
Cloudflare Inc ECC CA-3
2021-06-08 -
2022-06-07
a year crt.sh
*.google-analytics.com
GTS CA 1C3
2022-01-10 -
2022-04-04
3 months crt.sh
*.gstatic.com
GTS CA 1C3
2022-01-10 -
2022-04-04
3 months crt.sh
*.sitescout.com
GeoTrust TLS DV RSA Mixed SHA256 2020 CA-1
2021-12-15 -
2023-01-15
a year crt.sh
*.omeda.com
SSL.com RSA SSL subCA
2021-07-16 -
2022-07-21
a year crt.sh
*.cloudfront.net
Amazon
2021-03-19 -
2022-03-17
a year crt.sh
player.hbmp.mediafuse.com
R3
2021-12-12 -
2022-03-12
3 months crt.sh
*.marketo.net
DigiCert SHA2 Secure Server CA
2021-03-29 -
2022-04-06
a year crt.sh
*.dpmsrv.com
Amazon
2021-05-17 -
2022-06-15
a year crt.sh
zoominfo.com
Cloudflare Inc ECC CA-3
2021-06-04 -
2022-06-03
a year crt.sh
*.parsely.com
Amazon
2021-07-05 -
2022-08-03
a year crt.sh
*.ml314.com
Amazon
2021-12-17 -
2023-01-14
a year crt.sh
*.mktoresp.com
DigiCert TLS RSA SHA256 2020 CA1
2021-11-30 -
2022-11-30
a year crt.sh
ghb.hbmp.mediafuse.com
ZeroSSL ECC Domain Secure Site CA
2022-02-06 -
2022-05-07
3 months crt.sh
p.nodserving.com
R3
2021-12-19 -
2022-03-19
3 months crt.sh
player.adtelligent.com
R3
2022-01-18 -
2022-04-18
3 months crt.sh
ghb.adtelligent.com
ZeroSSL ECC Domain Secure Site CA
2022-02-06 -
2022-05-07
3 months crt.sh
*.crazyegg.com
DigiCert SHA2 Secure Server CA
2020-07-26 -
2022-07-23
2 years crt.sh
*.deepintent.com
Go Daddy Secure Certificate Authority - G2
2020-04-09 -
2022-06-08
2 years crt.sh
prebid.adnxs.com
GeoTrust TLS RSA CA G1
2020-03-29 -
2022-03-29
2 years crt.sh
web.ssp.yahoo.com
DigiCert SHA2 High Assurance Server CA
2021-10-14 -
2022-04-06
6 months crt.sh
*.rubiconproject.com
DigiCert TLS RSA SHA256 2020 CA1
2021-03-30 -
2022-04-04
a year crt.sh
*.go.sonobi.com
Go Daddy Secure Certificate Authority - G2
2021-12-08 -
2023-01-09
a year crt.sh
*.colossusssp.com
Go Daddy Secure Certificate Authority - G2
2021-11-07 -
2022-11-07
a year crt.sh
*.pubmatic.com
DigiCert Baltimore TLS RSA SHA256 2020 CA1
2021-08-04 -
2022-09-04
a year crt.sh
*.yieldmo.com
Amazon
2021-05-25 -
2022-06-23
a year crt.sh
*.e-planning.net
R3
2021-12-30 -
2022-03-30
3 months crt.sh
*.creativecdn.com
RapidSSL TLS DV RSA Mixed SHA256 2020 CA-1
2021-03-30 -
2022-04-12
a year crt.sh
*.1rx.io
Sectigo RSA Domain Validation Secure Server CA
2021-06-01 -
2022-07-02
a year crt.sh
*.lijit.com
Go Daddy Secure Certificate Authority - G2
2021-03-11 -
2022-04-12
a year crt.sh
*.contextweb.com
DigiCert SHA2 Secure Server CA
2020-05-07 -
2022-05-12
2 years crt.sh
san.casalemedia.com
GeoTrust RSA CA 2018
2021-12-12 -
2022-12-13
a year crt.sh
*.openx.net
GeoTrust RSA CA 2018
2021-07-08 -
2022-08-08
a year crt.sh
*.adnxs.com
GeoTrust ECC CA 2018
2021-03-05 -
2022-02-19
a year crt.sh
*.admixer.net
Sectigo ECC Domain Validation Secure Server CA
2021-11-16 -
2022-12-17
a year crt.sh
*.a-mo.net
R3
2021-12-28 -
2022-03-28
3 months crt.sh
*.onetag-sys.com
DigiCert TLS Hybrid ECC SHA384 2020 CA1
2022-01-10 -
2023-01-03
a year crt.sh
*.ads.betweendigital.com
Sectigo RSA Domain Validation Secure Server CA
2021-12-15 -
2023-01-15
a year crt.sh
*.criteo.com
DigiCert TLS Hybrid ECC SHA384 2020 CA1
2022-02-04 -
2022-05-03
3 months crt.sh
*.media.net
Sectigo RSA Domain Validation Secure Server CA
2021-04-12 -
2022-05-05
a year crt.sh
ads.servenobid.com
Amazon
2021-06-28 -
2022-07-27
a year crt.sh
*.google.de
GTS CA 1C3
2022-01-10 -
2022-04-04
3 months crt.sh
*.google.com
GTS CA 1C3
2022-01-17 -
2022-04-11
3 months crt.sh
sync.medidexs.com
R3
2022-01-09 -
2022-04-09
3 months crt.sh
*.ad.gt
Amazon
2021-06-09 -
2022-07-08
a year crt.sh
s827.travelagentcentral.com
Amazon
2021-10-12 -
2022-11-10
a year crt.sh
*.hybrid.ai
Sectigo RSA Domain Validation Secure Server CA
2020-07-07 -
2022-10-05
2 years crt.sh
*.spotible.com
Sectigo RSA Domain Validation Secure Server CA
2021-11-02 -
2022-12-03
a year crt.sh
*.rlcdn.com
Sectigo RSA Domain Validation Secure Server CA
2021-02-25 -
2022-03-28
a year crt.sh
aufp.io
Amazon
2021-11-26 -
2022-12-24
a year crt.sh
*.jquery.com
Sectigo RSA Domain Validation Secure Server CA
2021-07-14 -
2022-08-14
a year crt.sh
*.criteo.net
DigiCert TLS Hybrid ECC SHA384 2020 CA1
2022-02-02 -
2022-05-03
3 months crt.sh
cdn.adnxs.com
GlobalSign Organization Validated CA - SHA256 - G4
2021-05-10 -
2022-06-11
a year crt.sh
*.id5-sync.com
R3
2021-12-20 -
2022-03-20
3 months crt.sh

This page contains 15 frames:

Primary Page: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Frame ID: CDF0DAF442230834A8670964E41C5686
Requests: 159 HTTP requests in this frame

Frame: https://pixel.sitescout.com/dmp/asyncPixelSync
Frame ID: 651231E5D93932E5CA89C8F4CDA5D814
Requests: 1 HTTP requests in this frame

Frame: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
Frame ID: 8E4AEC592B3324920FBED30A41B56473
Requests: 22 HTTP requests in this frame

Frame: https://static.addtoany.com/menu/sm.23.html
Frame ID: 50062B843FD0E39FF16CCE6FE6B11B6A
Requests: 1 HTTP requests in this frame

Frame: https://p.nodserving.com/prebidlink/19031/j.html?i=11600
Frame ID: 447C03AC66B0E66C1A800AC242D2F308
Requests: 31 HTTP requests in this frame

Frame: https://88de716fcdb80ed5cefd22d492c50498.safeframe.googlesyndication.com/safeframe/1-0-38/html/container.html
Frame ID: 657DE867F8F6D3E99EF8B7A61D529066
Requests: 1 HTTP requests in this frame

Frame: https://ads.spotible.com/tag/universal-tag.js
Frame ID: 8F33F88E35F3AE1545909852532FA4D8
Requests: 2 HTTP requests in this frame

Frame: https://creative.spotible.com/tag/allstream.js
Frame ID: 8C21DAA01D0775930482FA637BD00421
Requests: 1 HTTP requests in this frame

Frame: https://creative.spotible.com/tag/storage-delegate.html
Frame ID: 9E390FF88D32E381A20508B3DA779214
Requests: 1 HTTP requests in this frame

Frame: https://acdn.adnxs.com/ib/static/usersync/v3/async_usersync.html
Frame ID: 4A1D415D12B99C0B530739A8DAA6A58C
Requests: 2 HTTP requests in this frame

Frame: https://onetag-sys.com/usync/?cb=1644329015956
Frame ID: 7C7680E15D3D681AC207B285B2DF27C6
Requests: 1 HTTP requests in this frame

Frame: https://onetag-sys.com/usync/?cb=1644329015958
Frame ID: C0BB7D4C792C5DA92064F718BC584B31
Requests: 1 HTTP requests in this frame

Frame: https://onetag-sys.com/usync/?cb=1644329015960
Frame ID: 6B8E311C3E8B78D1915E3992A72DB135
Requests: 1 HTTP requests in this frame

Frame: https://onetag-sys.com/usync/?cb=1644329015961
Frame ID: 717D7C5599079B03F234F8D239012494
Requests: 1 HTTP requests in this frame

Frame: https://onetag-sys.com/usync/?cb=1644329015963
Frame ID: 19DD3CCB736C41D6F2621838F03C9C67
Requests: 1 HTTP requests in this frame

Screenshot

Page Title

4. Deucravacitinib | FiercePharma

Detected technologies

Overall confidence: 100%
Detected patterns
  • addtoany\.com/menu/page\.js

Overall confidence: 100%
Detected patterns
  • adnxs\.(?:net|com)

Overall confidence: 100%
Detected patterns
  • script\.crazyegg\.com/pages/scripts/\d+/\d+\.js

Overall confidence: 100%
Detected patterns
  • googletagservices\.com/tag/js/gpt(?:_mobile)?\.js

Overall confidence: 100%
Detected patterns
  • googlesyndication\.com/

Overall confidence: 100%
Detected patterns
  • google-analytics\.com/(?:ga|urchin|analytics)\.js

Overall confidence: 100%
Detected patterns
  • googleapis\.com/.+webfont

Overall confidence: 100%
Detected patterns
  • googletagmanager\.com/gtm\.js

Overall confidence: 100%
Detected patterns
  • munchkin\.marketo\.\w+/(?:([\d.]+)/)?munchkin\.js

Overall confidence: 100%
Detected patterns
  • marketo\.\w+/js/forms(?:[\d.]+)/js/forms([\d.]+)\.min\.js

Overall confidence: 100%
Detected patterns
  • https?://[^/]*\.openx\.net

Overall confidence: 100%
Detected patterns
  • adnxs\.com/[^"]*(?:prebid|/pb\.js)

Overall confidence: 100%
Detected patterns
  • https?://[^/]*\.pubmatic\.com

Overall confidence: 100%
Detected patterns
  • https?://[^/]*\.rubiconproject\.com

Overall confidence: 100%
Detected patterns
  • jquery[.-]([\d.]*\d)[^/]*\.js
  • jquery.*\.js(?:\?ver(?:sion)?=([\d.]+))?

Page Statistics

233
Requests

91 %
HTTPS

24 %
IPv6

67
Domains

101
Subdomains

89
IPs

12
Countries

1713 kB
Transfer

4568 kB
Size

79
Cookies

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 23
  • https://pixel-a.basis.net/dmp/asyncPixelSync HTTP 301
  • https://pixel.sitescout.com/dmp/asyncPixelSync
Request Chain 24
  • https://pixel-a.basis.net/iap/7f1874304d399254 HTTP 301
  • https://pixel.sitescout.com/iap/7f1874304d399254
Request Chain 25
  • https://sample.dragonforms.com/FiercePharma_short HTTP 302
  • https://sample.dragonforms.com/init.do?omedasite=FiercePharma_short
Request Chain 44
  • https://ib.adnxs.com/getuid?https://a.dpmsrv.com/dpmpxl/index.php?id=$UID&q%3DxImp%26v%3D1.x%26cl%3D913%26pixelIndex%3D0%26r%3D718462%26tzOffset%3D0%26url%3Dhttps%253A%252F%252Fwww.fiercepharma.com%252Fspecial-report%252F10-most-anticipated-drug-launches-2022-4-deucravacitinib&_=1644329013515 HTTP 307
  • https://ib.adnxs.com/bounce?%2Fgetuid%3Fhttps%3A%2F%2Fa.dpmsrv.com%2Fdpmpxl%2Findex.php%3Fid%3D%24UID%26q%253DxImp%2526v%253D1.x%2526cl%253D913%2526pixelIndex%253D0%2526r%253D718462%2526tzOffset%253D0%2526url%253Dhttps%25253A%25252F%25252Fwww.fiercepharma.com%25252Fspecial-report%25252F10-most-anticipated-drug-launches-2022-4-deucravacitinib%26_%3D1644329013515 HTTP 302
  • https://a.dpmsrv.com/dpmpxl/index.php?id=5611407578940007418&q=xImp&v=1.x&cl=913&pixelIndex=0&r=718462&tzOffset=0&url=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&_=1644329013515
Request Chain 146
  • https://sync.adtelligent.com/csync?&redir=https%3A%2F%2Ft.trafmag.com%2Fimages%2Fimages%2F1px-matching-adtelligent.gif%3Fid%3D%7Buid%7D HTTP 302
  • https://t.trafmag.com/images/images/1px-matching-adtelligent.gif?id=dee7590cecd5b9a6
Request Chain 152
  • https://cm.g.doubleclick.net/pixel?google_nid=datapoint_dmp&google_cm&ap_id=5611407578940007418&pixelIndex=0&_=1644329013516 HTTP 302
  • https://a.dpmsrv.com/dpmpxl/index.php?q=dfp&ap_id=5611407578940007418&pixelIndex=0&_=1644329013516&google_gid=CAESEA3-l_Gnaz_pvXyZ-K0qbeA&google_cver=1
Request Chain 164
  • https://secure.adnxs.com/getuid?https://ids.ad.gt/api/v1/match?id=71ea94e0-0093-44cb-b4dd-d08066fc43e4&adnxs_id=$UID HTTP 302
  • https://ids.ad.gt/api/v1/match?id=71ea94e0-0093-44cb-b4dd-d08066fc43e4&adnxs_id=5611407578940007418
Request Chain 165
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=8gkxb6n&ttd_tpi=1&gpdr=0&ttd_puid=71ea94e0-0093-44cb-b4dd-d08066fc43e4 HTTP 302
  • https://match.adsrvr.org/track/cmb/generic?ttd_pid=8gkxb6n&ttd_tpi=1&gpdr=0&ttd_puid=71ea94e0-0093-44cb-b4dd-d08066fc43e4 HTTP 302
  • https://ids.ad.gt/api/v1/t_match?tdid=5f6d2359-c211-4f10-9b58-14dbad0adcf8&id=71ea94e0-0093-44cb-b4dd-d08066fc43e4
Request Chain 166
  • https://image2.pubmatic.com/AdServer/UCookieSetPug?rd=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fpbm_match%3Fpbm%3D%23PM_USER_ID%26id%3D71ea94e0-0093-44cb-b4dd-d08066fc43e4 HTTP 302
  • https://image2.pubmatic.com/AdServer/UCookieSetPug?ird=1&rd=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fpbm_match%3Fpbm%3D%23PM_USER_ID%26id%3D71ea94e0-0093-44cb-b4dd-d08066fc43e4 HTTP 302
  • https://ids.ad.gt/api/v1/pbm_match?pbm=BBFBF67E-52FE-430F-93B6-E6A55E905C12&id=71ea94e0-0093-44cb-b4dd-d08066fc43e4
Request Chain 167
  • https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_cm&google_sc&google_ula=450542624&id=71ea94e0-0093-44cb-b4dd-d08066fc43e4 HTTP 302
  • https://ids.ad.gt/api/v1/g_match?id=71ea94e0-0093-44cb-b4dd-d08066fc43e4&google_gid=CAESEK46dYDDn1ptvDyhgNKmnDA&google_cver=1&google_ula=450542624,0
Request Chain 168
  • https://ids.ad.gt/api/v1/g_hosted?id=71ea94e0-0093-44cb-b4dd-d08066fc43e4 HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_hm=NzFlYTk0ZTAtMDA5My00NGNiLWI0ZGQtZDA4MDY2ZmM0M2U0
Request Chain 169
  • https://ad.360yield.com/ux?&publisher_dmp_id=15&r=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fimpr_match%3Fid%3D71ea94e0-0093-44cb-b4dd-d08066fc43e4%26impr_uid%3D%7BPUB_USER_ID%7D HTTP 302
  • https://ad.360yield.com/ul_cb/ux?&publisher_dmp_id=15&r=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fimpr_match%3Fid%3D71ea94e0-0093-44cb-b4dd-d08066fc43e4%26impr_uid%3D%7BPUB_USER_ID%7D HTTP 302
  • https://ids.ad.gt/api/v1/impr_match?id=71ea94e0-0093-44cb-b4dd-d08066fc43e4&impr_uid=bcc9beb1-8e48-4422-8855-3bd127e27e5e
Request Chain 170
  • https://match.prod.bidr.io/cookie-sync/audigent?buyer_user_id=71ea94e0-0093-44cb-b4dd-d08066fc43e4 HTTP 303
  • https://match.prod.bidr.io/cookie-sync/audigent?buyer_user_id=71ea94e0-0093-44cb-b4dd-d08066fc43e4&_bee_ppp=1 HTTP 303
  • https://ids.ad.gt/api/v1/beeswax_match?beeswax_id=AAFhKk7EBPAAAAJ4odOVww&id=71ea94e0-0093-44cb-b4dd-d08066fc43e4
Request Chain 171
  • https://ids.ad.gt/api/v1/rub?id=71ea94e0-0093-44cb-b4dd-d08066fc43e4 HTTP 302
  • https://token.rubiconproject.com/token?pid=50242&puid=71ea94e0-0093-44cb-b4dd-d08066fc43e4&gdpr=0
Request Chain 172
  • https://api-54-185-136-237.b2c.com/api/x?OgzmBuJbPLPWQouR$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 HTTP 302
  • https://v4-api-54-185-136-237.b2c.com:444/api/4?OgzmBuJbPLPWQouR
Request Chain 230
  • https://gum.criteo.com/sid/json?origin=prebid&topUrl=https%3A%2F%2Fwww.fiercepharma.com%2F&domain=www.fiercepharma.com&cw=1&pbt=1&lsw=1 HTTP 302
  • https://mug.criteo.com/sid?cpp=DvZvzHwzWWNyRS9zbCtmQWFwQVBoT1BxeS9yMlhVc0pYbG9GZTczMWFZS3VVbE9OKzZBb0dWejV4ZHAyVjJwcmY4QUJGemFRdkg2Mmk4WWtXMmlUYVU0N2Rab04vUzBlNTJJR1d5SHRCelBJaStLeGhwZjdGZVdYWXlJTFhQZDFPc25DdmtueStDU29SUjlWNy83bnlhY09UOVRJOXMzd2h5RGlWdFhrNTAwRmc0RGw1d3VyeFVSdVNxbzR3TStYWmFScVhkTGdOOURZWnN4L1dlNW9GcHdnNlN1UkpiQmt3THFuNDVUNFNwYjU3RWhHN0d2Y2xlVXNIT2JJZTMyakRoMzlwfA&cppv=2

233 HTTP transactions

Resource
Path
Size
x-fer
Type
MIME-Type
Primary Request 10-most-anticipated-drug-launches-2022-4-deucravacitinib
www.fiercepharma.com/special-report/
70 KB
20 KB
Document
General
Full URL
https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
f43e5763cdf16e65fd23b9ff525d27d8cdc7a8a681708ee51026991d76e3c79a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Accept-Language
de-DE,de;q=0.9

Response headers

date
Tue, 08 Feb 2022 14:03:32 GMT
content-type
text/html; charset=UTF-8
cache-control
max-age=16588800, public
x-drupal-dynamic-cache
MISS
link
<https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib>; rel="canonical" <https://www.fiercepharma.com/node/518261>; rel="shortlink" <https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib>; rel="revision"
x-ua-compatible
IE=edge
content-language
en
x-content-type-options
nosniff
x-frame-options
SAMEORIGIN
expires
Sun, 19 Nov 1978 05:00:00 GMT
last-modified
Tue, 08 Feb 2022 14:03:32 GMT
vary
Cookie,Accept-Encoding
x-generator
Drupal 8 (https://www.drupal.org)
x-drupal-cache
MISS
x-request-id
v-e6327892-88e7-11ec-aef1-cba2e6898830
x-ah-environment
prod
via
varnish
x-cache
MISS
cf-cache-status
EXPIRED
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
server
cloudflare
cf-ray
6da566e5fafb90d6-FRA
content-encoding
br
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
css2
fonts.googleapis.com/
7 KB
1 KB
Stylesheet
General
Full URL
https://fonts.googleapis.com/css2?family=Overpass:ital,wght@0,400;0,700;0,900;1,400&display=swap
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82b::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
16bc5aa9539869018f77eb2a7edc3e56864ce7a05117202d044c7aed8caea080
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
x-xss-protection
0
last-modified
Tue, 08 Feb 2022 14:03:33 GMT
server
ESF
cross-origin-opener-policy
same-origin-allow-popups
date
Tue, 08 Feb 2022 14:03:33 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Tue, 08 Feb 2022 14:03:33 GMT
css_2cUrMdLa05pOjEKh0y2Vv3GJVjJ1S9FlveDonq3CWE8.css
www.fiercepharma.com/sites/fiercepharma/files/css/
8 KB
2 KB
Stylesheet
General
Full URL
https://www.fiercepharma.com/sites/fiercepharma/files/css/css_2cUrMdLa05pOjEKh0y2Vv3GJVjJ1S9FlveDonq3CWE8.css
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
2df8f7fcaa40376591e17d73d42fb68111d13f05c2feabbb9b89499d5a935ea0
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:33 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
HIT
age
404659
cf-polished
origSize=8029
x-cache
MISS
cf-bgj
minify
x-ah-environment
prod
content-encoding
br
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-request-id
v-884fe0da-6f5a-11ec-86a3-d3781fb1013f
x-robots-tag
noindex, nofollow
last-modified
Thu, 30 Dec 2021 18:15:55 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/css
cache-control
max-age=1209600
cf-ray
6da566eb6e9190d6-FRA
expires
Thu, 03 Feb 2022 07:03:31 GMT
css_OQCYQjGiXoYAdYeo0QfNaDBCZWYOPDNshs8IYXccnsY.css
www.fiercepharma.com/sites/fiercepharma/files/css/
605 KB
55 KB
Stylesheet
General
Full URL
https://www.fiercepharma.com/sites/fiercepharma/files/css/css_OQCYQjGiXoYAdYeo0QfNaDBCZWYOPDNshs8IYXccnsY.css
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
7533826884f96d6479ad16c923fb9ad6d9dad65930f9e3a4a5c82ebcdfd92f5c
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:33 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
HIT
age
15361
cf-polished
origSize=627000
x-cache
HIT
last-modified
Thu, 30 Dec 2021 18:15:55 GMT
x-cache-hits
67
x-ah-environment
prod
content-encoding
br
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-request-id
v-ce82ec8e-77c3-11ec-82b5-bf6f4cf2aaa7
x-robots-tag
noindex, nofollow
cf-bgj
minify
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/css
cache-control
max-age=1209600
cf-ray
6da566eb6e9490d6-FRA
expires
Mon, 14 Feb 2022 18:32:56 GMT
questex.js
cdn.blueconic.net/
141 KB
42 KB
Script
General
Full URL
https://cdn.blueconic.net/questex.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
65.9.63.73 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-65-9-63-73.fra56.r.cloudfront.net
Software
- /
Resource Hash
365bca218653492c7ccd4b2e285a3242b8f7d76fda1f62cd194eebf8f4a480a3
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 13:57:57 GMT
content-encoding
gzip
x-content-type-options
nosniff
x-permitted-cross-domain-policies
master-only
age
418
x-cache
Hit from cloudfront
content-length
42354
x-xss-protection
1; mode=block
last-modified
Wed, 19 Jan 2022 14:47:53 GMT
server
-
etag
"233e2-5d5f0787c7150-gzip"
vary
Accept-Encoding
content-type
text/javascript; charset=utf-8
via
1.1 910fc18161f0602555cc5b6397ca26f2.cloudfront.net (CloudFront)
cache-control
public, max-age=600, s-maxage=500
x-amz-cf-pop
FRA56-C1
accept-ranges
none
x-robots-tag
noindex, nofollow
x-amz-cf-id
ePp5u9iSPPLtlRXF1guKlG4T6YUlLxUSReiqVZnm9kMAyfhKD_fMLw==
logo-pharma.svg
www.fiercepharma.com/themes/custom/tektite_fierce/assets/images/logo/
4 KB
2 KB
Image
General
Full URL
https://www.fiercepharma.com/themes/custom/tektite_fierce/assets/images/logo/logo-pharma.svg?v=1.03
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
5f18dc38e84dbadb36b6e7d6da27e45e6fdf4c41ddac6a53452503922e96a73a
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:33 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
HIT
age
15454
x-cache
HIT
x-cache-hits
1
x-ah-environment
prod
content-encoding
br
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-request-id
v-0a9452a2-1947-11ec-986b-8bfed097753d
x-robots-tag
noindex, nofollow
last-modified
Tue, 31 Aug 2021 05:57:18 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
image/svg+xml
cache-control
max-age=1209600
cf-ray
6da566ec289e5bed-FRA
expires
Tue, 01 Feb 2022 12:27:41 GMT
BristolMyersSquibb.jpg
qtxasset.com/styles/breakpoint_xl_880px_w/s3/fiercepharma/1642681602/BristolMyersSquibb.jpg/
111 KB
111 KB
Image
General
Full URL
https://qtxasset.com/styles/breakpoint_xl_880px_w/s3/fiercepharma/1642681602/BristolMyersSquibb.jpg/BristolMyersSquibb.jpg?VersionId=AdZaqoFVRhdd3ZBuZzyhgWxAM7Es0gtz&itok=z94mDW5-
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.16.92.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
f05e455f97196795150073bcafe8d53f9f41a7defd1e6033c37b4bd34ec51231

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:33 GMT
cf-cache-status
HIT
age
102438
cf-polished
qual=85, origFmt=jpeg, origSize=402939
x-amz-replication-status
COMPLETED
content-length
113460
content-disposition
inline; filename="BristolMyersSquibb.webp"
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-amz-request-id
V0MVCZ03N361ND01
x-amz-id-2
l8U4HrbI/Y7ul2QutHOGY2QxGO1bY7FnPHx1K/5N55Xgau9+NPBUNugU8jFQfpqiKvNNoo54fs0=
last-modified
Thu, 20 Jan 2022 12:27:29 GMT
server
cloudflare
etag
"bb5678f142e86a1c2d1121f66e095e94"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept
content-type
image/webp
cache-control
public, max-age=604800
x-amz-version-id
AdZaqoFVRhdd3ZBuZzyhgWxAM7Es0gtz
accept-ranges
bytes
cf-ray
6da566ec793b905b-FRA
cf-bgj
imgq:85,h2pri
questex-logo-white.svg
www.fiercepharma.com/themes/custom/tektite/assets/images/
4 KB
2 KB
Image
General
Full URL
https://www.fiercepharma.com/themes/custom/tektite/assets/images/questex-logo-white.svg?v=0.1
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
680030a41d9b8dcd5edc79e159a420da353dd6638a041a6db69eb0df8b5073b2
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:33 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
HIT
age
498228
x-cache
HIT
x-cache-hits
3
x-ah-environment
prod
content-encoding
br
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-request-id
v-3fa602e8-23aa-11ec-8f9e-075ba2d22459
x-robots-tag
noindex, nofollow
last-modified
Tue, 31 Aug 2021 05:57:18 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
image/svg+xml
cache-control
max-age=1209600
cf-ray
6da566ec28a15bed-FRA
expires
Tue, 01 Feb 2022 12:27:41 GMT
hb_302826_6936.js
player.mediafuse.com/prebidlink/456758/
467 KB
140 KB
Script
General
Full URL
https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
45.133.44.3 Philadelphia, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software
nginx /
Resource Hash
cfe7744f8ac2b57c06c2b660fca24158c1856b663b0644355ddef5b32e3d1b63

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:33 GMT
content-encoding
gzip
last-modified
Tue, 08 Feb 2022 02:12:46 GMT
server
nginx
etag
W/"6201d19e-74a4d"
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=3600
expires
Tue, 08 Feb 2022 15:03:33 GMT
gpt.js
securepubads.g.doubleclick.net/tag/js/
80 KB
27 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/tag/js/gpt.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.250.184.226 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s12-in-f2.1e100.net
Software
sffe /
Resource Hash
f67a5337a8e4032d7c3a506c5065bf6aaf5cbde4a2d53756608dff852111ce48
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:33 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
27199
x-xss-protection
0
server
sffe
etag
"1125 / 680 of 1000 / last-modified: 1644322105"
vary
Accept-Encoding
report-to
{"group":"ads-gpt-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-gpt-scs"}]}
content-type
text/javascript
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="ads-gpt-scs"
expires
Tue, 08 Feb 2022 14:03:33 GMT
wrapper_hb_302826_6936.js
player.mediafuse.com/prebidlink/456758/
1 KB
841 B
Script
General
Full URL
https://player.mediafuse.com/prebidlink/456758/wrapper_hb_302826_6936.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
45.133.44.3 Philadelphia, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software
nginx /
Resource Hash
6325f7a25c4403ed680a95172069a4571086cbcbf4aac2ea1f028e8ced4818d8

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:33 GMT
content-encoding
gzip
last-modified
Tue, 08 Feb 2022 05:07:50 GMT
server
nginx
etag
W/"6201faa6-421"
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=3600
expires
Tue, 08 Feb 2022 15:03:33 GMT
js_c8LbWbHV1txem3q8oAzuadnL-HiBShaQH_WRviNqT_g.js
www.fiercepharma.com/sites/fiercepharma/files/js/
87 KB
32 KB
Script
General
Full URL
https://www.fiercepharma.com/sites/fiercepharma/files/js/js_c8LbWbHV1txem3q8oAzuadnL-HiBShaQH_WRviNqT_g.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
b541d631712bc34f7472aabf9cdeaf0fcb2257fd2436ffced1530f5d4f5a0383
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:33 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
HIT
age
15459
cf-polished
origSize=89478
x-cache
HIT
last-modified
Thu, 30 Dec 2021 18:15:57 GMT
x-cache-hits
41
x-ah-environment
prod
content-encoding
br
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-request-id
v-d25ab1a8-7164-11ec-9e34-1b558f64b334
x-robots-tag
noindex, nofollow
cf-bgj
minify
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/javascript
cache-control
max-age=1209600
cf-ray
6da566ebefe55bed-FRA
expires
Tue, 01 Feb 2022 13:57:21 GMT
js_hQSXU_zbJqof3y12MhPI7Ysd2kGl33cJXGVpYtnDbf0.js
www.fiercepharma.com/sites/fiercepharma/files/js/
16 KB
7 KB
Script
General
Full URL
https://www.fiercepharma.com/sites/fiercepharma/files/js/js_hQSXU_zbJqof3y12MhPI7Ysd2kGl33cJXGVpYtnDbf0.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
8111f22e56354c8880315afdd87fe63c7d82284596f7288969247a118accc642
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:33 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
HIT
age
15459
cf-polished
origSize=16281
x-cache
HIT
last-modified
Thu, 30 Dec 2021 18:15:57 GMT
x-cache-hits
17
x-ah-environment
prod
content-encoding
br
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-request-id
v-874103aa-7215-11ec-a44a-83c705574550
x-robots-tag
noindex, nofollow
cf-bgj
minify
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/javascript
cache-control
max-age=1209600
cf-ray
6da566ec28805bed-FRA
expires
Mon, 31 Jan 2022 09:15:07 GMT
page.js
static.addtoany.com/menu/
72 KB
26 KB
Script
General
Full URL
https://static.addtoany.com/menu/page.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:10::6816:47c5 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
f22120d1591b5397235fec8a01ffcc7d45fa6bd0b4cd6f93b8999c9365b359f1
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:33 GMT
via
e1s
x-content-type-options
nosniff
cf-cache-status
HIT
age
105957
p3p
CP="ALL DSP COR CURa ADMa DEVa TAIa PSAa PSDa OUR IND UNI COM NAV INT"
content-encoding
br
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
last-modified
Wed, 01 Dec 2021 08:23:25 GMT
server
cloudflare
etag
W/"11ee2-5d2116348919c"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
application/javascript; charset=utf-8
vary
Accept-Encoding
cache-control
public, max-age=172800
cf-ray
6da566ec6cbe5bf5-FRA
cf-bgj
minify
js_K8WjWylJMuC9X7UPhFnx2PKpGfKXSmt2neJ09X-RgCQ.js
www.fiercepharma.com/sites/fiercepharma/files/js/
21 KB
8 KB
Script
General
Full URL
https://www.fiercepharma.com/sites/fiercepharma/files/js/js_K8WjWylJMuC9X7UPhFnx2PKpGfKXSmt2neJ09X-RgCQ.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
9b17ed6f201a539d617120eb2b829a3a32a661daf2f04893c5978b25dd781034
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:33 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
HIT
age
15459
cf-polished
origSize=21128
x-cache
HIT
last-modified
Thu, 30 Dec 2021 18:15:57 GMT
x-cache-hits
16
x-ah-environment
prod
content-encoding
br
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-request-id
v-94fea102-6e2b-11ec-8e41-3325e2a98abd
x-robots-tag
noindex, nofollow
cf-bgj
minify
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/javascript
cache-control
max-age=1209600
cf-ray
6da566ec28865bed-FRA
expires
Fri, 04 Feb 2022 10:23:45 GMT
webfont.js
ajax.googleapis.com/ajax/libs/webfont/1.6.26/
13 KB
6 KB
Script
General
Full URL
https://ajax.googleapis.com/ajax/libs/webfont/1.6.26/webfont.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:827::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
81016ac6be850b72df5d4faa0c3cec8e2c1b0ba0045712144a6766adfad40bee
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Mon, 07 Feb 2022 22:38:54 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
55479
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/hosted-libraries-pushers
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
5437
x-xss-protection
0
last-modified
Tue, 03 Mar 2020 19:15:00 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="hosted-libraries-pushers"
vary
Accept-Encoding
report-to
{"group":"hosted-libraries-pushers","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/hosted-libraries-pushers"}]}
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
public, max-age=31536000, stale-while-revalidate=2592000
accept-ranges
bytes
timing-allow-origin
*
expires
Tue, 07 Feb 2023 22:38:54 GMT
js_6txShFh2kqJNyQ8zIiSXaxbK3dpMeRh5Z0PsEAh7qp8.js
www.fiercepharma.com/sites/fiercepharma/files/js/
762 B
722 B
Script
General
Full URL
https://www.fiercepharma.com/sites/fiercepharma/files/js/js_6txShFh2kqJNyQ8zIiSXaxbK3dpMeRh5Z0PsEAh7qp8.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
19d8552b92ae03e066893a9d818a5336bd0d107812dff3c05daef636d8750d38
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:33 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
HIT
age
15459
cf-polished
origSize=763
x-cache
HIT
last-modified
Thu, 30 Dec 2021 18:15:57 GMT
x-cache-hits
12
x-ah-environment
prod
content-encoding
br
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-request-id
v-99d5f14a-72bc-11ec-9c36-17d9743aa17f
x-robots-tag
noindex, nofollow
cf-bgj
minify
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/javascript
cache-control
max-age=1209600
cf-ray
6da566ec28a45bed-FRA
expires
Fri, 04 Feb 2022 10:12:35 GMT
forms2.min.js
app-sj10.marketo.com/js/forms2/js/
205 KB
68 KB
Script
General
Full URL
https://app-sj10.marketo.com/js/forms2/js/forms2.min.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.16.94.80 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
2689a0237a95cfd8135f8da3ac79c430e903f3c542f8b862f68141c84c348c43
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:33 GMT
content-encoding
gzip
x-content-type-options
nosniff
cf-cache-status
HIT
last-modified
Wed, 12 Jan 2022 18:47:30 GMT
server
cloudflare
age
941
etag
"1e40b8f-33210-5d567007b9480"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/x-javascript
cache-control
public, max-age=14400
cf-ray
6da566ee2cc79249-FRA
expires
Tue, 08 Feb 2022 18:03:33 GMT
js_7D5NINMm97AVjKhvsRV_XgPiqQeouLiSNcG1CZ8eWQM.js
www.fiercepharma.com/sites/fiercepharma/files/js/
5 KB
2 KB
Script
General
Full URL
https://www.fiercepharma.com/sites/fiercepharma/files/js/js_7D5NINMm97AVjKhvsRV_XgPiqQeouLiSNcG1CZ8eWQM.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
8f00fec474ffe65144177c5c92038cc7ce0695fc9975ebf2130d3bc393a3e645
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:33 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
HIT
age
15459
cf-polished
origSize=4669
x-cache
HIT
last-modified
Thu, 30 Dec 2021 18:15:58 GMT
x-cache-hits
1
x-ah-environment
prod
content-encoding
br
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-request-id
v-f4329574-6f1c-11ec-ae90-033872d0c646
x-robots-tag
noindex, nofollow
cf-bgj
minify
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/javascript
cache-control
max-age=1209600
cf-ray
6da566ec28985bed-FRA
expires
Thu, 03 Feb 2022 21:43:55 GMT
gtm.js
www.googletagmanager.com/
161 KB
56 KB
Script
General
Full URL
https://www.googletagmanager.com/gtm.js?id=GTM-KLQFWCZ
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:808::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
3aefa9d4ae02d3109f5686b2c422bb5cd6c902098f31e5fc123ea3ffa4646736
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:33 GMT
content-encoding
br
vary
Accept-Encoding
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
56392
x-xss-protection
0
last-modified
Tue, 08 Feb 2022 12:00:00 GMT
server
Google Tag Manager
strict-transport-security
max-age=31536000; includeSubDomains
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
access-control-allow-headers
Cache-Control
expires
Tue, 08 Feb 2022 14:03:33 GMT
qFdH35WCmI96Ajtm81GlU9s.woff2
fonts.gstatic.com/s/overpass/v10/
38 KB
38 KB
Font
General
Full URL
https://fonts.gstatic.com/s/overpass/v10/qFdH35WCmI96Ajtm81GlU9s.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css2?family=Overpass:ital,wght@0,400;0,700;0,900;1,400&display=swap
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:810::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
995dfb0c839090c9461662fca31b3d886f80dd9e881db8ea224374866eade55f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://fonts.googleapis.com/
Origin
https://www.fiercepharma.com
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Thu, 03 Feb 2022 03:01:59 GMT
x-content-type-options
nosniff
age
471694
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
38496
x-xss-protection
0
last-modified
Thu, 03 Feb 2022 00:25:12 GMT
server
sffe
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="apps-themes"
expires
Fri, 03 Feb 2023 03:01:59 GMT
cs
questex.blueconic.net/DG/DEFAULT/
0
0
Script
General
Full URL
https://questex.blueconic.net/DG/DEFAULT/cs?&callback=bc_json795
Requested by
Host: cdn.blueconic.net
URL: https://cdn.blueconic.net/questex.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.72.7.92 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-54-72-7-92.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

qFdU35WCmI96Ajtm81GgSdXCNs-VMF0vNLADeqqIncM.woff2
fonts.gstatic.com/s/overpass/v10/
16 KB
16 KB
Font
General
Full URL
https://fonts.gstatic.com/s/overpass/v10/qFdU35WCmI96Ajtm81GgSdXCNs-VMF0vNLADeqqIncM.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css2?family=Overpass:ital,wght@0,400;0,700;0,900;1,400&display=swap
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:810::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
94e5daea972ac93120f8535bff5a2bd57f1dc36dd36e5dbfe70639b75f1f8e33
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://fonts.googleapis.com/
Origin
https://www.fiercepharma.com
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Thu, 03 Feb 2022 10:53:47 GMT
x-content-type-options
nosniff
age
443386
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
16324
x-xss-protection
0
last-modified
Thu, 03 Feb 2022 00:25:41 GMT
server
sffe
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="apps-themes"
expires
Fri, 03 Feb 2023 10:53:47 GMT
fontello.woff2
www.fiercepharma.com/themes/custom/tektite/assets/fonts/
6 KB
7 KB
Font
General
Full URL
https://www.fiercepharma.com/themes/custom/tektite/assets/fonts/fontello.woff2
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/sites/fiercepharma/files/css/css_OQCYQjGiXoYAdYeo0QfNaDBCZWYOPDNshs8IYXccnsY.css
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
1daf67a5a85e55210b5e212a8be8392f1f93c01ce54effd63eab78f0b80dfb44
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.fiercepharma.com/sites/fiercepharma/files/css/css_OQCYQjGiXoYAdYeo0QfNaDBCZWYOPDNshs8IYXccnsY.css
Origin
https://www.fiercepharma.com
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:33 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
HIT
age
15350
x-cache
HIT
x-cache-hits
231
x-ah-environment
prod
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
content-length
6644
x-request-id
v-6f862608-28e3-11ec-a436-bbed65516c8b
x-robots-tag
noindex, nofollow
last-modified
Tue, 31 Aug 2021 05:57:18 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
cache-control
max-age=1209600
accept-ranges
bytes
cf-ray
6da566ec38ce5bed-FRA
expires
Sun, 30 Jan 2022 08:03:34 GMT
asyncPixelSync
pixel.sitescout.com/dmp/ Frame 6512
Redirect Chain
  • https://pixel-a.basis.net/dmp/asyncPixelSync
  • https://pixel.sitescout.com/dmp/asyncPixelSync
0
0
Document
General
Full URL
https://pixel.sitescout.com/dmp/asyncPixelSync
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
66.155.71.150 Portsmouth, United Kingdom, ASN13768 (COGECO-PEER1, CA),
Reverse DNS
Software
AC1.1 /
Resource Hash

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib

Response headers

cache-control
max-age=0,no-cache,no-store
pragma
no-cache
expires
Tue, 11 Oct 1977 12:34:56 GMT
p3p
CP="NON DEVa PSAa PSDa OUR NOR NAV",policyref="/w3c/p3p.xml"
date
Tue, 08 Feb 2022 14:03:32 GMT
server
AC1.1

Redirect headers

content-length
0
location
https://pixel.sitescout.com/dmp/asyncPixelSync
7f1874304d399254
pixel.sitescout.com/iap/
Redirect Chain
  • https://pixel-a.basis.net/iap/7f1874304d399254
  • https://pixel.sitescout.com/iap/7f1874304d399254
0
191 B
Image
General
Full URL
https://pixel.sitescout.com/iap/7f1874304d399254
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
H2
Server
66.155.71.150 Portsmouth, United Kingdom, ASN13768 (COGECO-PEER1, CA),
Reverse DNS
Software
AC1.1 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 08 Feb 2022 14:03:32 GMT
cache-control
max-age=0,no-cache,no-store
server
AC1.1
p3p
CP="NON DEVa PSAa PSDa OUR NOR NAV",policyref="/w3c/p3p.xml"
expires
Tue, 11 Oct 1977 12:34:56 GMT

Redirect headers

location
https://pixel.sitescout.com/iap/7f1874304d399254
content-length
0
init.do
sample.dragonforms.com/ Frame 8E4A
Redirect Chain
  • https://sample.dragonforms.com/FiercePharma_short
  • https://sample.dragonforms.com/init.do?omedasite=FiercePharma_short
279 B
620 B
Document
General
Full URL
https://sample.dragonforms.com/init.do?omedasite=FiercePharma_short
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.190 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
Software
Apache /
Resource Hash
82bf27f408e3d524f53a94492b845458ebb576e5873d57a452815f859953dff2
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/

Response headers

X-Content-Type-Options
nosniff
X-XSS-Protection
1; mode=block
Access-Control-Allow-Origin
*
Content-Type
text/html;charset=ISO-8859-1
Date
Tue, 08 Feb 2022 14:03:33 GMT
Server
Apache
Vary
Accept-Encoding
Content-Encoding
gzip
Transfer-Encoding
chunked

Redirect headers

Location
init.do?omedasite=FiercePharma_short
Content-Length
0
Date
Tue, 08 Feb 2022 14:03:33 GMT
Server
Apache
p.js
d1z2jf7jlzjs58.cloudfront.net/
930 B
1 KB
Script
General
Full URL
https://d1z2jf7jlzjs58.cloudfront.net/p.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/sites/fiercepharma/files/js/js_K8WjWylJMuC9X7UPhFnx2PKpGfKXSmt2neJ09X-RgCQ.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
65.9.58.62 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-65-9-58-62.fra56.r.cloudfront.net
Software
nginx /
Resource Hash
62f586be8571b23584eb4a60a45a3157ff7c8388b1b1e3b4e8890e243b3e47de

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Tue, 08 Feb 2022 04:13:53 GMT
Via
1.1 a383f82b5d4e98bbd66535c2c4b20c9e.cloudfront.net (CloudFront)
Age
84652
X-Cache
Hit from cloudfront
Connection
keep-alive
Content-Length
930
Pragma
public
Last-Modified
Wed, 06 May 2020 20:19:48 GMT
Server
nginx
ETag
"5eb31be4-3a2"
Content-Type
application/javascript
Cache-Control
max-age=86400, public
X-Amz-Cf-Pop
FRA56-C1
Accept-Ranges
bytes
X-Amz-Cf-Id
TGouGZfanYfJ1PqJTERCx1zN7qdqb2chkeaoTxV-35YJDawbxn6i3w==
Expires
Tue, 08 Feb 2022 14:32:41 GMT
sm.23.html
static.addtoany.com/menu/ Frame 5006
741 B
784 B
Document
General
Full URL
https://static.addtoany.com/menu/sm.23.html
Requested by
Host: static.addtoany.com
URL: https://static.addtoany.com/menu/page.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700:10::6816:47c5 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
4ca130786a2d2531241f8b8c7aaad6a4e27271f51b417b9c23f51bfb0c65c080
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/

Response headers

date
Tue, 08 Feb 2022 14:03:33 GMT
content-type
text/html; charset=utf-8
p3p
CP="ALL DSP COR CURa ADMa DEVa TAIa PSAa PSDa OUR IND UNI COM NAV INT"
last-modified
Wed, 22 Sep 2021 23:42:51 GMT
etag
W/"2e5-5cc9e128a4c38"
cache-control
max-age=315360000, immutable
vary
Accept-Encoding
via
e4s
cf-cache-status
HIT
age
1234996
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-content-type-options
nosniff
server
cloudflare
cf-ray
6da566ee19b26949-FRA
content-encoding
br
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
truncated
/
34 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
1e85ec81b9800b4c443d39caca0d0926089a3ac201120db1ceb45b93789480b8

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Content-Type
image/gif
icons.30.svg.js
static.addtoany.com/menu/svg/
77 KB
33 KB
Script
General
Full URL
https://static.addtoany.com/menu/svg/icons.30.svg.js
Requested by
Host: static.addtoany.com
URL: https://static.addtoany.com/menu/page.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700:10::6816:47c5 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
7e6f3eacf6af919ace45f10e39eda3e72143e0f57aad29590a6d37d5ddd0292f
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:33 GMT
via
e3s
x-content-type-options
nosniff
cf-cache-status
HIT
age
1272797
p3p
CP="ALL DSP COR CURa ADMa DEVa TAIa PSAa PSDa OUR IND UNI COM NAV INT"
content-encoding
br
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
last-modified
Wed, 10 Nov 2021 01:49:04 GMT
server
cloudflare
etag
W/"132a9-5d0656e4a26b3"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
application/javascript; charset=utf-8
vary
Accept-Encoding
cache-control
max-age=315360000, immutable
cf-ray
6da566ee199b6949-FRA
cf-bgj
minify
hbw_master_302826_6936.js
player.hbmp.mediafuse.com/prebidlink/456758/
95 KB
30 KB
Script
General
Full URL
https://player.hbmp.mediafuse.com/prebidlink/456758/hbw_master_302826_6936.js
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/wrapper_hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
45.133.44.4 Philadelphia, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software
nginx /
Resource Hash
4d31dc39c5de30ffabb9f461e50ba53f19f5b2453451d4c2dcb90687d0aa6775

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:33 GMT
content-encoding
gzip
last-modified
Tue, 08 Feb 2022 05:07:50 GMT
server
nginx
etag
W/"6201faa6-17d96"
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=3600
expires
Tue, 08 Feb 2022 15:03:33 GMT
analytics.js
www.google-analytics.com/
49 KB
20 KB
Script
General
Full URL
https://www.google-analytics.com/analytics.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-KLQFWCZ
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:810::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
a1925038db769477ab74b4df34350c35688a795bb718727b0f4292a4a78a6210
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

strict-transport-security
max-age=10886400; includeSubDomains; preload
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Tue, 02 Nov 2021 17:39:06 GMT
server
Golfe2
age
1719
date
Tue, 08 Feb 2022 13:34:54 GMT
vary
Accept-Encoding
content-type
text/javascript
cache-control
public, max-age=7200
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
20006
expires
Tue, 08 Feb 2022 15:34:54 GMT
4740.js
script.crazyegg.com/pages/scripts/0092/
5 KB
2 KB
Script
General
Full URL
https://script.crazyegg.com/pages/scripts/0092/4740.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-KLQFWCZ
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6813:9308 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
daaf47e176780239d864e64b1729d088b9e9a005e19b1bd39fda65dee2e26a6f

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:33 GMT
content-encoding
gzip
cf-cache-status
HIT
age
3937
cf-polished
origSize=4899
cf-ray
6da566ee2b2f5c68-FRA
ce-version
11.1.381
last-modified
Tue, 08 Feb 2022 12:57:56 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/javascript
access-control-allow-origin
*
access-control-expose-headers
CE-Version
cache-control
public, max-age=300, s-maxage=1209600
timing-allow-origin
*
cf-bgj
minify
munchkin.js
munchkin.marketo.net/
1 KB
1 KB
Script
General
Full URL
https://munchkin.marketo.net/munchkin.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
104.111.234.67 Frankfurt am Main, Germany, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-234-67.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
4bf3aca933aa233702f890083af601fb16149ec8a17f8c1b90d30450562bde08

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Tue, 08 Feb 2022 14:03:33 GMT
Content-Encoding
gzip
Last-Modified
Fri, 29 Oct 2021 01:24:07 GMT
Server
AkamaiNetStorage
ETag
"461ce1cffaadfebf2e7659745618ba8e:1635470647.434977"
Vary
Accept-Encoding
P3P
policyref="http://www.marketo.com/w3c/p3p.xml", CP="NOI DSP COR NID CURi OUR NOR"
Connection
keep-alive
Accept-Ranges
bytes
Content-Type
application/x-javascript
Content-Length
753
dpm_fa5b7e293127b3837c39f7fbd05598f32c8ce1c9.min.js
s.dpmsrv.com/
127 KB
39 KB
Script
General
Full URL
https://s.dpmsrv.com/dpm_fa5b7e293127b3837c39f7fbd05598f32c8ce1c9.min.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
143.204.215.21 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-143-204-215-21.fra53.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
9d2da124cff01ac4a3756346555d1f2cf049de603f2fb44a5d9fcb973a85686d

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Mon, 07 Feb 2022 15:42:58 GMT
Content-Encoding
gzip
Last-Modified
Thu, 03 Feb 2022 15:40:11 GMT
Server
AmazonS3
Age
80579
ETag
"bef77cacda1dde40b3506b2bde1566de"
X-Cache
Hit from cloudfront
Content-Type
application/x-javascript
Via
1.1 ab39b007ab81966ada6e7fb1536bf376.cloudfront.net (CloudFront)
Connection
keep-alive
X-Amz-Cf-Pop
FRA53-C1
Accept-Ranges
bytes
Content-Length
39698
X-Amz-Cf-Id
aa6gEEo0YVV1hGGbxeKHXV-tLYh_62huYGqGWFsholNeMRaPCB5TrQ==
WgRbL7NLS90BFPSb6pBa
ws.zoominfo.com/pixel/
1 KB
1 KB
Script
General
Full URL
https://ws.zoominfo.com/pixel/WgRbL7NLS90BFPSb6pBa
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6810:a852 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare / Express
Resource Hash
ba8a68a79c27e3e5c5e617a1d99422de0ef3185b8937269e18c584ed86a6cb60
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:33 GMT
content-encoding
gzip
x-content-type-options
nosniff
cf-cache-status
DYNAMIC
server
cloudflare
x-powered-by
Express
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/javascript
access-control-allow-origin
*
access-control-allow-credentials
true
cf-ray
6da566ee3bbe92b1-FRA
access-control-allow-headers
Content-Type,cf-ipcountry,service-version,x-appengine-user-ip,x-forwarded-for
via
1.1 google
olytics.min.js
olytics.omeda.com/olytics/js/v3/p/
271 KB
73 KB
Script
General
Full URL
https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash
d3db6456c45bfe697359d0c3c52564b0661ec8ad2f1b8de6e0c1926a90f44d8c
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Tue, 08 Feb 2022 14:03:33 GMT
Content-Encoding
gzip
X-Content-Type-Options
nosniff
Last-Modified
Tue, 18 Jan 2022 16:42:56 GMT
Server
Apache
ETag
W/"277838-1642524176000"
X-Frame-Options
SAMEORIGIN
Content-Type
application/javascript
Access-Control-Allow-Origin
*
Cache-Control
max-age=21600
Transfer-Encoding
chunked
Accept-Ranges
bytes
vary
accept-encoding
X-XSS-Protection
1; mode=block
Expires
Tue, 08 Feb 2022 20:03:33 GMT
olytics.css
olytics.omeda.com/olytics/css/v3/p/
28 KB
3 KB
Stylesheet
General
Full URL
https://olytics.omeda.com/olytics/css/v3/p/olytics.css
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-KLQFWCZ
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash
78057ff881c7ceb369c163fee7ab0d93ae4754f3a7503d5dbfd4a0b80e203a79
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Tue, 08 Feb 2022 14:03:33 GMT
Content-Encoding
gzip
X-Content-Type-Options
nosniff
Last-Modified
Fri, 27 Aug 2021 04:05:28 GMT
Server
Apache
ETag
W/"28820-1630037128000"
X-Frame-Options
SAMEORIGIN
Content-Type
text/css
Access-Control-Allow-Origin
*
Cache-Control
max-age=21600
Transfer-Encoding
chunked
Accept-Ranges
bytes
vary
accept-encoding
X-XSS-Protection
1; mode=block
Expires
Tue, 08 Feb 2022 20:03:33 GMT
794
c405.fiercepharma.com/DG/DEFAULT/rest/rpc/
0
0

pubads_impl_2022020301.js
securepubads.g.doubleclick.net/gpt/
351 KB
119 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022020301.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/tag/js/gpt.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.184.226 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s12-in-f2.1e100.net
Software
sffe /
Resource Hash
05ed7424c6f3c3d2aec5dfe7fa92e5f617afe58a01666c1c584d342a8b57a0e7
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 13:59:21 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
252
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
122037
x-xss-protection
0
last-modified
Thu, 03 Feb 2022 09:34:49 GMT
server
sffe
vary
Accept-Encoding
report-to
{"group":"ads-gpt-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-gpt-scs"}]}
content-type
text/javascript
cache-control
public, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="ads-gpt-scs"
expires
Wed, 08 Feb 2023 13:59:21 GMT
ppub_config
securepubads.g.doubleclick.net/pagead/
39 B
79 B
XHR
General
Full URL
https://securepubads.g.doubleclick.net/pagead/ppub_config?ippd=www.fiercepharma.com
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/tag/js/gpt.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.184.226 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s12-in-f2.1e100.net
Software
cafe /
Resource Hash
2ad9341e45c5e7676ed8925d391b5a96802a29c898d1e4909c4537c0f5a6a2ce
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 08 Feb 2022 14:03:33 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private, max-age=3600, stale-while-revalidate=3600
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/json; charset=UTF-8
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
55
x-xss-protection
0
expires
Tue, 08 Feb 2022 14:03:33 GMT
p.js
cdn.parsely.com/keys/fiercepharma.com/
47 KB
18 KB
Script
General
Full URL
https://cdn.parsely.com/keys/fiercepharma.com/p.js
Requested by
Host: d1z2jf7jlzjs58.cloudfront.net
URL: https://d1z2jf7jlzjs58.cloudfront.net/p.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
65.9.61.60 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-65-9-61-60.fra56.r.cloudfront.net
Software
nginx /
Resource Hash
e1feaafecf95d6dfa9fd5dc4ade49fcb29c6a697c713e423940b83e00ae3ad35

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

pragma
public
date
Mon, 07 Feb 2022 20:26:11 GMT
content-encoding
gzip
last-modified
Fri, 02 Jul 2021 02:33:20 GMT
server
nginx
age
63442
etag
W/"60de7af0-bd27"
x-cache
Hit from cloudfront
content-type
application/javascript
via
1.1 f358cf5f46d10c349187abd5e20e06ce.cloudfront.net (CloudFront)
cache-control
max-age=86400, public
x-amz-cf-pop
FRA56-C1
x-amz-cf-id
OFKeieNmfArq0Y-eqZhw7mgFqUnZY83IdYzDXx3Pu1VpF2FcJKrFHA==
expires
Tue, 08 Feb 2022 20:26:11 GMT
munchkin.js
munchkin.marketo.net/161/
11 KB
5 KB
Script
General
Full URL
https://munchkin.marketo.net/161/munchkin.js
Requested by
Host: munchkin.marketo.net
URL: https://munchkin.marketo.net/munchkin.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
104.111.234.67 Frankfurt am Main, Germany, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-234-67.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
c2aee78040b4ed46c2377e6825db12a9691a2eb584adf338e77312c8978d8537

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Tue, 08 Feb 2022 14:03:33 GMT
Content-Encoding
gzip
Last-Modified
Wed, 08 Sep 2021 00:38:21 GMT
Server
AkamaiNetStorage
ETag
"0e0eefac8daf874e8b1aa34aeb160c52:1631061501.737429"
Vary
Accept-Encoding
P3P
policyref="http://www.marketo.com/w3c/p3p.xml", CP="NOI DSP COR NID CURi OUR NOR"
Cache-Control
max-age=8640000
Connection
keep-alive
Accept-Ranges
bytes
Content-Type
application/x-javascript
Content-Length
4681
Expires
Thu, 19 May 2022 14:03:33 GMT
collect
www.google-analytics.com/j/
2 B
22 B
XHR
General
Full URL
https://www.google-analytics.com/j/collect?v=1&_v=j96&a=2005409921&t=pageview&_s=1&dl=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&ul=en-us&de=UTF-8&dt=4.%20Deucravacitinib%20%7C%20FiercePharma&sd=24-bit&sr=1600x1200&vp=1600x1200&je=0&_u=YGBACAABBAAAAC~&jid=1061368758&gjid=1052400620&cid=800578055.1644329014&tid=UA-336524-28&_gid=421591499.1644329014&_r=1&gtm=2wg220KLQFWCZ&z=457728274
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:810::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
de3246094525b21a870fc7d2a67490d0132535c6fa5993755c549f1a9d1bd8af
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 08 Feb 2022 14:03:33 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
2
expires
Fri, 01 Jan 1990 00:00:00 GMT
index.php
a.dpmsrv.com/dpmpxl/
Redirect Chain
  • https://ib.adnxs.com/getuid?https://a.dpmsrv.com/dpmpxl/index.php?id=$UID&q%3DxImp%26v%3D1.x%26cl%3D913%26pixelIndex%3D0%26r%3D718462%26tzOffset%3D0%26url%3Dhttps%253A%252F%252Fwww.fiercepharma.com...
  • https://ib.adnxs.com/bounce?%2Fgetuid%3Fhttps%3A%2F%2Fa.dpmsrv.com%2Fdpmpxl%2Findex.php%3Fid%3D%24UID%26q%253DxImp%2526v%253D1.x%2526cl%253D913%2526pixelIndex%253D0%2526r%253D718462%2526tzOffset%25...
  • https://a.dpmsrv.com/dpmpxl/index.php?id=5611407578940007418&q=xImp&v=1.x&cl=913&pixelIndex=0&r=718462&tzOffset=0&url=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-...
244 B
992 B
Script
General
Full URL
https://a.dpmsrv.com/dpmpxl/index.php?id=5611407578940007418&q=xImp&v=1.x&cl=913&pixelIndex=0&r=718462&tzOffset=0&url=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&_=1644329013515
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
HTTP/1.1
Server
3.226.203.17 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-226-203-17.compute-1.amazonaws.com
Software
/
Resource Hash
404035635d522c9a85543004f6d196333741e1def8b9301ce992f3e7ca6356eb

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Pragma
no-cache
content-encoding
gzip
Access-Control-Max-Age
10
Access-Control-Allow-Methods
GET, POST, PUT, DELETE, OPTIONS
P3P
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
Access-Control-Allow-Origin
*
Cache-Control
no-cache, no-store, must-revalidate
Connection
keep-alive
Content-Type
text/javascript
Access-Control-Allow-Headers
content-type, accept
Content-Length
215
Expires
0

Redirect headers

Pragma
no-cache
Date
Tue, 08 Feb 2022 14:03:33 GMT
X-Proxy-Origin
84.19.175.183; 84.19.175.183; 691.bm-nginx-loadbalancer.mgmt.fra1; adnxs.com
AN-X-Request-Uuid
fe92bba4-32fa-4915-9a18-046e8427fd45
Server
nginx/1.17.9
Access-Control-Allow-Origin
*
P3P
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Location
https://a.dpmsrv.com/dpmpxl/index.php?id=5611407578940007418&q=xImp&v=1.x&cl=913&pixelIndex=0&r=718462&tzOffset=0&url=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&_=1644329013515
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
text/html; charset=utf-8
Content-Length
0
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
4740.json
script.crazyegg.com/pages/data-scripts/0092/
18 KB
2 KB
XHR
General
Full URL
https://script.crazyegg.com/pages/data-scripts/0092/4740.json?t=1
Requested by
Host: script.crazyegg.com
URL: https://script.crazyegg.com/pages/scripts/0092/4740.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6813:9308 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
e062944d38e4916266dd0b916d7e59de57b659cf4fcd675e08a3a5c698780bbc

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:33 GMT
content-encoding
gzip
cf-cache-status
HIT
age
3735
ce-version
11.1.381
content-length
1899
timing-allow-origin
*
last-modified
Tue, 08 Feb 2022 13:01:18 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
*
access-control-expose-headers
CE-Version
cache-control
public, max-age=300, s-maxage=1209600
accept-ranges
bytes
cf-ray
6da566eeff8e90a8-FRA
tag.aspx
ml314.com/
27 KB
12 KB
Script
General
Full URL
https://ml314.com/tag.aspx?812022
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.208.138.90 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-208-138-90.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
e0eb74c400dded823098e4cdb9f71e9b360a3f33cad9b346879205851e70f887

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Tue, 08 Feb 2022 14:03:33 GMT
Content-Encoding
gzip
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
Content-Type
application/javascript
Cache-Control
public, max-age=86400
Connection
keep-alive
Content-Length
11617
lead
www.fiercepharma.com/api/v1/marketo/
34 B
563 B
Fetch
General
Full URL
https://www.fiercepharma.com/api/v1/marketo/lead?mkto=null&blueconicProfileId=null
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.14.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
336a2c6b0eaf929e5c5be1659be540dcc2cd6df5cc2971ecf4d65480f7505609
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:33 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
HIT
age
1104344
x-cache
HIT
content-type
application/json
x-drupal-dynamic-cache
UNCACHEABLE
x-ah-environment
prod
content-encoding
br
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-request-id
v-e2047ce8-76c7-11ec-a3f1-a3c97edf9918
x-ua-compatible
IE=edge
last-modified
Sun, 16 Jan 2022 12:29:00 GMT
server
cloudflare
x-frame-options
SAMEORIGIN
etag
W/"1642336140"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Cookie,Accept-Encoding
content-language
en
x-generator
Drupal 8 (https://www.drupal.org)
expires
Sun, 19 Nov 1978 05:00:00 GMT
cache-control
max-age=16588800, public
cf-ray
6da566eedf535bed-FRA
x-drupal-cache
MISS
x-cache-hits
54
visitWebPage
294-mqf-056.mktoresp.com/webevents/
2 B
311 B
Ping
General
Full URL
https://294-mqf-056.mktoresp.com/webevents/visitWebPage?_mchNc=1644329013575&_mchCn=&_mchId=294-MQF-056&_mchTk=_mch-fiercepharma.com-1644329013575-25283&_mchHo=www.fiercepharma.com&_mchPo=&_mchRu=%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&_mchPc=https%3A&_mchVr=161&_mchEcid=&_mchHa=&_mchRe=&_mchQp=
Requested by
Host: munchkin.marketo.net
URL: https://munchkin.marketo.net/161/munchkin.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
192.28.147.68 , United States, ASN15224 (OMNITURE, US),
Reverse DNS
Software
nginx /
Resource Hash
565339bc4d33d72817b583024112eb7f5cdf3e5eef0252d6ec1b9c9a94e12bb3

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Date
Tue, 08 Feb 2022 14:03:34 GMT
Content-Encoding
gzip
Server
nginx
Transfer-Encoding
chunked
Content-Type
text/plain; charset=UTF-8
Access-Control-Allow-Origin
*
Connection
keep-alive
X-Request-Id
9795641b-ed8c-4d18-b158-1a8cde0bf456
/
ghb.hbmp.mediafuse.com/geo/
142 B
398 B
XHR
General
Full URL
https://ghb.hbmp.mediafuse.com/geo/
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/456758/hbw_master_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
2a0c:5c81:5142::2 London, United Kingdom, ASN55081 (24SHELLS, US),
Reverse DNS
Software
VertaMedia 1.0 /
Resource Hash
c1ec65706585d1f809e5c8e8eb105d5a55f9b3cbf20bea45cb546ec2b3f9fde3

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Access-Control-Allow-Origin
https://www.fiercepharma.com
Date
Tue, 08 Feb 2022 14:03:33 GMT
Access-Control-Allow-Credentials
true
Server
VertaMedia 1.0
Connection
Keep-Alive
Content-Length
142
Content-Type
application/json
tracking
ghb.hbmp.mediafuse.com/adunit/
43 B
425 B
XHR
General
Full URL
https://ghb.hbmp.mediafuse.com/adunit/tracking?event=11&type=0&client_id=302826&site_id=6936&full_page_url=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&adid=e71ezv.sf&features=32&vpbv=N048&lifecycle_tte=1495
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/456758/hbw_master_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
2a0c:5c81:5142::2 London, United Kingdom, ASN55081 (24SHELLS, US),
Reverse DNS
Software
VertaMedia 1.0 /
Resource Hash
2dfe28cbdb83f01c940de6a88ab86200154fd772d568035ac568664e52068363

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Access-Control-Allow-Origin
https://www.fiercepharma.com
Date
Tue, 08 Feb 2022 14:03:33 GMT
Access-Control-Allow-Credentials
true
Server
VertaMedia 1.0
Connection
Keep-Alive
Content-Length
43
Content-Type
image/gif
j.html
p.nodserving.com/prebidlink/19031/ Frame 447C
1 KB
879 B
Document
General
Full URL
https://p.nodserving.com/prebidlink/19031/j.html?i=11600
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
45.133.44.4 Philadelphia, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software
nginx /
Resource Hash
cf35c9e8af47d8cd7233bebf1b785af16546782547f31501432cb7ad97d84714

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/

Response headers

date
Tue, 08 Feb 2022 14:03:33 GMT
content-type
text/html; charset=utf-8
server
nginx
last-modified
Wed, 16 Sep 2020 14:50:15 GMT
etag
W/"5f622627-434"
cache-control
max-age=3600
content-encoding
gzip
expires
Tue, 08 Feb 2022 15:03:33 GMT
access-control-allow-origin
*
collect
stats.g.doubleclick.net/j/
1 B
443 B
XHR
General
Full URL
https://stats.g.doubleclick.net/j/collect?t=dc&aip=1&_r=3&v=1&_v=j96&tid=UA-336524-28&cid=800578055.1644329014&jid=1061368758&gjid=1052400620&_gid=421591499.1644329014&_u=YGBACAAABAAAAC~&z=779059295
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:400c:c08::9c Brussels, Belgium, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
6b86b273ff34fce19d6b804eff5a3f5747ada4eaa22f1d49c01e52ddb7875b4b
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
strict-transport-security
max-age=10886400; includeSubDomains; preload
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
date
Tue, 08 Feb 2022 14:03:33 GMT
content-type
text/plain
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
1
expires
Fri, 01 Jan 1990 00:00:00 GMT
config.json
player.adtelligent.com/exchange_rates/279934/
9 KB
4 KB
XHR
General
Full URL
https://player.adtelligent.com/exchange_rates/279934/config.json?cb=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
45.133.44.4 Philadelphia, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software
nginx /
Resource Hash
de7174e4a1d44716d1acc4bb9b0e64bcc9ad77bc1ca0a561077e86587c17339b

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 08 Feb 2022 14:03:33 GMT
content-encoding
gzip
last-modified
Tue, 08 Feb 2022 12:01:05 GMT
server
nginx
etag
W/"62025b81-2204"
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
expires
Tue, 08 Feb 2022 15:03:33 GMT
cache-control
max-age=3600
x-proxy-cache
HIT
/
p1.parsely.com/plogger/
43 B
258 B
Image
General
Full URL
https://p1.parsely.com/plogger/?rand=1644329013621&plid=83083648&idsite=fiercepharma.com&url=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&urlref=&screen=1600x1200%7C1600x1200%7C24&data=%7B%7D&sid=1&surl=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&sref=&sts=1644329013617&slts=0&title=4.+Deucravacitinib+%7C+FiercePharma&date=Tue+Feb+08+2022+14%3A03%3A33+GMT%2B0000+(GMT)&action=pageview&pvid=22527747&u=pid%3D7c909c60890d123c6bb653f8bb6696b3
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.194.161.83 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-194-161-83.compute-1.amazonaws.com
Software
nginx /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Tue, 08 Feb 2022 14:03:34 GMT
Cache-Control
no-cache
Last-Modified
Tuesday, 08-Feb-2022 14:03:34 GMT
Server
nginx
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
11.1.381.js
script.crazyegg.com/pages/versioned/common-scripts/
72 KB
23 KB
Script
General
Full URL
https://script.crazyegg.com/pages/versioned/common-scripts/11.1.381.js
Requested by
Host: script.crazyegg.com
URL: https://script.crazyegg.com/pages/scripts/0092/4740.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6813:9308 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
dbd801aa2433b01869ff0b65be422a10ab7c59e680b8aff9a9f093615f37e2e0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 08 Feb 2022 14:03:33 GMT
content-encoding
gzip
cf-cache-status
HIT
last-modified
Mon, 31 Jan 2022 14:08:13 GMT
server
cloudflare
age
3967
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000, s-maxage=31536000
accept-ranges
bytes
cf-ray
6da566ef4dc45c68-FRA
content-length
23750
pbm_307825_11600.js
p.nodserving.com/prebidlink/19031/ Frame 447C
35 KB
13 KB
Script
General
Full URL
https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js
Requested by
Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/j.html?i=11600
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
45.133.44.4 Philadelphia, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software
nginx /
Resource Hash
59bfc18a344153d9409a185725e201b2b625c25667b1546ddf2a5fab387ff94d

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://p.nodserving.com/prebidlink/19031/j.html?i=11600
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:33 GMT
content-encoding
gzip
last-modified
Fri, 04 Feb 2022 15:03:17 GMT
server
nginx
etag
W/"61fd4035-8d88"
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=3600
expires
Tue, 08 Feb 2022 15:03:33 GMT
4740.json
script.crazyegg.com/pages/sampling-data-scripts/0092/
1 KB
455 B
XHR
General
Full URL
https://script.crazyegg.com/pages/sampling-data-scripts/0092/4740.json?t=456758
Requested by
Host: script.crazyegg.com
URL: https://script.crazyegg.com/pages/versioned/common-scripts/11.1.381.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6813:9308 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
dab74169a9865e9ecf8d9a5f5f065488ae86f2b5336132a42d4945883e935d14

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:33 GMT
content-encoding
gzip
cf-cache-status
HIT
age
3735
ce-version
11.1.381
content-length
389
timing-allow-origin
*
last-modified
Tue, 08 Feb 2022 13:01:18 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
*
access-control-expose-headers
CE-Version
cache-control
public, max-age=300, s-maxage=1209600
accept-ranges
bytes
cf-ray
6da566ef888690a8-FRA
tracking
ghb.adtelligent.com/adunit/ Frame 447C
43 B
418 B
XHR
General
Full URL
https://ghb.adtelligent.com/adunit/tracking?pubbid=0&event=11&full_page_url=https%3A%2F%2Fwww.fiercepharma.com&adid=1ba4efb87e1009&vpbv=M055&client_id=307825&site_id=11600&lifecycle_tte=111
Requested by
Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
2a0c:5c81:5142::2 London, United Kingdom, ASN55081 (24SHELLS, US),
Reverse DNS
Software
VertaMedia 1.0 /
Resource Hash
2dfe28cbdb83f01c940de6a88ab86200154fd772d568035ac568664e52068363

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://p.nodserving.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Access-Control-Allow-Origin
https://p.nodserving.com
Date
Tue, 08 Feb 2022 14:03:33 GMT
Access-Control-Allow-Credentials
true
Server
VertaMedia 1.0
Connection
Keep-Alive
Content-Length
43
Content-Type
image/gif
/
ghb.adtelligent.com/geo/ Frame 447C
142 B
394 B
XHR
General
Full URL
https://ghb.adtelligent.com/geo/
Requested by
Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
2a0c:5c81:5142::2 London, United Kingdom, ASN55081 (24SHELLS, US),
Reverse DNS
Software
VertaMedia 1.0 /
Resource Hash
c1ec65706585d1f809e5c8e8eb105d5a55f9b3cbf20bea45cb546ec2b3f9fde3

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://p.nodserving.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Access-Control-Allow-Origin
https://p.nodserving.com
Date
Tue, 08 Feb 2022 14:03:33 GMT
Access-Control-Allow-Credentials
true
Server
VertaMedia 1.0
Connection
Keep-Alive
Content-Length
142
Content-Type
application/json
healthcheck
pagestates-tracking.crazyegg.com/
19 B
417 B
XHR
General
Full URL
https://pagestates-tracking.crazyegg.com/healthcheck
Requested by
Host: script.crazyegg.com
URL: https://script.crazyegg.com/pages/versioned/common-scripts/11.1.381.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.86.3.25 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-3-25.fra6.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
830e67bda2532cd5880ee86e3b33e69721082f8458bb0df0cd4edbb1577fd375

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 21 Dec 2021 13:52:43 GMT
via
1.1 3095e870e1a1a1b03178e40ab1872de4.cloudfront.net (CloudFront)
last-modified
Tue, 05 Oct 2021 13:53:30 GMT
server
AmazonS3
age
4234251
etag
"d06f04fccf68d0b228a5923187ce1afd"
access-control-max-age
31536000
access-control-allow-methods
GET, HEAD
content-type
binary/octet-stream
access-control-allow-origin
*
x-cache
Hit from cloudfront
x-amz-cf-pop
FRA6-C1
accept-ranges
bytes
content-length
19
x-amz-cf-id
9Lc38L9X4G_44szEnLqrjgzP0Eq-EOlLwPd4z4fQ-5bnEdENgSLe5A==
healthcheck
assets-tracking.crazyegg.com/
19 B
421 B
XHR
General
Full URL
https://assets-tracking.crazyegg.com/healthcheck
Requested by
Host: script.crazyegg.com
URL: https://script.crazyegg.com/pages/versioned/common-scripts/11.1.381.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
18.66.248.91 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-18-66-248-91.dus51.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
830e67bda2532cd5880ee86e3b33e69721082f8458bb0df0cd4edbb1577fd375

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 21 Dec 2021 13:24:28 GMT
via
1.1 5e696cef0c57cc6cd171bf72fe757bf4.cloudfront.net (CloudFront)
last-modified
Tue, 05 Oct 2021 13:53:30 GMT
server
AmazonS3
age
4235946
etag
"d06f04fccf68d0b228a5923187ce1afd"
access-control-max-age
31536000
access-control-allow-methods
GET, HEAD
content-type
binary/octet-stream
access-control-allow-origin
*
x-cache
Hit from cloudfront
x-amz-cf-pop
DUS51-P1
accept-ranges
bytes
content-length
19
x-amz-cf-id
MYalqCDgoP9XcKYK0_atTKxXvQmfCX-YJCXfvmFj51pvbK8MPmj_lg==
011d9558-baca-44d0-b0c1-1548b9b3945f
https://www.fiercepharma.com/
53 B
0
Other
General
Full URL
blob:https://www.fiercepharma.com/011d9558-baca-44d0-b0c1-1548b9b3945f
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
BLOB
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
8ff09cd0ee012fe06ed1b67dc914858cde819f21bb479f629994d9e49f3c0049

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Content-Length
53
Content-Type
text/javascript
utsync.ashx
ml314.com/
62 B
572 B
Script
General
Full URL
https://ml314.com/utsync.ashx?pub=&adv=&et=0&eid=66459&ct=js&pi=&fp=GA1.2.800578055.1644329014&clid=&if=0&ps=&cl=&mlt=&data=&&cp=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&pv=1644329013770_py351f8cb&bl=en-us&cb=4814555&return=&ht=&d=&dc=&si=1644329013770_py351f8cb&cid=&s=1600x1200&rp=
Requested by
Host: ml314.com
URL: https://ml314.com/tag.aspx?812022
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.208.138.90 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-208-138-90.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
5a1ba6ff6db12f791bbbfc4da3cb389e06f0cd53eede09ef3eb3ceb074089ef1

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 08 Feb 2022 14:03:33 GMT
Content-Encoding
gzip
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
p3P
CP="NON DSP COR ADMo PSAo DEVo BUS COM UNI NAV DEM STA"
Cache-Control
no-cache, no-store, must-revalidate
Connection
keep-alive
Content-Type
application/javascript; charset=utf-8
Content-Length
147
Expires
0
ud.ashx
in.ml314.com/
20 B
482 B
Script
General
Full URL
https://in.ml314.com/ud.ashx?topiclimit=&cb=812022
Requested by
Host: ml314.com
URL: https://ml314.com/tag.aspx?812022
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.200.182.42 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-200-182-42.compute-1.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
d0e4a6372d6fb5ffe9505dbe9e94aee8f1b9b96ec8e5e20684cce8b4c5a88fa7

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Tue, 08 Feb 2022 14:03:33 GMT
Content-Encoding
gzip
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
Content-Type
application/javascript; charset=utf-8
Cache-Control
public
Connection
keep-alive
Content-Length
138
Expires
Wed, 09 Feb 2022 14:03:34 GMT
prebid
prebid.deepintent.com/ Frame
0
0
Preflight
General
Full URL
https://prebid.deepintent.com/prebid
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
169.197.150.8 , United States, ASN398989 (DEEPINTENT, US),
Reverse DNS
g.deepintent.com
Software
c /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Method
POST
Access-Control-Request-Headers
content-type
Origin
https://www.fiercepharma.com
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

access-control-allow-origin
https://www.fiercepharma.com
vary
Origin,Access-Control-Request-Method,Access-Control-Request-Headers
access-control-max-age
3600
access-control-allow-credentials
true
access-control-allow-methods
POST, GET, OPTIONS, DELETE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, X-CSRF-TOKEN
allow
GET, HEAD, POST, PUT, DELETE, OPTIONS, PATCH
content-length
0
date
Tue, 08 Feb 2022 14:03:33 GMT
server
c
auction
prebid.adnxs.com/pbs/v1/openrtb2/
88 B
481 B
XHR
General
Full URL
https://prebid.adnxs.com/pbs/v1/openrtb2/auction
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
37.252.161.190 Southall, United Kingdom, ASN29990 (ASN-APPNEX, US),
Reverse DNS
prebid.ams1.adnexus.net
Software
nginx/1.19.0 /
Resource Hash
d1306870bdb1390bdd65f4db110c6837f6f9fd8f992950c5e257665720440bac

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 08 Feb 2022 14:03:33 GMT
Server
nginx/1.19.0
X-Prebid
pbs-go/0.194.0
Vary
Origin
Content-Type
text/plain; charset=utf-8
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
88
Expires
0
bidRequest
c2shb.ssp.yahoo.com/
62 B
92 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a96940d017575bc4351bd15f652001f&pos=8a9690f1017575bc3e53bd44ae0500ac&cmd=bid&secure=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
18.156.195.47 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-156-195-47.eu-central-1.compute.amazonaws.com
Software
ATS/9.1.0.33 /
Resource Hash
2d71b55377fe52cfb750c83536b807b5ee4180421166dd0a44c2498b552bb257

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 08 Feb 2022 14:03:34 GMT
server
ATS/9.1.0.33
age
1
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
access-control-allow-methods
POST,GET,HEAD,OPTIONS
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
content-length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
296 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a96940d017575bc4351bd15f652001f&pos=8a969d82017575bc3922bd44ad1a00b1&cmd=bid&secure=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
18.156.195.47 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-156-195-47.eu-central-1.compute.amazonaws.com
Software
ATS/9.1.0.33 /
Resource Hash
2adc428759847560082634985fd8600f56cde71947d5a60c7ea2b7a23f39c3b1

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 08 Feb 2022 14:03:33 GMT
server
ATS/9.1.0.33
age
0
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
access-control-allow-methods
POST,GET,HEAD,OPTIONS
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
content-length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
92 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a96940d017575bc4351bd15f652001f&pos=8a9690f1017575bc3e53bd44a8a300aa&cmd=bid&secure=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
18.156.195.47 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-156-195-47.eu-central-1.compute.amazonaws.com
Software
ATS/9.1.0.33 /
Resource Hash
3ad3efdb0fad0d4c1dc371ed474afddde3d62b4b447b8b3fe8d8db330a0cceee

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 08 Feb 2022 14:03:34 GMT
server
ATS/9.1.0.33
age
1
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
access-control-allow-methods
POST,GET,HEAD,OPTIONS
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
content-length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
92 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a96940d017575bc4351bd15f652001f&pos=8a969d82017575bc3922bd44aa6300b0&cmd=bid&secure=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
18.156.195.47 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-156-195-47.eu-central-1.compute.amazonaws.com
Software
ATS/9.1.0.33 /
Resource Hash
70fb921a66529f9facd631a2da433dd769e58e04fde9df5a006e2d474c74e652

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 08 Feb 2022 14:03:34 GMT
server
ATS/9.1.0.33
age
1
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
access-control-allow-methods
POST,GET,HEAD,OPTIONS
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
content-length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
92 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a9690f1017575bc3e53bd15f72c001b&pos=8a96940d017575bc4351bd44a97500c0&cmd=bid&secure=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
18.156.195.47 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-156-195-47.eu-central-1.compute.amazonaws.com
Software
ATS/9.1.0.33 /
Resource Hash
0afbcd84237cc883ddff36baadf71b03415342e77c3abb04cf528ba361213735

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 08 Feb 2022 14:03:33 GMT
server
ATS/9.1.0.33
age
0
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
access-control-allow-methods
POST,GET,HEAD,OPTIONS
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
content-length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
92 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a96940d017575bc4351bd15f652001f&pos=8a9690f1017575bc3e53bd44a8a300aa&cmd=bid&secure=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
18.156.195.47 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-156-195-47.eu-central-1.compute.amazonaws.com
Software
ATS/9.1.0.33 /
Resource Hash
230500b28a619490192335e9307ac4957bf3bae910eb7dca0efb6611efc7650d

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 08 Feb 2022 14:03:33 GMT
server
ATS/9.1.0.33
age
0
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
access-control-allow-methods
POST,GET,HEAD,OPTIONS
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
content-length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
92 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a96940d017575bc4351bd15f652001f&pos=8a969d82017575bc3922bd44aa6300b0&cmd=bid&secure=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
18.156.195.47 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-156-195-47.eu-central-1.compute.amazonaws.com
Software
ATS/9.1.0.33 /
Resource Hash
d42dce1ea8bc071664d258b40901777476fb58ddd0c34da161c47f94a8bcac93

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 08 Feb 2022 14:03:33 GMT
server
ATS/9.1.0.33
age
0
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
access-control-allow-methods
POST,GET,HEAD,OPTIONS
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
content-length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
117 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a9690f1017575bc3e53bd15f72c001b&pos=8a96940d017575bc4351bd44a97500c0&cmd=bid&secure=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
18.156.195.47 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-156-195-47.eu-central-1.compute.amazonaws.com
Software
ATS/9.1.0.33 /
Resource Hash
95e12ad63bff258407a49e675467727e866fa5d251e8e9d394162faf614e79ae

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 08 Feb 2022 14:03:34 GMT
server
ATS/9.1.0.33
age
1
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
access-control-allow-methods
POST,GET,HEAD,OPTIONS
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
content-length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
92 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a96940d017575bc4351bd15f652001f&pos=8a9690f1017575bc3e53bd44a8a300aa&cmd=bid&secure=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
18.156.195.47 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-156-195-47.eu-central-1.compute.amazonaws.com
Software
ATS/9.1.0.33 /
Resource Hash
6b7a1d00aa01ca41e6f29cd523eb60cb20fea8ed315e28e06e82e1167eca6798

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 08 Feb 2022 14:03:33 GMT
server
ATS/9.1.0.33
age
0
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
access-control-allow-methods
POST,GET,HEAD,OPTIONS
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
content-length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
92 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a96940d017575bc4351bd15f652001f&pos=8a969d82017575bc3922bd44aa6300b0&cmd=bid&secure=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
18.156.195.47 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-156-195-47.eu-central-1.compute.amazonaws.com
Software
ATS/9.1.0.33 /
Resource Hash
b8412495b3ab69312276b43eddfc7ba0c482abc369a15747f8ffeb41a7eef2b2

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 08 Feb 2022 14:03:34 GMT
server
ATS/9.1.0.33
age
1
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
access-control-allow-methods
POST,GET,HEAD,OPTIONS
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
content-length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
92 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a9690f1017575bc3e53bd15f72c001b&pos=8a96940d017575bc4351bd44a97500c0&cmd=bid&secure=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
18.156.195.47 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-156-195-47.eu-central-1.compute.amazonaws.com
Software
ATS/9.1.0.33 /
Resource Hash
1525f15e6a1c62e39b4d01e7f7aca9d78d5a19bd4f7875de363033113f60908f

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 08 Feb 2022 14:03:34 GMT
server
ATS/9.1.0.33
age
1
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
access-control-allow-methods
POST,GET,HEAD,OPTIONS
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
content-length
62
fastlane.json
fastlane.rubiconproject.com/a/api/
261 B
1 KB
XHR
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=17184&site_id=163630&zone_id=2126352&size_id=55&alt_size_ids=57&eid_pubcid.org=b3acf975-6694-4970-9538-76bd2b008d42%5E1&rf=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&tk_flint=pbjs_lite_v6.7.0-pre&x_source.tid=faea3b09-5183-4451-b9d2-3c4c05ae3db7&p_screen_res=1600x1200&rp_secure=1&rp_maxbids=1&slots=1&rand=0.7601881773860544
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_128_GCM
Server
2602:803:c003:200::41 Amsterdam, Netherlands, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.16.0 /
Resource Hash
0ef2ca95d47ddb90cf4af4893b7a7899a09469097868f890f11c0663a6ac2f06

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 08 Feb 2022 14:03:34 GMT
Server
nginx/1.16.0
Vary
Accept-Encoding
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json
Content-Length
261
Expires
Wed, 17 Sep 1975 21:32:10 GMT
fastlane.json
fastlane.rubiconproject.com/a/api/
261 B
1 KB
XHR
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=17184&site_id=163630&zone_id=2126352&size_id=15&alt_size_ids=10&eid_pubcid.org=b3acf975-6694-4970-9538-76bd2b008d42%5E1&rf=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&tk_flint=pbjs_lite_v6.7.0-pre&x_source.tid=3a111ff0-7aeb-413d-9ef0-0fc6ae61734a&p_screen_res=1600x1200&rp_secure=1&rp_maxbids=1&slots=1&rand=0.4829058713343808
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_128_GCM
Server
2602:803:c003:200::41 Amsterdam, Netherlands, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.16.0 /
Resource Hash
ca657e87582de6cf620b56d130e1c494e99afddcf204b0971d752d0f54a14173

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 08 Feb 2022 14:03:34 GMT
Server
nginx/1.16.0
Vary
Accept-Encoding
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json
Content-Length
261
Expires
Wed, 17 Sep 1975 21:32:10 GMT
fastlane.json
fastlane.rubiconproject.com/a/api/
261 B
1 KB
XHR
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=17184&site_id=163630&zone_id=2126352&size_id=15&alt_size_ids=10&eid_pubcid.org=b3acf975-6694-4970-9538-76bd2b008d42%5E1&rf=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&tk_flint=pbjs_lite_v6.7.0-pre&x_source.tid=9e864e7a-e240-41a5-b353-34e356d4ae85&p_screen_res=1600x1200&rp_secure=1&rp_maxbids=1&slots=1&rand=0.8087890697799562
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_128_GCM
Server
2602:803:c003:200::41 Amsterdam, Netherlands, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.16.0 /
Resource Hash
e8a6e7f7653520e7781ce9946aece169aa0dc7ad0e17ea3d3aec8a15e8c030ac

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 08 Feb 2022 14:03:34 GMT
Server
nginx/1.16.0
Vary
Accept-Encoding
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json
Content-Length
261
Expires
Wed, 17 Sep 1975 21:32:10 GMT
fastlane.json
fastlane.rubiconproject.com/a/api/
4 KB
3 KB
XHR
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=17184&site_id=163630&zone_id=2126352&size_id=15&alt_size_ids=10&eid_pubcid.org=b3acf975-6694-4970-9538-76bd2b008d42%5E1&rf=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&tk_flint=pbjs_lite_v6.7.0-pre&x_source.tid=feee019c-1149-4d18-8e7b-2383552ece21&p_screen_res=1600x1200&rp_secure=1&rp_maxbids=1&slots=1&rand=0.09238751382073773
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_128_GCM
Server
2602:803:c003:200::41 Amsterdam, Netherlands, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.16.0 /
Resource Hash
f99fbe58fea65b2715f93ca4d26ebd864fdb72eac2893ac5e4712c77dcf30d5d

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 08 Feb 2022 14:03:34 GMT
Content-Encoding
gzip
Server
nginx/1.16.0
Vary
Accept-Encoding
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json
Content-Length
1748
Expires
Wed, 17 Sep 1975 21:32:10 GMT
trinity.json
apex.go.sonobi.com/
179 B
887 B
XHR
General
Full URL
https://apex.go.sonobi.com/trinity.json?key_maker=%7B%2251468ec261389a5%22%3A%226af9de6bbe34255426d7%7C970x90%2C970x250%2C970x415%7Cgpid%3D%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fspecialreports%22%2C%225286de9e92b96f9%22%3A%226af9de6bbe34255426d7%7C300x600%2C300x250%7Cgpid%3D%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fspecialreports%22%2C%2253631eeb469daf7%22%3A%226af9de6bbe34255426d7%7C300x600%2C300x250%7Cgpid%3D%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fspecialreports%22%2C%225462ea710e54ec4%22%3A%226af9de6bbe34255426d7%7C300x600%2C300x250%7Cgpid%3D%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fspecialreports%22%2C%2255ccdf1f9a570a6%22%3A%226af9de6bbe34255426d7%7C1600x1000%7Cgpid%3D%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fspecialreports%22%7D&ref=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&s=7e320697-1f53-4b34-85e0-a58cb0323993&pv=70048e01-6310-4ac9-8d52-eec59105b095&vp=desktop&lib_name=prebid&lib_v=6.7.0-pre&us=0&ius=1&schain=%7B%22ver%22%3A%221.0%22%2C%22complete%22%3A1%2C%22nodes%22%3A%5B%7B%22asi%22%3A%22mediafuse.com%22%2C%22sid%22%3A%22358%22%2C%22hp%22%3A1%7D%5D%7D&userid=%7B%22pubcid%22%3A%22b3acf975-6694-4970-9538-76bd2b008d42%22%7D&eids=%5B%7B%22source%22%3A%22pubcid.org%22%2C%22uids%22%3A%5B%7B%22id%22%3A%22b3acf975-6694-4970-9538-76bd2b008d42%22%2C%22atype%22%3A1%7D%5D%7D%5D&coppa=0
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
178.162.133.150 Rotterdam, Netherlands, ASN60781 (LEASEWEB-NL-AMS-01 Netherlands, NL),
Reverse DNS
ams-1-apex.go.sonobi.com
Software
sonobi-go /
Resource Hash
f99ad6cbbab1d5235b0c8f4869e07a482d0ef45583d1039fde948748bc6c6ecb
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 08 Feb 2022 14:03:33 GMT
Content-Encoding
gzip
Server
sonobi-go
Vary
negotiate,Accept-Encoding
X-Go-Server
apex-ams-1-6-128
P3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-cache, no-store, private
Access-Control-Allow-Credentials
true
Tcn
Choice
Content-Type
application/json
Content-Length
154
X-Xss-Protection
0
Expires
Sat, 26 Jul 1997 05:00:00 GMT
/
ghb.adtelligent.com/v2/auction/
1 KB
598 B
XHR
General
Full URL
https://ghb.adtelligent.com/v2/auction/
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
2a0c:5c81:5142::2 London, United Kingdom, ASN55081 (24SHELLS, US),
Reverse DNS
Software
VertaMedia 1.0 /
Resource Hash
72052878df69ef7dfdc40564b2ff27f9ac2d90ba1c27fbd6d78dc0d884722b83

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 08 Feb 2022 14:03:34 GMT
Content-Encoding
gzip
Server
VertaMedia 1.0
Content-Type
application/json; charset=UTF-8
Access-Control-Allow-Origin
https://www.fiercepharma.com
Access-Control-Allow-Credentials
true
Connection
Keep-Alive
Content-Length
303
/
colossusssp.com/
2 B
247 B
XHR
General
Full URL
https://colossusssp.com/?c=o&m=multi
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_128_CBC
Server
8.2.111.126 , United States, ASN46636 (NATCOWEB, US),
Reverse DNS
Software
nginx /
Resource Hash
4f53cda18c2baa0c0354bb5f9a3ecbe5ed12ab4d8e11ba873c2f11161202b945

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

Access-Control-Allow-Origin
https://www.fiercepharma.com
Date
Tue, 08 Feb 2022 14:03:34 GMT
Access-Control-Allow-Credentials
true
Server
nginx
Connection
keep-alive
Content-Length
2
Content-Type
application/json
prebid
prebid.deepintent.com/
0
235 B
XHR
General
Full URL
https://prebid.deepintent.com/prebid
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
169.197.150.8 , United States, ASN398989 (DEEPINTENT, US),
Reverse DNS
g.deepintent.com
Software
a /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
application/json

Response headers

date
Tue, 08 Feb 2022 14:03:33 GMT
server
a
vary
Origin
access-control-allow-methods
POST, GET, OPTIONS, DELETE
access-control-allow-origin
https://www.fiercepharma.com
access-control-max-age
3600
access-control-allow-credentials
true
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, X-CSRF-TOKEN
translator
hbopenbid.pubmatic.com/
0
120 B
XHR
General
Full URL
https://hbopenbid.pubmatic.com/translator?source=prebid-client
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
185.64.189.112 , United Kingdom, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Tue, 08 Feb 2022 14:03:34 GMT
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
prebid
ads.yieldmo.com/exchange/
0
229 B
XHR
General
Full URL
https://ads.yieldmo.com/exchange/prebid?pbav=6.7.0-pre&p=%5B%7B%22placement_id%22%3A%22header-ad%22%2C%22callback_id%22%3A%228160c2facfc35e%22%2C%22sizes%22%3A%5B%5B970%2C90%5D%2C%5B970%2C250%5D%2C%5B970%2C415%5D%5D%2C%22ym_placement_id%22%3A%222926956988749259211%22%7D%2C%7B%22placement_id%22%3A%22sidebar-ad%22%2C%22callback_id%22%3A%2282b7a5d93c2510a%22%2C%22sizes%22%3A%5B%5B300%2C600%5D%2C%5B300%2C250%5D%5D%2C%22ym_placement_id%22%3A%222926956988749259211%22%7D%2C%7B%22placement_id%22%3A%22sidebar-ad2%22%2C%22callback_id%22%3A%22836db60f75a28e3%22%2C%22sizes%22%3A%5B%5B300%2C600%5D%2C%5B300%2C250%5D%5D%2C%22ym_placement_id%22%3A%222926956988749259211%22%7D%2C%7B%22placement_id%22%3A%22sidebar-ad3%22%2C%22callback_id%22%3A%228442482330b730d%22%2C%22sizes%22%3A%5B%5B300%2C600%5D%2C%5B300%2C250%5D%5D%2C%22ym_placement_id%22%3A%222926956988749259211%22%7D%2C%7B%22placement_id%22%3A%22wallpaper%22%2C%22callback_id%22%3A%228523308a199d636%22%2C%22sizes%22%3A%5B%5B1600%2C1000%5D%5D%2C%22ym_placement_id%22%3A%222926956988749259211%22%7D%5D&page_url=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&bust=1644329013871&dnt=false&description=With%20deucravacitinib%2C%20Bristol%20Myers%20Squibb%20took%20on%20an%20opportunity%20cost%20in%20losing%20out%20on%20Otezla%3B%20this%20year%2C%20industry%20watchers%20will%20start%20to%20see%20whether%20that%20bet%20could%20pay%20off.%20When%20faced%20with%20an%20antitrust%20roadblock%20to%20its%20megamerger%20with%20Celgene%20in%202019%2C%20BMS%20chose%20to%20keep%20experimental%20deucravacitinib%20and%20offload%20growing%20blockbuster%20Otezla%20to%20Amgen%20for%20%2413.4%20billion.&userConsent=%7B%22gdprApplies%22%3A%22%22%2C%22cmp%22%3A%22%22%7D&us_privacy=&pr=&scrd=1&title=4.%20Deucravacitinib%20%7C%20FiercePharma&w=1600&h=1200&pubcid=b3acf975-6694-4970-9538-76bd2b008d42&schain=%7B%22ver%22%3A%221.0%22%2C%22complete%22%3A1%2C%22nodes%22%3A%5B%7B%22asi%22%3A%22mediafuse.com%22%2C%22sid%22%3A%22358%22%2C%22hp%22%3A1%7D%5D%7D&eids=%5B%7B%22source%22%3A%22pubcid.org%22%2C%22uids%22%3A%5B%7B%22id%22%3A%22b3acf975-6694-4970-9538-76bd2b008d42%22%2C%22atype%22%3A1%7D%5D%7D%5D
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.251.249.129 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-34-251-249-129.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
pragma
no-cache
date
Tue, 08 Feb 2022 14:03:33 GMT
access-control-allow-credentials
true
x-robots-tag
none,NOINDEX,NOFOLLOW
access-control-allow-methods
POST, GET, OPTIONS
access-control-request-headers
Cache-Control, Pragma
ROS
pbjs.e-planning.net/pbjs/1/2e43c/1/www.fiercepharma.com/
2 B
162 B
XHR
General
Full URL
https://pbjs.e-planning.net/pbjs/1/2e43c/1/www.fiercepharma.com/ROS?rnd=0.11600488881120774&e=970x250_0%3A970x250%2C970x90%2C970x415%2B300x250_0%3A300x250%2C300x600%2B300x250_1%3A300x250%2C300x600%2B300x250_2%3A300x250%2C300x600%2B1600x1000_0%3A1600x1000&ur=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&pbv=6.7.0-pre&ncb=1&vs=FFFFF&crs=UTF-8&fr=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&e_pubcid=b3acf975-6694-4970-9538-76bd2b008d42
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
5.178.65.246 Amsterdam, Netherlands, ASN50673 (SERVERIUS-AS, NL),
Reverse DNS
ads.us.e-planning.net
Software
openresty /
Resource Hash
44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Tue, 08 Feb 2022 14:03:33 GMT
access-control-allow-credentials
true
server
openresty
content-type
text/plain
content-length
2
x-sid
AMS-602
translator
hbopenbid.pubmatic.com/
0
64 B
XHR
General
Full URL
https://hbopenbid.pubmatic.com/translator?source=prebid-client
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
185.64.189.112 , United Kingdom, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Tue, 08 Feb 2022 14:03:34 GMT
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
bids
prebid-us.creativecdn.com/bidder/prebid/
0
182 B
XHR
General
Full URL
https://prebid-us.creativecdn.com/bidder/prebid/bids
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
185.184.10.30 , Poland, ASN203690 (RTB-HOUSE-ASH, PL),
Reverse DNS
ip-185-184-10-30.rtbhouse.net
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Tue, 08 Feb 2022 14:03:34 GMT
access-control-allow-credentials
true
access-control-max-age
3600
vary
Origin
access-control-allow-methods
POST
mvo
tag.1rx.io/rmp/212473/0/
0
176 B
XHR
General
Full URL
https://tag.1rx.io/rmp/212473/0/mvo?z=1r&hbv=6.7.0-pre,2.1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
213.19.147.42 , United Kingdom, ASN26120 (RHYTHMONE, US),
Reverse DNS
Software
Tengine /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
pragma
no-cache
date
Tue, 08 Feb 2022 14:03:33 GMT
cache-control
private, max-age=0, no-cache, no-store
access-control-allow-credentials
true
server
Tengine
bid
ap.lijit.com/rtb/
25 B
526 B
XHR
General
Full URL
https://ap.lijit.com/rtb/bid?src=prebid_prebid_6.7.0-pre
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
216.52.2.48 , United States, ASN29791 (VOXEL-DOT-NET, US),
Reverse DNS
Software
/
Resource Hash
c7675aa27a1871ec830b3d0c7af4b63ff47669a4f4689b76fa3685182308feb8

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 08 Feb 2022 14:03:33 GMT
Vary
Accept-Encoding, User-Agent
Access-Control-Allow-Methods
GET, POST, DELETE, PUT
Content-Type
application/json
Access-Control-Allow-Origin
https://www.fiercepharma.com
Access-Control-Allow-Credentials
true
X-Sovrn-Pod
ad_ap5ams1
Access-Control-Allow-Headers
X-Requested-With, Content-Type
Content-Length
25
ortb
bid.contextweb.com/header/
0
572 B
XHR
General
Full URL
https://bid.contextweb.com/header/ortb?src=prebid
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
198.148.27.133 New York, United States, ASN19189 (PULSEPOINT, US),
Reverse DNS
Software
envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 08 Feb 2022 14:03:34 GMT
server
envoy
cwdl
22/148,22/148,22/148,22/148,22/148,22/148,22/148,22/148,22/148,22/148,22/148,22/148,22/148,22/148,22/148
access-control-allow-origin
https://www.fiercepharma.com
access-control-expose-headers
Access-Control-Allow-Origin
access-control-allow-credentials
true
x-envoy-upstream-service-time
4
cw-server
bid-deployment-66f4d6749f-nrlht
cygnus
htlb.casalemedia.com/
38 B
336 B
XHR
General
Full URL
https://htlb.casalemedia.com/cygnus?s=356568&v=7.2&ac=j&sd=1&r=%7B%22id%22%3A%221706ac1d37e2910c%22%2C%22site%22%3A%7B%22page%22%3A%22https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib%22%7D%2C%22ext%22%3A%7B%22source%22%3A%22prebid%22%2C%22ixdiag%22%3A%7B%22msd%22%3A4%2C%22msi%22%3A4%2C%22mfu%22%3A0%2C%22bu%22%3A4%2C%22iu%22%3A0%2C%22nu%22%3A0%2C%22ou%22%3A0%2C%22allu%22%3A4%2C%22ren%22%3Afalse%2C%22version%22%3A%226.7.0-pre%22%2C%22userIds%22%3A%5B%22pubcid%22%5D%7D%7D%2C%22imp%22%3A%5B%7B%22id%22%3A%221716f89c458d4b1b%22%2C%22banner%22%3A%7B%22topframe%22%3A1%2C%22format%22%3A%5B%7B%22w%22%3A970%2C%22h%22%3A250%2C%22ext%22%3A%7B%22siteID%22%3A%22356568%22%2C%22sid%22%3A%22970x250%22%7D%7D%5D%7D%7D%2C%7B%22id%22%3A%22173e6c4f2f1c7c4d%22%2C%22banner%22%3A%7B%22topframe%22%3A1%2C%22format%22%3A%5B%7B%22w%22%3A300%2C%22h%22%3A250%2C%22ext%22%3A%7B%22siteID%22%3A%22356568%22%2C%22sid%22%3A%22300x250%22%7D%7D%5D%7D%7D%2C%7B%22id%22%3A%22175725abcf0147dc%22%2C%22banner%22%3A%7B%22topframe%22%3A1%2C%22format%22%3A%5B%7B%22w%22%3A300%2C%22h%22%3A250%2C%22ext%22%3A%7B%22siteID%22%3A%22356568%22%2C%22sid%22%3A%22300x250%22%7D%7D%5D%7D%7D%2C%7B%22id%22%3A%22177b500d5d85b45b%22%2C%22banner%22%3A%7B%22topframe%22%3A1%2C%22format%22%3A%5B%7B%22w%22%3A300%2C%22h%22%3A250%2C%22ext%22%3A%7B%22siteID%22%3A%22356568%22%2C%22sid%22%3A%22300x250%22%7D%7D%5D%7D%7D%5D%2C%22at%22%3A1%2C%22user%22%3A%7B%22eids%22%3A%5B%7B%22source%22%3A%22pubcid.org%22%2C%22uids%22%3A%5B%7B%22id%22%3A%22b3acf975-6694-4970-9538-76bd2b008d42%22%7D%5D%7D%5D%7D%7D
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.37.38.181 Frankfurt am Main, Germany, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-37-38-181.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
958e317f7d88a18fbc53eb6b932757ddad2790c94f999a87be0140cb7f8f6634

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 08 Feb 2022 14:03:33 GMT
x-ak-initial-geo
CC:[DE], RC:[HE], CN:[EU], CIP:[84.19.175.183], XFF:[]
server
Apache
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
x-cs-client-geo
12
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
38
x-ak-client-geo
12
expires
Tue, 08 Feb 2022 14:03:33 GMT
arj
adtelligent-d.openx.net/w/1.0/
73 B
383 B
XHR
General
Full URL
https://adtelligent-d.openx.net/w/1.0/arj?ju=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&ch=UTF-8&res=1600x1200x24&ifr=false&tz=0&tws=1600x1200&be=1&bc=hb_pb_3.0.3&dddid=faea3b09-5183-4451-b9d2-3c4c05ae3db7%2C3a111ff0-7aeb-413d-9ef0-0fc6ae61734a%2C9e864e7a-e240-41a5-b353-34e356d4ae85%2Cfeee019c-1149-4d18-8e7b-2383552ece21%2Cfc800c78-cf39-4d82-a550-bf3fa1e209bf&nocache=1644329013882&pubcid=b3acf975-6694-4970-9538-76bd2b008d42&schain=1.0%2C1!adtelligent.com%2C283366%2C1%2C%2C%2C&aus=970x90%2C970x250%2C970x415%7C300x600%2C300x250%7C300x600%2C300x250%7C300x600%2C300x250%7C1600x1000&divids=header-ad%2Csidebar-ad%2Csidebar-ad2%2Csidebar-ad3%2Cwallpaper&aucs=%2C%2C%2C%2C&auid=541177132%2C541177132%2C541177132%2C541177132%2C541177132
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.244.159.8 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
8.159.244.35.bc.googleusercontent.com
Software
OXGW/17.1.0 /
Resource Hash
a6dd5890bd6d1448cbb4b08f5799ab7ade6a0057431400e539bf33e729422476

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 08 Feb 2022 14:03:33 GMT
content-encoding
gzip
server
OXGW/17.1.0
vary
Accept, Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.fiercepharma.com
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
79
via
1.1 google
expires
Mon, 26 Jul 1997 05:00:00 GMT
prebid
ib.adnxs.com/ut/v3/
19 B
857 B
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
37.252.172.37 Frankfurt am Main, Germany, ASN29990 (ASN-APPNEX, US),
Reverse DNS
691.bm-nginx-loadbalancer.mgmt.fra1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
0c09c070833c786cb25be38bc30992b30bad578f817dbc9e34beacd8b8ea44c5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 08 Feb 2022 14:03:33 GMT
X-Proxy-Origin
84.19.175.183; 84.19.175.183; 691.bm-nginx-loadbalancer.mgmt.fra1; adnxs.com
AN-X-Request-Uuid
e899e328-c5a6-40a9-9837-d6946e5a2419
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json; charset=utf-8
Content-Length
19
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
prebid.1.2.aspx
inv-nets.admixer.net/
42 B
510 B
XHR
General
Full URL
https://inv-nets.admixer.net/prebid.1.2.aspx
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
146.0.227.109 , Ascension Island, ASN20773 (GODADDY, DE),
Reverse DNS
Software
nginx /
Resource Hash
c979ffd70003be58ccc574778b78d9303e8b5b3494a6cdeb01449d65a5a815e6
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 08 Feb 2022 14:03:33 GMT
Server
nginx
P3p
CP="NID DSP ALL COR"
Access-Control-Allow-Origin
https://www.fiercepharma.com
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
text/javascript; charset=utf-8
Keep-Alive
timeout=25
Content-Length
42
X-Xss-Protection
0
c
prebid.a-mo.net/a/
0
205 B
XHR
General
Full URL
https://prebid.a-mo.net/a/c
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
147.75.38.124 Amsterdam, Netherlands, ASN54825 (PACKET, US),
Reverse DNS
Software
envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Tue, 08 Feb 2022 14:03:33 GMT
cache-control
max-age=0, private, must-revalidate
access-control-allow-credentials
true
server
envoy
x-envoy-upstream-service-time
229
vary
origin, Accept-Encoding
prebid-request
onetag-sys.com/
15 B
367 B
XHR
General
Full URL
https://onetag-sys.com/prebid-request
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
51.38.120.206 , France, ASN16276 (OVH, FR),
Reverse DNS
ip206.ip-51-38-120.eu
Software
/
Resource Hash
663dab1310a7e64c3bdd7dfdc81b7fc9a28884d4ee290b96077c7b32bbe84707
Security Headers
Name Value
Strict-Transport-Security max-age=15552000

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

strict-transport-security
max-age=15552000
content-encoding
gzip
p3p
CP='CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR'
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-transform, no-cache
access-control-allow-credentials
true
content-type
application/json
access-control-allow-headers
content-type, origin, referer, user-agent
content-length
41
adjson
ads.betweendigital.com/
2 B
916 B
XHR
General
Full URL
https://ads.betweendigital.com/adjson?t=prebid
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
88.212.252.22 , Russian Federation, ASN7979 (SERVERS-COM, US),
Reverse DNS
Software
/
Resource Hash
4f53cda18c2baa0c0354bb5f9a3ecbe5ed12ab4d8e11ba873c2f11161202b945

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
content-encoding
gzip
vary
Accept-Encoding
content-type
application/json
cdb
bidder.criteo.com/
18 B
317 B
XHR
General
Full URL
https://bidder.criteo.com/cdb?profileId=207&av=34&wv=6.7.0-pre&cb=87765431518
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
178.250.0.165 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
bidder.par.vip.prod.criteo.com
Software
Finatra /
Resource Hash
ad6aa18e132c373e6a0be7543103d4e5dfde8680587cea250550686591419910
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 08 Feb 2022 14:03:33 GMT
content-encoding
gzip
server
Finatra
vary
Origin
content-type
application/json; charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
strict-transport-security
max-age=31536000; preload;
timing-allow-origin
*
content-length
44
prebid
prebid.media.net/rtb/
1 KB
869 B
XHR
General
Full URL
https://prebid.media.net/rtb/prebid?cid=8CUO2I9ST
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.107.148.139 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
139.148.107.34.bc.googleusercontent.com
Software
nginx /
Resource Hash
4c6b42db7c45f36affdfb23ee816bd45f80d1f192dca5e26e5b773d43a0888e9

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 08 Feb 2022 14:03:34 GMT
content-encoding
gzip
server
nginx
content-type
application/json;charset=UTF-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
via
1.1 google
fastlane.json
fastlane.rubiconproject.com/a/api/
260 B
1 KB
XHR
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=12398&site_id=48990&zone_id=1998744&size_id=55&alt_size_ids=57&rp_schain=1.0,1!luponmedia.com,1994122,1,,,&eid_pubcid.org=b3acf975-6694-4970-9538-76bd2b008d42%5E1&rf=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&tk_flint=pbjs_lite_v6.7.0-pre&x_source.tid=faea3b09-5183-4451-b9d2-3c4c05ae3db7&p_screen_res=1600x1200&rp_secure=1&rp_maxbids=1&slots=1&rand=0.6149527456005925
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_128_GCM
Server
2602:803:c003:200::41 Amsterdam, Netherlands, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.16.0 /
Resource Hash
f96087b9045ddc2b32771acdcdc7319ab1b56e24b8740d24d770e097037ab8f5

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 08 Feb 2022 14:03:34 GMT
Server
nginx/1.16.0
Vary
Accept-Encoding
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json
Content-Length
260
Expires
Wed, 17 Sep 1975 21:32:10 GMT
fastlane.json
fastlane.rubiconproject.com/a/api/
260 B
1 KB
XHR
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=12398&site_id=48990&zone_id=1998744&size_id=15&alt_size_ids=10&rp_schain=1.0,1!luponmedia.com,1994122,1,,,&eid_pubcid.org=b3acf975-6694-4970-9538-76bd2b008d42%5E1&rf=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&tk_flint=pbjs_lite_v6.7.0-pre&x_source.tid=3a111ff0-7aeb-413d-9ef0-0fc6ae61734a&p_screen_res=1600x1200&rp_secure=1&rp_maxbids=1&slots=1&rand=0.7011219033683482
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_128_GCM
Server
2602:803:c003:200::41 Amsterdam, Netherlands, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.16.0 /
Resource Hash
b016b2747c1598a861aeeacf570427137f7a88fa534b1c3437e518ec51cce9e8

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 08 Feb 2022 14:03:34 GMT
Server
nginx/1.16.0
Vary
Accept-Encoding
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json
Content-Length
260
Expires
Wed, 17 Sep 1975 21:32:10 GMT
fastlane.json
fastlane.rubiconproject.com/a/api/
260 B
1 KB
XHR
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=12398&site_id=48990&zone_id=1998744&size_id=15&alt_size_ids=10&rp_schain=1.0,1!luponmedia.com,1994122,1,,,&eid_pubcid.org=b3acf975-6694-4970-9538-76bd2b008d42%5E1&rf=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&tk_flint=pbjs_lite_v6.7.0-pre&x_source.tid=9e864e7a-e240-41a5-b353-34e356d4ae85&p_screen_res=1600x1200&rp_secure=1&rp_maxbids=1&slots=1&rand=0.057555571509197545
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_128_GCM
Server
2602:803:c003:200::41 Amsterdam, Netherlands, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.16.0 /
Resource Hash
ced8403d1a68d9d30d9e8b27451f0aded7bd3d9bcf20984fb2f8a27fd408af4a

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 08 Feb 2022 14:03:34 GMT
Server
nginx/1.16.0
Vary
Accept-Encoding
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json
Content-Length
260
Expires
Wed, 17 Sep 1975 21:32:10 GMT
fastlane.json
fastlane.rubiconproject.com/a/api/
260 B
1 KB
XHR
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=12398&site_id=48990&zone_id=1998744&size_id=15&alt_size_ids=10&rp_schain=1.0,1!luponmedia.com,1994122,1,,,&eid_pubcid.org=b3acf975-6694-4970-9538-76bd2b008d42%5E1&rf=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&tk_flint=pbjs_lite_v6.7.0-pre&x_source.tid=feee019c-1149-4d18-8e7b-2383552ece21&p_screen_res=1600x1200&rp_secure=1&rp_maxbids=1&slots=1&rand=0.08536596974154809
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_128_GCM
Server
2602:803:c003:200::41 Amsterdam, Netherlands, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.16.0 /
Resource Hash
2e2600b8a7f6b404746d40feb94c439ff230759bcb619137ef0be9b2a75341ea

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 08 Feb 2022 14:03:34 GMT
Server
nginx/1.16.0
Vary
Accept-Encoding
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json
Content-Length
260
Expires
Wed, 17 Sep 1975 21:32:10 GMT
c
prebid.a-mo.net/a/
0
352 B
XHR
General
Full URL
https://prebid.a-mo.net/a/c
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
147.75.38.124 Amsterdam, Netherlands, ASN54825 (PACKET, US),
Reverse DNS
Software
envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Tue, 08 Feb 2022 14:03:33 GMT
cache-control
max-age=0, private, must-revalidate
access-control-allow-credentials
true
server
envoy
x-envoy-upstream-service-time
227
vary
origin, Accept-Encoding
adreq
ads.servenobid.com/
596 B
638 B
XHR
General
Full URL
https://ads.servenobid.com/adreq?cb=7194
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
63.32.247.12 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-63-32-247-12.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash
99515c31921234d243da4528d95a3590ae16d185e9829c0b7d855816f075a34a

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 08 Feb 2022 14:03:34 GMT
content-encoding
gzip
amp-access-control-allow-source-origin
*
vary
accept-encoding
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
access-control-expose-headers
AMP-Access-Control-Allow-Source-Origin
cache-control
no-store, no-cache, must-revalidate, proxy-revalidate, max-age=0
access-control-allow-credentials
true
prebid
ib.adnxs.com/ut/v3/
19 B
857 B
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
37.252.172.37 Frankfurt am Main, Germany, ASN29990 (ASN-APPNEX, US),
Reverse DNS
691.bm-nginx-loadbalancer.mgmt.fra1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
0c09c070833c786cb25be38bc30992b30bad578f817dbc9e34beacd8b8ea44c5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 08 Feb 2022 14:03:33 GMT
X-Proxy-Origin
84.19.175.183; 84.19.175.183; 691.bm-nginx-loadbalancer.mgmt.fra1; adnxs.com
AN-X-Request-Uuid
674cd8b7-1b15-4620-9645-feff1c979377
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json; charset=utf-8
Content-Length
19
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
prebid
ib.adnxs.com/ut/v3/
19 B
857 B
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
37.252.172.37 Frankfurt am Main, Germany, ASN29990 (ASN-APPNEX, US),
Reverse DNS
691.bm-nginx-loadbalancer.mgmt.fra1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
0c09c070833c786cb25be38bc30992b30bad578f817dbc9e34beacd8b8ea44c5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 08 Feb 2022 14:03:33 GMT
X-Proxy-Origin
84.19.175.183; 84.19.175.183; 691.bm-nginx-loadbalancer.mgmt.fra1; adnxs.com
AN-X-Request-Uuid
45dce81c-1d56-43cd-b210-8c52bf30a3dd
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json; charset=utf-8
Content-Length
19
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
integrator.js
adservice.google.de/adsid/
107 B
792 B
Script
General
Full URL
https://adservice.google.de/adsid/integrator.js?domain=www.fiercepharma.com
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022020301.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:813::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
a4a1824defec1084ca81d496ee77891684c26196924bdc4fc21dd3482ce15e14
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 08 Feb 2022 14:03:33 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
cache-control
private, no-cache, no-store
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
h3="googleads.g.doubleclick.net:443"; ma=2592000,h3=":443"; ma=2592000,h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
100
x-xss-protection
0
integrator.js
adservice.google.com/adsid/
107 B
549 B
Script
General
Full URL
https://adservice.google.com/adsid/integrator.js?domain=www.fiercepharma.com
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022020301.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80f::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
a4a1824defec1084ca81d496ee77891684c26196924bdc4fc21dd3482ce15e14
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 08 Feb 2022 14:03:33 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
cache-control
private, no-cache, no-store
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
100
x-xss-protection
0
ads
securepubads.g.doubleclick.net/gampad/
11 KB
5 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=3715860651702850&correlator=2090527831706528&output=ldjh&impl=fifs&vrg=2022020301&ptt=17&sc=1&sfv=1-0-38&ecs=20220208&iu_parts=298443%2Cquestex.lifesciences%2Cfiercepharma%2Cspecialreports&enc_prev_ius=%2F0%2F1%2F2%2F3%2C%2F0%2F1%2F2%2F3%2C%2F0%2F1%2F2%2F3%2C%2F0%2F1%2F2%2F3&prev_iu_szs=1x1%2C1x1%2C1x1%2C1x1&ists=15&prev_scp=pos%3D4%26hb_rfBid%3D0%7Cpos%3D7%26hb_rfBid%3D0%7Cpos%3D9%26hb_rfBid%3D0%7Cpos%3D8%26hb_rfBid%3D0&eri=1&cust_params=section%3DSpecial%2520Reports%26homefront%3D0%26sectionfront%3D0%26article%3D1%26nodeid%3D518261%26fm-tester%3Dundefined%26topic%3Dpsoriasis%252C%2520JAK%2520inhibitor%252C%2520drug%2520launch%252C%2520megamergers%26keyword%3DBristol%2520Myers%2520Squibb%252C%2520Deucravacitinib%252C%2520Otezla%252C%2520Celgene%252C%2520Amgen%252C%2520Novartis%252C%2520Cosentyx%252C%2520Eli%2520Lilly%252C%2520Taltz%252C%2520AbbVie%252C%2520Skyrizi%26tag%3DBristol%2520Myers%2520Squibb%252C%2520Deucravacitinib%252C%2520Otezla%252C%2520Celgene%252C%2520Amgen%252C%2520Novartis%252C%2520Cosentyx%252C%2520Eli%2520Lilly%252C%2520Taltz%252C%2520AbbVie%252C%2520Skyrizi%252Cpsoriasis%252C%2520JAK%2520inhibitor%252C%2520drug%2520launch%252C%2520megamergers%252CSpecial%2520Reports%26path%3D%252Fspecial-report%252F10-most-anticipated-drug-launches-2022-4-deucravacitinib%26browserLargerThan1460%3D1&cookie_enabled=1&bc=31&abxe=1&dt=1644329013933&lmt=1644329012&dlt=1644329013005&idt=591&frm=20&biw=1600&bih=1200&oid=2&adxs=200%2C-12245933%2C800%2C262&adys=24%2C-12245933%2C3143%2C1095&adks=788811237%2C3513369560%2C376738169%2C326019841&ucis=1%7C2%7C3%7C4&ifi=1&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&dmc=8&url=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&vis=1&scr_x=0&scr_y=0&psz=1200x0%7C1200x0%7C1600x0%7C710x0&msz=1200x0%7C0x0%7C1600x0%7C710x0&ga_vid=800578055.1644329014&ga_sid=1644329014&ga_hid=2005409921&ga_fc=true&fws=0%2C128%2C0%2C0&ohw=0%2C0%2C0%2C0&btvi=0%7C-1%7C1%7C0&uach=WyIiLCIiLCIiLCIiLCIiLFtdLG51bGwsbnVsbCwiIixbXV0.&nvt=1
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022020301.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.184.226 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s12-in-f2.1e100.net
Software
cafe /
Resource Hash
ca654ca012f00a16a69a197a73a81f859d7b6bc47b16e7ba2375a2a1bd6b9753
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:34 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2,-2,-2,-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
4645
x-xss-protection
0
google-lineitem-id
4686405525,5899017965,-2,-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138234349545,138379843108,-2,-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
container.html
88de716fcdb80ed5cefd22d492c50498.safeframe.googlesyndication.com/safeframe/1-0-38/html/ Frame 657D
6 KB
4 KB
Document
General
Full URL
https://88de716fcdb80ed5cefd22d492c50498.safeframe.googlesyndication.com/safeframe/1-0-38/html/container.html
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022020301.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:810::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
a73730123a43c3040d889aaee11ec35094277ce5f778076b262c23a293870adb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/

Response headers

accept-ranges
bytes
vary
Accept-Encoding
content-encoding
gzip
content-type
text/html
cross-origin-resource-policy
cross-origin
cross-origin-opener-policy-report-only
same-origin; report-to="ads-gpt-scs"
report-to
{"group":"ads-gpt-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-gpt-scs"}]}
timing-allow-origin
*
content-length
3108
date
Tue, 08 Feb 2022 14:03:34 GMT
expires
Wed, 08 Feb 2023 14:03:34 GMT
cache-control
public, immutable, max-age=31536000
last-modified
Tue, 02 Mar 2021 20:17:03 GMT
x-content-type-options
nosniff
server
sffe
x-xss-protection
0
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
clock
tracking.crazyegg.com/
27 B
134 B
XHR
General
Full URL
https://tracking.crazyegg.com/clock?t=1644329013950
Requested by
Host: script.crazyegg.com
URL: https://script.crazyegg.com/pages/versioned/common-scripts/11.1.381.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.249.212.247 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-34-249-212-247.eu-west-1.compute.amazonaws.com
Software
awselb/2.0 /
Resource Hash
aa095b0aa406f5e0ca743a71ff9523663e57d3874d514854b4d184075d60590d

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

access-control-allow-origin
*
date
Tue, 08 Feb 2022 14:03:34 GMT
cache-control
no-store
server
awselb/2.0
content-length
27
content-type
text/plain
prebid
ib.adnxs.com/ut/v3/ Frame 447C
19 B
853 B
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
37.252.172.37 Frankfurt am Main, Germany, ASN29990 (ASN-APPNEX, US),
Reverse DNS
691.bm-nginx-loadbalancer.mgmt.fra1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
0c09c070833c786cb25be38bc30992b30bad578f817dbc9e34beacd8b8ea44c5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://p.nodserving.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Pragma
no-cache
Date
Tue, 08 Feb 2022 14:03:34 GMT
X-Proxy-Origin
84.19.175.183; 84.19.175.183; 691.bm-nginx-loadbalancer.mgmt.fra1; adnxs.com
AN-X-Request-Uuid
0bd30138-b73b-4954-bcb3-241c43f24fad
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
https://p.nodserving.com
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json; charset=utf-8
Content-Length
19
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
cdb
bidder.criteo.com/ Frame 447C
0
217 B
XHR
General
Full URL
https://bidder.criteo.com/cdb?profileId=207&av=31&wv=3.22&cb=66197187782
Requested by
Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
178.250.0.165 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
bidder.par.vip.prod.criteo.com
Software
Finatra /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Referer
https://p.nodserving.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

date
Tue, 08 Feb 2022 14:03:33 GMT
server
Finatra
vary
Origin
access-control-allow-origin
https://p.nodserving.com
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
strict-transport-security
max-age=31536000; preload;
timing-allow-origin
*
prebid-request
onetag-sys.com/ Frame 447C
15 B
363 B
XHR
General
Full URL
https://onetag-sys.com/prebid-request
Requested by
Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
51.38.120.206 , France, ASN16276 (OVH, FR),
Reverse DNS
ip206.ip-51-38-120.eu
Software
/
Resource Hash
663dab1310a7e64c3bdd7dfdc81b7fc9a28884d4ee290b96077c7b32bbe84707
Security Headers
Name Value
Strict-Transport-Security max-age=15552000

Request headers

Referer
https://p.nodserving.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

strict-transport-security
max-age=15552000
content-encoding
gzip
p3p
CP='CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR'
access-control-allow-origin
https://p.nodserving.com
cache-control
no-transform, no-cache
access-control-allow-credentials
true
content-type
application/json
access-control-allow-headers
content-type, origin, referer, user-agent
content-length
41
bids
prebid-eu.creativecdn.com/bidder/prebid/ Frame 447C
0
178 B
XHR
General
Full URL
https://prebid-eu.creativecdn.com/bidder/prebid/bids
Requested by
Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
185.184.8.65 Amsterdam, Netherlands, ASN204995 (RTB-HOUSE-AMS, PL),
Reverse DNS
ip-185-184-8-65.rtbhouse.net
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://p.nodserving.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

access-control-allow-origin
https://p.nodserving.com
date
Tue, 08 Feb 2022 14:03:34 GMT
access-control-allow-credentials
true
access-control-max-age
3600
vary
Origin
access-control-allow-methods
POST
auction
rtb.adxpremium.services/openrtb2/ Frame 447C
0
0

prebid
ib.adnxs.com/ut/v3/ Frame 447C
19 B
853 B
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
37.252.172.37 Frankfurt am Main, Germany, ASN29990 (ASN-APPNEX, US),
Reverse DNS
691.bm-nginx-loadbalancer.mgmt.fra1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
0c09c070833c786cb25be38bc30992b30bad578f817dbc9e34beacd8b8ea44c5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://p.nodserving.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Pragma
no-cache
Date
Tue, 08 Feb 2022 14:03:34 GMT
X-Proxy-Origin
84.19.175.183; 84.19.175.183; 691.bm-nginx-loadbalancer.mgmt.fra1; adnxs.com
AN-X-Request-Uuid
83b7db2e-6954-49e5-93b8-13ae77faa7a9
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
https://p.nodserving.com
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json; charset=utf-8
Content-Length
19
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
cdb
bidder.criteo.com/ Frame 447C
0
217 B
XHR
General
Full URL
https://bidder.criteo.com/cdb?profileId=207&av=31&wv=3.22&cb=34832903244
Requested by
Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
178.250.0.165 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
bidder.par.vip.prod.criteo.com
Software
Finatra /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Referer
https://p.nodserving.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

date
Tue, 08 Feb 2022 14:03:33 GMT
server
Finatra
vary
Origin
access-control-allow-origin
https://p.nodserving.com
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
strict-transport-security
max-age=31536000; preload;
timing-allow-origin
*
prebid-request
onetag-sys.com/ Frame 447C
15 B
363 B
XHR
General
Full URL
https://onetag-sys.com/prebid-request
Requested by
Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
51.38.120.206 , France, ASN16276 (OVH, FR),
Reverse DNS
ip206.ip-51-38-120.eu
Software
/
Resource Hash
663dab1310a7e64c3bdd7dfdc81b7fc9a28884d4ee290b96077c7b32bbe84707
Security Headers
Name Value
Strict-Transport-Security max-age=15552000

Request headers

Referer
https://p.nodserving.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

strict-transport-security
max-age=15552000
content-encoding
gzip
p3p
CP='CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR'
access-control-allow-origin
https://p.nodserving.com
cache-control
no-transform, no-cache
access-control-allow-credentials
true
content-type
application/json
access-control-allow-headers
content-type, origin, referer, user-agent
content-length
41
bids
prebid-eu.creativecdn.com/bidder/prebid/ Frame 447C
0
178 B
XHR
General
Full URL
https://prebid-eu.creativecdn.com/bidder/prebid/bids
Requested by
Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
185.184.8.65 Amsterdam, Netherlands, ASN204995 (RTB-HOUSE-AMS, PL),
Reverse DNS
ip-185-184-8-65.rtbhouse.net
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://p.nodserving.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

access-control-allow-origin
https://p.nodserving.com
date
Tue, 08 Feb 2022 14:03:34 GMT
access-control-allow-credentials
true
access-control-max-age
3600
vary
Origin
access-control-allow-methods
POST
auction
rtb.adxpremium.services/openrtb2/ Frame 447C
0
0

prebid
ib.adnxs.com/ut/v3/ Frame 447C
19 B
853 B
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
37.252.172.37 Frankfurt am Main, Germany, ASN29990 (ASN-APPNEX, US),
Reverse DNS
691.bm-nginx-loadbalancer.mgmt.fra1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
0c09c070833c786cb25be38bc30992b30bad578f817dbc9e34beacd8b8ea44c5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://p.nodserving.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Pragma
no-cache
Date
Tue, 08 Feb 2022 14:03:34 GMT
X-Proxy-Origin
84.19.175.183; 84.19.175.183; 691.bm-nginx-loadbalancer.mgmt.fra1; adnxs.com
AN-X-Request-Uuid
a1f65d59-c90a-4c4d-9a59-fe997710b867
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
https://p.nodserving.com
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json; charset=utf-8
Content-Length
19
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
cdb
bidder.criteo.com/ Frame 447C
0
217 B
XHR
General
Full URL
https://bidder.criteo.com/cdb?profileId=207&av=31&wv=3.22&cb=36878908682
Requested by
Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
178.250.0.165 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
bidder.par.vip.prod.criteo.com
Software
Finatra /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Referer
https://p.nodserving.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

date
Tue, 08 Feb 2022 14:03:33 GMT
server
Finatra
vary
Origin
access-control-allow-origin
https://p.nodserving.com
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
strict-transport-security
max-age=31536000; preload;
timing-allow-origin
*
prebid-request
onetag-sys.com/ Frame 447C
15 B
363 B
XHR
General
Full URL
https://onetag-sys.com/prebid-request
Requested by
Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
51.38.120.206 , France, ASN16276 (OVH, FR),
Reverse DNS
ip206.ip-51-38-120.eu
Software
/
Resource Hash
663dab1310a7e64c3bdd7dfdc81b7fc9a28884d4ee290b96077c7b32bbe84707
Security Headers
Name Value
Strict-Transport-Security max-age=15552000

Request headers

Referer
https://p.nodserving.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

strict-transport-security
max-age=15552000
content-encoding
gzip
p3p
CP='CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR'
access-control-allow-origin
https://p.nodserving.com
cache-control
no-transform, no-cache
access-control-allow-credentials
true
content-type
application/json
access-control-allow-headers
content-type, origin, referer, user-agent
content-length
41
bids
prebid-eu.creativecdn.com/bidder/prebid/ Frame 447C
0
178 B
XHR
General
Full URL
https://prebid-eu.creativecdn.com/bidder/prebid/bids
Requested by
Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
185.184.8.65 Amsterdam, Netherlands, ASN204995 (RTB-HOUSE-AMS, PL),
Reverse DNS
ip-185-184-8-65.rtbhouse.net
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://p.nodserving.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

access-control-allow-origin
https://p.nodserving.com
date
Tue, 08 Feb 2022 14:03:34 GMT
access-control-allow-credentials
true
access-control-max-age
3600
vary
Origin
access-control-allow-methods
POST
auction
rtb.adxpremium.services/openrtb2/ Frame 447C
0
0

prebid
ib.adnxs.com/ut/v3/ Frame 447C
19 B
853 B
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
37.252.172.37 Frankfurt am Main, Germany, ASN29990 (ASN-APPNEX, US),
Reverse DNS
691.bm-nginx-loadbalancer.mgmt.fra1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
0c09c070833c786cb25be38bc30992b30bad578f817dbc9e34beacd8b8ea44c5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://p.nodserving.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Pragma
no-cache
Date
Tue, 08 Feb 2022 14:03:34 GMT
X-Proxy-Origin
84.19.175.183; 84.19.175.183; 691.bm-nginx-loadbalancer.mgmt.fra1; adnxs.com
AN-X-Request-Uuid
f70e3de8-a09c-4f23-8268-799a7533331d
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
https://p.nodserving.com
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json; charset=utf-8
Content-Length
19
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
cdb
bidder.criteo.com/ Frame 447C
0
217 B
XHR
General
Full URL
https://bidder.criteo.com/cdb?profileId=207&av=31&wv=3.22&cb=65022985886
Requested by
Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
178.250.0.165 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
bidder.par.vip.prod.criteo.com
Software
Finatra /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Referer
https://p.nodserving.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

date
Tue, 08 Feb 2022 14:03:33 GMT
server
Finatra
vary
Origin
access-control-allow-origin
https://p.nodserving.com
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
strict-transport-security
max-age=31536000; preload;
timing-allow-origin
*
prebid-request
onetag-sys.com/ Frame 447C
15 B
363 B
XHR
General
Full URL
https://onetag-sys.com/prebid-request
Requested by
Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
51.38.120.206 , France, ASN16276 (OVH, FR),
Reverse DNS
ip206.ip-51-38-120.eu
Software
/
Resource Hash
663dab1310a7e64c3bdd7dfdc81b7fc9a28884d4ee290b96077c7b32bbe84707
Security Headers
Name Value
Strict-Transport-Security max-age=15552000

Request headers

Referer
https://p.nodserving.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

strict-transport-security
max-age=15552000
content-encoding
gzip
p3p
CP='CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR'
access-control-allow-origin
https://p.nodserving.com
cache-control
no-transform, no-cache
access-control-allow-credentials
true
content-type
application/json
access-control-allow-headers
content-type, origin, referer, user-agent
content-length
41
bids
prebid-eu.creativecdn.com/bidder/prebid/ Frame 447C
0
178 B
XHR
General
Full URL
https://prebid-eu.creativecdn.com/bidder/prebid/bids
Requested by
Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
185.184.8.65 Amsterdam, Netherlands, ASN204995 (RTB-HOUSE-AMS, PL),
Reverse DNS
ip-185-184-8-65.rtbhouse.net
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://p.nodserving.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

access-control-allow-origin
https://p.nodserving.com
date
Tue, 08 Feb 2022 14:03:34 GMT
access-control-allow-credentials
true
access-control-max-age
3600
vary
Origin
access-control-allow-methods
POST
auction
rtb.adxpremium.services/openrtb2/ Frame 447C
0
0

prebid
ib.adnxs.com/ut/v3/ Frame 447C
19 B
853 B
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
37.252.172.37 Frankfurt am Main, Germany, ASN29990 (ASN-APPNEX, US),
Reverse DNS
691.bm-nginx-loadbalancer.mgmt.fra1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
0c09c070833c786cb25be38bc30992b30bad578f817dbc9e34beacd8b8ea44c5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://p.nodserving.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Pragma
no-cache
Date
Tue, 08 Feb 2022 14:03:34 GMT
X-Proxy-Origin
84.19.175.183; 84.19.175.183; 691.bm-nginx-loadbalancer.mgmt.fra1; adnxs.com
AN-X-Request-Uuid
b4ecff5d-54ec-41dd-b3d7-bbc70baa560f
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
https://p.nodserving.com
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json; charset=utf-8
Content-Length
19
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
cdb
bidder.criteo.com/ Frame 447C
0
217 B
XHR
General
Full URL
https://bidder.criteo.com/cdb?profileId=207&av=31&wv=3.22&cb=78221222204
Requested by
Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
178.250.0.165 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
bidder.par.vip.prod.criteo.com
Software
Finatra /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Referer
https://p.nodserving.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

date
Tue, 08 Feb 2022 14:03:33 GMT
server
Finatra
vary
Origin
access-control-allow-origin
https://p.nodserving.com
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
strict-transport-security
max-age=31536000; preload;
timing-allow-origin
*
prebid-request
onetag-sys.com/ Frame 447C
15 B
363 B
XHR
General
Full URL
https://onetag-sys.com/prebid-request
Requested by
Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
51.38.120.206 , France, ASN16276 (OVH, FR),
Reverse DNS
ip206.ip-51-38-120.eu
Software
/
Resource Hash
663dab1310a7e64c3bdd7dfdc81b7fc9a28884d4ee290b96077c7b32bbe84707
Security Headers
Name Value
Strict-Transport-Security max-age=15552000

Request headers

Referer
https://p.nodserving.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

strict-transport-security
max-age=15552000
content-encoding
gzip
p3p
CP='CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR'
access-control-allow-origin
https://p.nodserving.com
cache-control
no-transform, no-cache
access-control-allow-credentials
true
content-type
application/json
access-control-allow-headers
content-type, origin, referer, user-agent
content-length
41
bids
prebid-eu.creativecdn.com/bidder/prebid/ Frame 447C
0
178 B
XHR
General
Full URL
https://prebid-eu.creativecdn.com/bidder/prebid/bids
Requested by
Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
185.184.8.65 Amsterdam, Netherlands, ASN204995 (RTB-HOUSE-AMS, PL),
Reverse DNS
ip-185-184-8-65.rtbhouse.net
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://p.nodserving.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

access-control-allow-origin
https://p.nodserving.com
date
Tue, 08 Feb 2022 14:03:34 GMT
access-control-allow-credentials
true
access-control-max-age
3600
vary
Origin
access-control-allow-methods
POST
auction
rtb.adxpremium.services/openrtb2/ Frame 447C
0
0

csyncs
ghb.hbmp.mediafuse.com/
441 B
578 B
XHR
General
Full URL
https://ghb.hbmp.mediafuse.com/csyncs?aid1=535746&aid2=535749&aid3=undefined
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/456758/hbw_master_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
2a0c:5c81:5142::2 London, United Kingdom, ASN55081 (24SHELLS, US),
Reverse DNS
Software
VertaMedia 1.0 /
Resource Hash
8511f98206804fb8c0075966c6b5d03399d359e87c22aa0a4285ed906fdeffe0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Tue, 08 Feb 2022 14:03:33 GMT
Content-Encoding
gzip
Server
VertaMedia 1.0
Content-Type
application/json; charset=UTF-8
Access-Control-Allow-Origin
https://www.fiercepharma.com
Access-Control-Allow-Credentials
true
Connection
Keep-Alive
Content-Length
283
7c3.js
sync.medidexs.com/ps/10/
57 KB
21 KB
Script
General
Full URL
https://sync.medidexs.com/ps/10/7c3.js
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/456758/hbw_master_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
45.133.44.3 Philadelphia, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software
nginx /
Resource Hash
baf0ab84c1595ad02bf60b1d84cb1f271fd13486fd76dc599ec425f0c91c65be

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:34 GMT
content-encoding
gzip
last-modified
Mon, 07 Feb 2022 10:35:22 GMT
server
nginx
etag
W/"6200f5ea-e3ef"
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=3600
expires
Tue, 08 Feb 2022 15:03:34 GMT
170
a.ad.gt/api/v1/u/matches/
3 KB
4 KB
Script
General
Full URL
https://a.ad.gt/api/v1/u/matches/170
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/456758/hbw_master_302826_6936.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.149.174.3 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-54-149-174-3.us-west-2.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash
621905724521efdbc3275b3656e78a7441085d19eca88217d46bb827dd6046eb

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:34 GMT
server
nginx/1.18.0
content-length
3210
content-type
application/javascript
init-1016mnvd6jvjr44ajs9g.js
api.fouanalytics.com/api/
473 B
929 B
Script
General
Full URL
https://api.fouanalytics.com/api/init-1016mnvd6jvjr44ajs9g.js
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/456758/hbw_master_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:3033::6815:3a2a , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
5e828d5a3812a8c7d5599ea964aee835230f4581353e1d4745981773df5d6bd9

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:34 GMT
content-encoding
br
cf-cache-status
DYNAMIC
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=CMgGsVPM46U8gWDF3TwUYh4o7TIgLAhY9rLJHKyeFw8ttBaakMdyZcwumVvJC4liROhw1Bf0NZM60pnd87rqqgtH%2B972TGC4pmiv92VMpWEeDpTqpdDQVq34afFMRrYjCGAPiBChD%2Fx6vmkbT4WMWfrFEg%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type
text/javascript
cache-control
no-cache, no-store, must-revalidate
cf-ray
6da566f1ca9d924d-FRA
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
expires
0
/
c405.fiercepharma.com/DG/DEFAULT/rest/rpc/
0
0
Script
General
Full URL
https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22getProfile%22%2C%22params%22%3A%22null%22%2C%22id%22%3A%221644329013130%22%7D%2C%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22language%5C%22%3A%5B%5C%22en%5C%22%5D%2C%5C%22currentscreenwidth%5C%22%3A%5B1600%5D%2C%5C%22currentscreenheight%5C%22%3A%5B1200%5D%2C%5C%22currentresolution%5C%22%3A%5B%5C%221600x1200%5C%22%5D%2C%5C%22entrypage%5C%22%3A%5B%5C%22https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib%5C%22%5D%2C%5C%22new_visit_bc%5C%22%3A%5B%5C%22true%5C%22%5D%7D%2C%5C%22sources%5C%22%3A%7B%5C%22listenerinteractiontype%5C%22%3A%5B%5C%22language%5C%22%2C%5C%22currentscreenwidth%5C%22%2C%5C%22currentscreenheight%5C%22%2C%5C%22currentresolution%5C%22%2C%5C%22entrypage%5C%22%5D%2C%5C%22newvisitlistener%5C%22%3A%5B%5C%22new_visit_bc%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644329013132%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22resolution%5C%22%3A%5B%5C%221600x1200%5C%22%5D%7D%2C%5C%22sources%5C%22%3A%7B%5C%22listenerinteractiontype%5C%22%3A%5B%5C%22resolution%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644329013133%22%7D%2C%7B%22method%22%3A%22createEvent%22%2C%22params%22%3A%22%7B%5C%22type%5C%22%3A%5B%5C%22PAGEVIEW%5C%22%5D%2C%5C%22referrer%5C%22%3A%5B%5C%22%5C%22%5D%2C%5C%22profile%5C%22%3A%5B%5D%7D%22%2C%22id%22%3A%221644329013134%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-08T14%3A03%3A33%2B00%3A00&callback=bc_json796
Requested by
Host: cdn.blueconic.net
URL: https://cdn.blueconic.net/questex.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.86.3.109 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-3-109.fra6.r.cloudfront.net
Software
/
Resource Hash

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

1px-matching-adtelligent.gif
t.trafmag.com/images/images/
Redirect Chain
  • https://sync.adtelligent.com/csync?&redir=https%3A%2F%2Ft.trafmag.com%2Fimages%2Fimages%2F1px-matching-adtelligent.gif%3Fid%3D%7Buid%7D
  • https://t.trafmag.com/images/images/1px-matching-adtelligent.gif?id=dee7590cecd5b9a6
35 B
351 B
Image
General
Full URL
https://t.trafmag.com/images/images/1px-matching-adtelligent.gif?id=dee7590cecd5b9a6
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
HTTP/1.1
Server
193.200.65.5 Amsterdam, Netherlands, ASN6681 (GIVEME-CLOUD, PL),
Reverse DNS
t.trafmag.com
Software
nginx /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Tue, 08 Feb 2022 14:03:36 GMT
Server
nginx
Connection
keep-alive
Content-Type
image/gif
Content-Length
35
P3P
CP="NON DSP COR CURa TIA"

Redirect headers

Location
https://t.trafmag.com/images/images/1px-matching-adtelligent.gif?id=dee7590cecd5b9a6
Date
Tue, 08 Feb 2022 14:03:35 GMT
Server
VertaMedia 1.0
Etag
dee7590cecd5b9a6
Content-Length
0
match
dm.hybrid.ai/
0
238 B
Image
General
Full URL
https://dm.hybrid.ai/match?id=186&burl=https%3A%2F%2Fsync.adtelligent.com%2Fcsync%3Ft%3Da%26ep%3D324902%26extuid%3D%24%7BVID%7D
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
37.18.16.16 , Russian Federation, ASN205675 (HYBRID-AS, RU),
Reverse DNS
Software
Hybrid Web Server /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 08 Feb 2022 14:03:34 GMT
server
Hybrid Web Server
p3p
CP="NOI DSP COR CUR ADMa DEVo TAIo PSAo PSDo IVAo IVDo OUR IND COM NAV INT STA OTC"
access-control-allow-origin
*
cache-control
no-cache, no-store
x-mode
106
x-xss-protection
1; mode=block
expires
-1
universal-tag.js
ads.spotible.com/tag/ Frame 8F33
0
0

truncated
/ Frame 8F33
212 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
7dbd08f38e653616e532e19722470d509ea90219f9f1285f19f60587e71e1dae

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Content-Type
image/png
allstream.js
creative.spotible.com/tag/ Frame 8C21
4 KB
2 KB
Script
General
Full URL
https://creative.spotible.com/tag/allstream.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022020301.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
54.144.118.149 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-144-118-149.compute-1.amazonaws.com
Software
/
Resource Hash
13b3e0ebce53b1bad544de9ab941325c97244335a255d701f964667fdcec7e12

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:33 GMT
cache-control
public, max-age=3600
content-encoding
gzip
etag
"13d60a009d7a4ed35e01731ee02c2db7"
vary
accept-encoding
content-type
application/javascript
spinner.gif
cdn.omeda.com/hosted/images/dragon/generic/ Frame 8E4A
9 KB
9 KB
Image
General
Full URL
https://cdn.omeda.com/hosted/images/dragon/generic/spinner.gif
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/init.do?omedasite=FiercePharma_short
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
205.162.42.5 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
cdn.omeda.com
Software
Apache /
Resource Hash
056dd44aece96c67e45ba421d734f125e1497bbdb3b70194b7aadb8a68d10085
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Tue, 08 Feb 2022 15:03:34 CET
X-Content-Type-Options
nosniff
Last-Modified
Mon, 10 Oct 2016 22:45:02 CEST
Server
Apache
ETag
W/"8851-1476132302920"
X-Frame-Options
SAMEORIGIN
Content-Type
image/gif
Access-Control-Allow-Origin
*
Access-Control-Expose-Headers
Access-Control-Allow-Origin,Access-Control-Allow-Credentials
Transfer-Encoding
chunked
Accept-Ranges
bytes
X-XSS-Protection
1; mode=block
index.php
a.dpmsrv.com/dpmpxl/
Redirect Chain
  • https://cm.g.doubleclick.net/pixel?google_nid=datapoint_dmp&google_cm&ap_id=5611407578940007418&pixelIndex=0&_=1644329013516
  • https://a.dpmsrv.com/dpmpxl/index.php?q=dfp&ap_id=5611407578940007418&pixelIndex=0&_=1644329013516&google_gid=CAESEA3-l_Gnaz_pvXyZ-K0qbeA&google_cver=1
0
597 B
Script
General
Full URL
https://a.dpmsrv.com/dpmpxl/index.php?q=dfp&ap_id=5611407578940007418&pixelIndex=0&_=1644329013516&google_gid=CAESEA3-l_Gnaz_pvXyZ-K0qbeA&google_cver=1
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
HTTP/1.1
Server
3.226.203.17 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-226-203-17.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Pragma
no-cache
Access-Control-Max-Age
10
Access-Control-Allow-Methods
GET, POST, PUT, DELETE, OPTIONS
P3P
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
Access-Control-Allow-Origin
*
Cache-Control
no-cache, no-store, must-revalidate
Connection
keep-alive
Content-Type
text/javascript
Access-Control-Allow-Headers
content-type, accept
Content-Length
0
Expires
0

Redirect headers

pragma
no-cache
date
Tue, 08 Feb 2022 14:03:34 GMT
server
HTTP server (unknown)
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
location
https://a.dpmsrv.com/dpmpxl/index.php?q=dfp&ap_id=5611407578940007418&pixelIndex=0&_=1644329013516&google_gid=CAESEA3-l_Gnaz_pvXyZ-K0qbeA&google_cver=1
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
text/html; charset=UTF-8
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
368
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
423396.gif
idsync.rlcdn.com/
0
66 B
Image
General
Full URL
https://idsync.rlcdn.com/423396.gif?partner_uid=5611407578940007418
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.244.174.68 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
68.174.244.35.bc.googleusercontent.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:34 GMT
via
1.1 google
alt-svc
clear
content-length
0
pp.js
api-54-185-136-237.b2c.com/s/
13 KB
5 KB
Script
General
Full URL
https://api-54-185-136-237.b2c.com/s/pp.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::681a:723 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
4f999f96da9bb7bd681b62c42ef5e5e2c9d80896b8aafa4a030279c0d05ea674

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:34 GMT
content-encoding
br
cf-cache-status
HIT
last-modified
Mon, 03 Jan 2022 15:12:15 GMT
server
cloudflare
age
811
etag
W/"61d3124f-3346"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=3ZWcX7rYSIwvZLgTAWV66zIN4qBgQmLKu%2BS993CiRB6d447%2BPUQs%2BrMiMldRKrZxSggv1zPLtCNshKKqey7ZGt7QT%2BtqIfWpp68uu1wPruWyq%2FgPgPP2hgG%2BuhGTV%2B4UeMDHwVZZWUCvKcdJRV%2B%2B0sx0yJ45cvbJ"}],"group":"cf-nel","max_age":604800}
content-type
text/javascript
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
cf-ray
6da566f39de59116-FRA
ad.gif
api-54-185-136-237.b2c.com/s/
43 B
379 B
Image
General
Full URL
https://api-54-185-136-237.b2c.com/s/ad.gif
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::681a:723 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
dcecab1355b5c2b9ecef281322bf265ac5840b4688748586e9632b473a5fe56b

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:34 GMT
cf-cache-status
HIT
last-modified
Mon, 03 Jan 2022 15:12:15 GMT
server
cloudflare
age
812
etag
"61d3124f-2b"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=RohicjZ9Un6pC%2F%2BvwRMSeEBbq0tOLefQWGWwQy5N6QJ%2BIAmD%2Bx%2FbUUvZ6KkfGeIVyarpBbECys1I2JBngtrjvLD3OAC5ztc4ANjjx9cgF8mztYXRuOFKP20T2PpBp5oXrfDWCUF4xg8wE7IemvDZPfbf9CVOLQE3"}],"group":"cf-nel","max_age":604800}
content-type
text/plain; charset=utf-8
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
accept-ranges
bytes
cf-ray
6da566f41f3b9116-FRA
content-length
43
/
c405.fiercepharma.com/DG/DEFAULT/rest/rpc/
0
0
Script
General
Full URL
https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22getProfile%22%2C%22params%22%3A%22null%22%2C%22id%22%3A%221644329013130%22%7D%2C%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22language%5C%22%3A%5B%5C%22en%5C%22%5D%2C%5C%22currentscreenwidth%5C%22%3A%5B1600%5D%2C%5C%22currentscreenheight%5C%22%3A%5B1200%5D%2C%5C%22currentresolution%5C%22%3A%5B%5C%221600x1200%5C%22%5D%2C%5C%22entrypage%5C%22%3A%5B%5C%22https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib%5C%22%5D%2C%5C%22new_visit_bc%5C%22%3A%5B%5C%22true%5C%22%5D%7D%2C%5C%22sources%5C%22%3A%7B%5C%22listenerinteractiontype%5C%22%3A%5B%5C%22language%5C%22%2C%5C%22currentscreenwidth%5C%22%2C%5C%22currentscreenheight%5C%22%2C%5C%22currentresolution%5C%22%2C%5C%22entrypage%5C%22%5D%2C%5C%22newvisitlistener%5C%22%3A%5B%5C%22new_visit_bc%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644329013132%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22resolution%5C%22%3A%5B%5C%221600x1200%5C%22%5D%7D%2C%5C%22sources%5C%22%3A%7B%5C%22listenerinteractiontype%5C%22%3A%5B%5C%22resolution%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644329013133%22%7D%2C%7B%22method%22%3A%22createEvent%22%2C%22params%22%3A%22%7B%5C%22type%5C%22%3A%5B%5C%22PAGEVIEW%5C%22%5D%2C%5C%22referrer%5C%22%3A%5B%5C%22%5C%22%5D%2C%5C%22profile%5C%22%3A%5B%5D%7D%22%2C%22id%22%3A%221644329013134%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-08T14%3A03%3A34%2B00%3A00&callback=bc_json797
Requested by
Host: cdn.blueconic.net
URL: https://cdn.blueconic.net/questex.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.86.3.109 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-3-109.fra6.r.cloudfront.net
Software
/
Resource Hash

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

storage-delegate.html
creative.spotible.com/tag/ Frame 9E39
581 B
498 B
Document
General
Full URL
https://creative.spotible.com/tag/storage-delegate.html
Requested by
Host: creative.spotible.com
URL: https://creative.spotible.com/tag/allstream.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
54.144.118.149 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-144-118-149.compute-1.amazonaws.com
Software
/
Resource Hash
3560bdf6b103e68c5e0aa13507ad74e7e2ced19d36257d4f7685e121fa4fa30d

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/

Response headers

etag
"60fdf8d946db5045a34df20232ae250b"
cache-control
public, max-age=3600
vary
accept-encoding
content-encoding
gzip
content-type
text/html
date
Tue, 08 Feb 2022 14:03:33 GMT
delivery.js
creative.spotible.com/creative/GxHs/
75 KB
25 KB
Script
General
Full URL
https://creative.spotible.com/creative/GxHs/delivery.js?referrer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib
Requested by
Host: creative.spotible.com
URL: https://creative.spotible.com/tag/allstream.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
54.144.118.149 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-144-118-149.compute-1.amazonaws.com
Software
/
Resource Hash
c791e7be198c73b6ed9350db2456e8f132f2b89d81e9a8c4cc75fee614ecc77d

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:33 GMT
cache-control
no-cache
content-encoding
gzip
etag
"8faf25c4203e7c4a91631eeb4b78c34e"
vary
accept-encoding
content-type
application/javascript;charset=utf-8
olytics
oqs.omeda.com/oqs/rest/ Frame
0
0
Preflight
General
Full URL
https://oqs.omeda.com/oqs/rest/olytics
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.165 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
Software
Apache /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Accept
*/*
Access-Control-Request-Method
POST
Access-Control-Request-Headers
content-type
Origin
https://www.fiercepharma.com
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

X-Frame-Options
SAMEORIGIN
X-Content-Type-Options
nosniff
X-XSS-Protection
1; mode=block
Access-Control-Max-Age
600
Access-Control-Allow-Origin
*
Access-Control-Allow-Headers
Access-Control-Request-Headers, Content-Type, Origin, Accept, Accept-Encoding, Accept-Language, HOST, User-Agent, Access-Control-Request-Method, Access-Control-Max-Age
Content-Type
text/plain
Content-Length
0
Date
Tue, 08 Feb 2022 14:03:34 GMT
Server
Apache
adsbygoogle.js
pagead2.googlesyndication.com/pagead/js/
0
0
Fetch
General
Full URL
https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js
Requested by
Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:827::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 08 Feb 2022 14:03:34 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
etag
2869578527140438266
vary
Accept-Encoding, Origin
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
private, max-age=3600
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
text/javascript; charset=UTF-8
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
x-xss-protection
0
expires
Tue, 08 Feb 2022 14:03:34 GMT
olytics
oqs.omeda.com/oqs/rest/
15 B
307 B
XHR
General
Full URL
https://oqs.omeda.com/oqs/rest/olytics
Requested by
Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.165 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
Software
Apache /
Resource Hash
ee2bd946a7a0e25dd3f7606bf975cfaa824c7eb902568f5e711f361be35196ee
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
application/json

Response headers

Date
Tue, 08 Feb 2022 14:03:34 GMT
X-Content-Type-Options
nosniff
Server
Apache
X-Frame-Options
SAMEORIGIN
Content-Type
application/json
Access-Control-Allow-Origin
*
Cache-Control
no-cache
Transfer-Encoding
chunked
X-XSS-Protection
1; mode=block
haloid
aufp.io/api/v1/
6 KB
3 KB
Script
General
Full URL
https://aufp.io/api/v1/haloid
Requested by
Host: a.ad.gt
URL: https://a.ad.gt/api/v1/u/matches/170
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.35.70.100 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-35-70-100.us-west-2.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash
85e50082d7ce113bfa87dbade18dbf747d1bacfcffdbd628296dcffa98a08f94

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:35 GMT
content-encoding
gzip
last-modified
Wed, 02 Feb 2022 00:28:16 GMT
server
nginx/1.18.0
etag
W/"1643761696.0-6132-2958560116"
access-control-allow-methods
GET, POST, OPTIONS
content-type
application/javascript
access-control-allow-origin
*, *
access-control-expose-headers
DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Content-Range,Range
cache-control
public, max-age=43200
origin-trial
A/KTxPuSXtwcggydvUxw5B4dXspsb2iweedc7KDi2xv9M89MtnOpULTs7DQJVHBxGDV5wj5a3LW9S4ev3WfQkwIAAAB+eyJvcmlnaW4iOiJodHRwczovL2hhbG9mbG9jLmNvbTo0NDMiLCJmZWF0dXJlIjoiSW50ZXJlc3RDb2hvcnRBUEkiLCJleHBpcnkiOjE2MjYyMjA3OTksImlzU3ViZG9tYWluIjp0cnVlLCJpc1RoaXJkUGFydHkiOnRydWV9
access-control-allow-headers
DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Content-Range,Range
expires
Wed, 09 Feb 2022 02:03:35 GMT
170
p.ad.gt/api/v1/p/
26 KB
8 KB
Script
General
Full URL
https://p.ad.gt/api/v1/p/170
Requested by
Host: a.ad.gt
URL: https://a.ad.gt/api/v1/u/matches/170
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
44.230.193.23 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-44-230-193-23.us-west-2.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash
e6974b62b821dafba979149e0d3dd2d2942c2f49be62d2d2c581c1e2899a9027

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:35 GMT
content-encoding
gzip
last-modified
Wed, 02 Feb 2022 00:25:44 GMT
server
nginx/1.18.0
etag
W/"1643761544.0-26279-2710964840"
access-control-allow-methods
GET, POST, OPTIONS
content-type
application/javascript
access-control-allow-origin
*
access-control-expose-headers
DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Content-Range,Range
cache-control
public, max-age=43200
access-control-allow-headers
DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Content-Range,Range
expires
Wed, 09 Feb 2022 02:03:35 GMT
match
ids.ad.gt/api/v1/
Redirect Chain
  • https://secure.adnxs.com/getuid?https://ids.ad.gt/api/v1/match?id=71ea94e0-0093-44cb-b4dd-d08066fc43e4&adnxs_id=$UID
  • https://ids.ad.gt/api/v1/match?id=71ea94e0-0093-44cb-b4dd-d08066fc43e4&adnxs_id=5611407578940007418
43 B
565 B
Image
General
Full URL
https://ids.ad.gt/api/v1/match?id=71ea94e0-0093-44cb-b4dd-d08066fc43e4&adnxs_id=5611407578940007418
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
H2
Server
52.43.149.174 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-43-149-174.us-west-2.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:35 GMT
cache-control
public, max-age=43200
server
nginx/1.18.0
content-type
image/gif
expires
Wed, 09 Feb 2022 02:03:35 GMT

Redirect headers

Pragma
no-cache
Date
Tue, 08 Feb 2022 14:03:34 GMT
X-Proxy-Origin
84.19.175.183; 84.19.175.183; 721.bm-nginx-loadbalancer.mgmt.ams1; adnxs.com
AN-X-Request-Uuid
e162a994-a6a2-47a5-a8b2-89eebe3488ac
Server
nginx/1.17.9
Access-Control-Allow-Origin
*
P3P
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Location
https://ids.ad.gt/api/v1/match?id=71ea94e0-0093-44cb-b4dd-d08066fc43e4&adnxs_id=5611407578940007418
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
text/html; charset=utf-8
Content-Length
0
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
t_match
ids.ad.gt/api/v1/
Redirect Chain
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=8gkxb6n&ttd_tpi=1&gpdr=0&ttd_puid=71ea94e0-0093-44cb-b4dd-d08066fc43e4
  • https://match.adsrvr.org/track/cmb/generic?ttd_pid=8gkxb6n&ttd_tpi=1&gpdr=0&ttd_puid=71ea94e0-0093-44cb-b4dd-d08066fc43e4
  • https://ids.ad.gt/api/v1/t_match?tdid=5f6d2359-c211-4f10-9b58-14dbad0adcf8&id=71ea94e0-0093-44cb-b4dd-d08066fc43e4
43 B
569 B
Image
General
Full URL
https://ids.ad.gt/api/v1/t_match?tdid=5f6d2359-c211-4f10-9b58-14dbad0adcf8&id=71ea94e0-0093-44cb-b4dd-d08066fc43e4
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
H2
Server
52.43.149.174 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-43-149-174.us-west-2.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:35 GMT
cache-control
public, max-age=43200
server
nginx/1.18.0
content-type
image/gif
expires
Wed, 09 Feb 2022 02:03:35 GMT

Redirect headers

pragma
no-cache
date
Tue, 08 Feb 2022 14:03:34 GMT
x-aspnet-version
4.0.30319
p3p
CP="NOI DSP COR CUR ADMo DEVo PSAo PSDo OUR SAMo BUS UNI NAV"
location
https://ids.ad.gt/api/v1/t_match?tdid=5f6d2359-c211-4f10-9b58-14dbad0adcf8&id=71ea94e0-0093-44cb-b4dd-d08066fc43e4
cache-control
private,no-cache, must-revalidate
content-type
text/html
content-length
259
pbm_match
ids.ad.gt/api/v1/
Redirect Chain
  • https://image2.pubmatic.com/AdServer/UCookieSetPug?rd=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fpbm_match%3Fpbm%3D%23PM_USER_ID%26id%3D71ea94e0-0093-44cb-b4dd-d08066fc43e4
  • https://image2.pubmatic.com/AdServer/UCookieSetPug?ird=1&rd=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fpbm_match%3Fpbm%3D%23PM_USER_ID%26id%3D71ea94e0-0093-44cb-b4dd-d08066fc43e4
  • https://ids.ad.gt/api/v1/pbm_match?pbm=BBFBF67E-52FE-430F-93B6-E6A55E905C12&id=71ea94e0-0093-44cb-b4dd-d08066fc43e4
43 B
573 B
Image
General
Full URL
https://ids.ad.gt/api/v1/pbm_match?pbm=BBFBF67E-52FE-430F-93B6-E6A55E905C12&id=71ea94e0-0093-44cb-b4dd-d08066fc43e4
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
H2
Server
52.43.149.174 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-43-149-174.us-west-2.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:35 GMT
cache-control
public, max-age=43200
server
nginx/1.18.0
content-type
image/gif
expires
Wed, 09 Feb 2022 02:03:35 GMT

Redirect headers

location
https://ids.ad.gt/api/v1/pbm_match?pbm=BBFBF67E-52FE-430F-93B6-E6A55E905C12&id=71ea94e0-0093-44cb-b4dd-d08066fc43e4
date
Tue, 08 Feb 2022 14:03:34 GMT
cache-control
no-store, no-cache, private
server
nginx
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
g_match
ids.ad.gt/api/v1/
Redirect Chain
  • https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_cm&google_sc&google_ula=450542624&id=71ea94e0-0093-44cb-b4dd-d08066fc43e4
  • https://ids.ad.gt/api/v1/g_match?id=71ea94e0-0093-44cb-b4dd-d08066fc43e4&google_gid=CAESEK46dYDDn1ptvDyhgNKmnDA&google_cver=1&google_ula=450542624,0
43 B
572 B
Image
General
Full URL
https://ids.ad.gt/api/v1/g_match?id=71ea94e0-0093-44cb-b4dd-d08066fc43e4&google_gid=CAESEK46dYDDn1ptvDyhgNKmnDA&google_cver=1&google_ula=450542624,0
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
H2
Server
52.43.149.174 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-43-149-174.us-west-2.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:35 GMT
cache-control
public, max-age=43200
server
nginx/1.18.0
content-type
image/gif
expires
Wed, 09 Feb 2022 02:03:35 GMT

Redirect headers

pragma
no-cache
date
Tue, 08 Feb 2022 14:03:34 GMT
server
HTTP server (unknown)
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
location
https://ids.ad.gt/api/v1/g_match?id=71ea94e0-0093-44cb-b4dd-d08066fc43e4&google_gid=CAESEK46dYDDn1ptvDyhgNKmnDA&google_cver=1&google_ula=450542624,0
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
text/html; charset=UTF-8
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
357
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
pixel
cm.g.doubleclick.net/
Redirect Chain
  • https://ids.ad.gt/api/v1/g_hosted?id=71ea94e0-0093-44cb-b4dd-d08066fc43e4
  • https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_hm=NzFlYTk0ZTAtMDA5My00NGNiLWI0ZGQtZDA4MDY2ZmM0M2U0
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_hm=NzFlYTk0ZTAtMDA5My00NGNiLWI0ZGQtZDA4MDY2ZmM0M2U0
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
H3
Server
142.250.185.66 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s48-in-f2.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 08 Feb 2022 14:03:35 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

location
https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_hm=NzFlYTk0ZTAtMDA5My00NGNiLWI0ZGQtZDA4MDY2ZmM0M2U0
date
Tue, 08 Feb 2022 14:03:35 GMT
server
nginx/1.18.0
content-length
473
content-type
text/html; charset=utf-8
impr_match
ids.ad.gt/api/v1/
Redirect Chain
  • https://ad.360yield.com/ux?&publisher_dmp_id=15&r=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fimpr_match%3Fid%3D71ea94e0-0093-44cb-b4dd-d08066fc43e4%26impr_uid%3D%7BPUB_USER_ID%7D
  • https://ad.360yield.com/ul_cb/ux?&publisher_dmp_id=15&r=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fimpr_match%3Fid%3D71ea94e0-0093-44cb-b4dd-d08066fc43e4%26impr_uid%3D%7BPUB_USER_ID%7D
  • https://ids.ad.gt/api/v1/impr_match?id=71ea94e0-0093-44cb-b4dd-d08066fc43e4&impr_uid=bcc9beb1-8e48-4422-8855-3bd127e27e5e
43 B
484 B
Image
General
Full URL
https://ids.ad.gt/api/v1/impr_match?id=71ea94e0-0093-44cb-b4dd-d08066fc43e4&impr_uid=bcc9beb1-8e48-4422-8855-3bd127e27e5e
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
H2
Server
52.43.149.174 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-43-149-174.us-west-2.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:35 GMT
cache-control
public, max-age=43200
server
nginx/1.18.0
content-type
image/gif
expires
Wed, 09 Feb 2022 02:03:35 GMT

Redirect headers

location
https://ids.ad.gt/api/v1/impr_match?id=71ea94e0-0093-44cb-b4dd-d08066fc43e4&impr_uid=bcc9beb1-8e48-4422-8855-3bd127e27e5e
date
Tue, 08 Feb 2022 14:03:34 GMT
access-control-allow-origin
*
content-type
text/plain
content-length
0
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
beeswax_match
ids.ad.gt/api/v1/
Redirect Chain
  • https://match.prod.bidr.io/cookie-sync/audigent?buyer_user_id=71ea94e0-0093-44cb-b4dd-d08066fc43e4
  • https://match.prod.bidr.io/cookie-sync/audigent?buyer_user_id=71ea94e0-0093-44cb-b4dd-d08066fc43e4&_bee_ppp=1
  • https://ids.ad.gt/api/v1/beeswax_match?beeswax_id=AAFhKk7EBPAAAAJ4odOVww&id=71ea94e0-0093-44cb-b4dd-d08066fc43e4
43 B
478 B
Image
General
Full URL
https://ids.ad.gt/api/v1/beeswax_match?beeswax_id=AAFhKk7EBPAAAAJ4odOVww&id=71ea94e0-0093-44cb-b4dd-d08066fc43e4
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
H2
Server
52.43.149.174 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-43-149-174.us-west-2.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:35 GMT
cache-control
public, max-age=43200
server
nginx/1.18.0
content-type
image/gif
expires
Wed, 09 Feb 2022 02:03:35 GMT

Redirect headers

location
https://ids.ad.gt/api/v1/beeswax_match?beeswax_id=AAFhKk7EBPAAAAJ4odOVww&id=71ea94e0-0093-44cb-b4dd-d08066fc43e4
Date
Tue, 08 Feb 2022 14:03:34 GMT
Server
nginx
Connection
keep-alive
Content-Length
0
strict-transport-security
max-age=2592000; includeSubDomains
token
token.rubiconproject.com/
Redirect Chain
  • https://ids.ad.gt/api/v1/rub?id=71ea94e0-0093-44cb-b4dd-d08066fc43e4
  • https://token.rubiconproject.com/token?pid=50242&puid=71ea94e0-0093-44cb-b4dd-d08066fc43e4&gdpr=0
0
214 B
Image
General
Full URL
https://token.rubiconproject.com/token?pid=50242&puid=71ea94e0-0093-44cb-b4dd-d08066fc43e4&gdpr=0
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
HTTP/1.1
Server
69.173.144.165 Frankfurt am Main, Germany, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Pragma
no-cache
Expires
0
Cache-Control
no-cache,no-store,must-revalidate
X-RPHost
78e3bdce5107450057bade54d54a0a7e
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"

Redirect headers

location
https://token.rubiconproject.com/token?pid=50242&puid=71ea94e0-0093-44cb-b4dd-d08066fc43e4&gdpr=0
date
Tue, 08 Feb 2022 14:03:35 GMT
server
nginx/1.18.0
content-length
417
content-type
text/html; charset=utf-8
4
v4-api-54-185-136-237.b2c.com/api/
Redirect Chain
  • https://api-54-185-136-237.b2c.com/api/x?OgzmBuJbPLPWQouR$dXJsJDAkaHR0cHM6Ly93d3cuZmllcmNlcGhhcm1hLmNvbS9zcGVjaWFsLXJlcG9ydC8xMC1tb3N0LWFudGljaXBhdGVkLWRydWctbGF1bmNoZXMtMjAyMi00LWRldWNyYXZhY2l0aW5...
  • https://v4-api-54-185-136-237.b2c.com:444/api/4?OgzmBuJbPLPWQouR
0
141 B
XHR
General
Full URL
https://v4-api-54-185-136-237.b2c.com:444/api/4?OgzmBuJbPLPWQouR
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
HTTP/1.1
Server
54.185.136.237 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-54-185-136-237.us-west-2.compute.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Access-Control-Allow-Origin
*
Connection
keep-alive
Transfer-Encoding
chunked
Access-Control-Allow-Methods
*

Redirect headers

date
Tue, 08 Feb 2022 14:03:34 GMT
cf-cache-status
DYNAMIC
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
location
https://v4-api-54-185-136-237.b2c.com:444/api/4?OgzmBuJbPLPWQouR
access-control-allow-methods
*
content-type
text/html
access-control-allow-origin
*
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=qwIf8INWjDVufuaJ8xRL18G5jE2Njhhd%2F1M5xslul8gQwpvHN8XJiROyjC4wqx%2FXFN8G3MCmQz7ngZrQIy3C6pxY8dRlFVcHbnWd6A%2FCwZJUoi8145mTKE8OyaW6%2F8lTWi9p720lBaGizQzrIcMZzjtWKTDTbOkl"}],"group":"cf-nel","max_age":604800}
cf-ray
6da566f5beae9193-FRA
Carlsbad_RollAd_BG_LoRes_MS_1920x1080_updated.png
cdn.spotible.com/creative/GxHs/hashed/6132531ad7b4768e3db434f032381d4d/
123 KB
124 KB
Image
General
Full URL
https://cdn.spotible.com/creative/GxHs/hashed/6132531ad7b4768e3db434f032381d4d/Carlsbad_RollAd_BG_LoRes_MS_1920x1080_updated.png
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.86.3.4 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-3-4.fra6.r.cloudfront.net
Software
/
Resource Hash
2e70a27b585fe780d4d8089fc032feeb2849cc36140e542d5092535911fa2b5a

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 05:20:48 GMT
via
1.1 d357d5d597708d2b41e0fea397aa2620.cloudfront.net (CloudFront)
age
31365
etag
"6132531ad7b4768e3db434f032381d4d"
x-cache
Hit from cloudfront
content-type
image/png
cache-control
public, max-age=604800
x-amz-cf-pop
FRA6-C1
accept-ranges
bytes
content-length
126039
x-amz-cf-id
ATdWRIP95hTzMO3gB3eLSVqxFsPUe2VceED2XWjGz_2H6E5u7y4_4Q==
Carlsbad_RollAd_FG_LoRes_720x900.png
cdn.spotible.com/creative/GxHs/hashed/d8c4a5fa958a1671af168cbfcdb57b3a/
60 KB
60 KB
Image
General
Full URL
https://cdn.spotible.com/creative/GxHs/hashed/d8c4a5fa958a1671af168cbfcdb57b3a/Carlsbad_RollAd_FG_LoRes_720x900.png
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
99.86.3.4 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-99-86-3-4.fra6.r.cloudfront.net
Software
/
Resource Hash
81eba80f4d17808b3c750f78ed8033d24e359092cb2a7241046341b2f759fa71

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 05:20:48 GMT
via
1.1 d357d5d597708d2b41e0fea397aa2620.cloudfront.net (CloudFront)
age
31365
etag
"d8c4a5fa958a1671af168cbfcdb57b3a"
x-cache
Hit from cloudfront
content-type
image/png
cache-control
public, max-age=604800
x-amz-cf-pop
FRA6-C1
accept-ranges
bytes
content-length
61330
x-amz-cf-id
Tr1rDnJxOjbYGrxUs5x-trrc3U3QL7h8ipvOh8Az1qHBKU6B9n1aYg==
gpt.js
www.googletagservices.com/tag/js/
0
0
Fetch
General
Full URL
https://www.googletagservices.com/tag/js/gpt.js
Requested by
Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:812::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:34 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1125 / 76 of 1000 / last-modified: 1644322105"
vary
Accept-Encoding
report-to
{"group":"ads-gpt-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-gpt-scs"}]}
content-type
text/javascript
cache-control
private, max-age=900, stale-while-revalidate=3600
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
x-xss-protection
0
cross-origin-opener-policy-report-only
same-origin; report-to="ads-gpt-scs"
expires
Tue, 08 Feb 2022 14:03:34 GMT
multitracking
ghb.hbmp.mediafuse.com/adunit/
0
211 B
XHR
General
Full URL
https://ghb.hbmp.mediafuse.com/adunit/multitracking
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/456758/hbw_master_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
2a0c:5c81:5142::2 London, United Kingdom, ASN55081 (24SHELLS, US),
Reverse DNS
Software
VertaMedia 1.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Access-Control-Allow-Origin
https://www.fiercepharma.com
Date
Tue, 08 Feb 2022 14:03:34 GMT
Access-Control-Allow-Credentials
true
Server
VertaMedia 1.0
Connection
Keep-Alive
mut
ghb.adtelligent.com/adunit/ Frame 447C
0
207 B
XHR
General
Full URL
https://ghb.adtelligent.com/adunit/mut
Requested by
Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
2a0c:5c81:5142::2 London, United Kingdom, ASN55081 (24SHELLS, US),
Reverse DNS
Software
VertaMedia 1.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://p.nodserving.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Access-Control-Allow-Origin
https://p.nodserving.com
Date
Tue, 08 Feb 2022 14:03:34 GMT
Access-Control-Allow-Credentials
true
Server
VertaMedia 1.0
Connection
Keep-Alive
loading.do
sample.dragonforms.com/ Frame 8E4A
21 KB
6 KB
Document
General
Full URL
https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/init.do?omedasite=FiercePharma_short
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.190 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
Software
Apache /
Resource Hash
d041c9665e943501277d812df8c037ded41e8e8534038426103c6b0a98892e92
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/init.do?omedasite=FiercePharma_short

Response headers

X-Content-Type-Options
nosniff
X-XSS-Protection
1; mode=block
Access-Control-Allow-Origin
*
Content-Type
text/html;charset=ISO-8859-1
Date
Tue, 08 Feb 2022 14:03:34 GMT
Server
Apache
Vary
Accept-Encoding
Content-Encoding
gzip
Transfer-Encoding
chunked
halo_match
ids.ad.gt/api/v1/
43 B
653 B
Image
General
Full URL
https://ids.ad.gt/api/v1/halo_match?id=71ea94e0-0093-44cb-b4dd-d08066fc43e4&halo_id=0201tlxlfd07jv2yg08xizqr0bwpa1w0evvljv1k7cm961o8b5po0ntek210qskvk40trr7270wqxik90zq3u2c12pa5j31k0gxf118nmsj90fzd0bt1elzfjf1hl5r1i1kkc2jl
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.43.149.174 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-43-149-174.us-west-2.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:35 GMT
cache-control
public, max-age=43200
server
nginx/1.18.0
content-type
image/gif
expires
Wed, 09 Feb 2022 02:03:35 GMT
getpixels
pixels.ad.gt/api/v1/
0
344 B
Script
General
Full URL
https://pixels.ad.gt/api/v1/getpixels?tagger_id=e0fc5aa47bed062e265fc29d169e5770&url=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&code=%27none%27
Requested by
Host: p.ad.gt
URL: https://p.ad.gt/api/v1/p/170
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.83.23.20 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-35-83-23-20.us-west-2.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

access-control-allow-origin
*
date
Tue, 08 Feb 2022 14:03:35 GMT
server
nginx/1.18.0
access-control-allow-headers
DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Content-Range,Range
access-control-allow-methods
GET, POST, OPTIONS
access-control-expose-headers
DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Content-Range,Range
ecommerce.js
www.google-analytics.com/plugins/ua/
1 KB
763 B
Script
General
Full URL
https://www.google-analytics.com/plugins/ua/ecommerce.js
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:810::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
8e1b84265e633c043720dd0921476c16bc9f75e393e855c9116ca7c3a847b5c7
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 13:13:54 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
2981
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
738
x-xss-protection
0
last-modified
Tue, 22 Oct 2019 18:15:00 GMT
server
sffe
vary
Accept-Encoding
report-to
{"group":"static-on-bigtable","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/static-on-bigtable"}]}
content-type
text/javascript
cache-control
public, max-age=3600
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="static-on-bigtable"
expires
Tue, 08 Feb 2022 14:13:54 GMT
ec.js
www.google-analytics.com/plugins/ua/
3 KB
1 KB
Script
General
Full URL
https://www.google-analytics.com/plugins/ua/ec.js
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:810::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
058ed961bfe422af7bfc65865f4c08531ec8ace995f8a1ec560a46581cb7712c
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 13:38:33 GMT
content-encoding
br
x-content-type-options
nosniff
age
1502
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
1129
x-xss-protection
0
last-modified
Thu, 30 Dec 2021 12:48:00 GMT
server
sffe
vary
Accept-Encoding
report-to
{"group":"static-on-bigtable","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/static-on-bigtable"}]}
content-type
text/javascript
cache-control
public, max-age=3600
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="static-on-bigtable"
expires
Tue, 08 Feb 2022 14:38:33 GMT
cm
u.openx.net/w/1.0/
43 B
131 B
Image
General
Full URL
https://u.openx.net/w/1.0/cm?id=998eaf06-9905-4eae-9e26-9fac75960c53&r=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fopenx%3Fopenx_id%3D%7BOPENX_ID%7D%26id%3D0201tlxlfd07jv2yg08xizqr0bwpa1w0evvljv1k7cm961o8b5po0ntek210qskvk40trr7270wqxik90zq3u2c12pa5j31k0gxf118nmsj90fzd0bt1elzfjf1hl5r1i1kkc2jl%26auid%3D71ea94e0-0093-44cb-b4dd-d08066fc43e4
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.244.159.8 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
8.159.244.35.bc.googleusercontent.com
Software
OXGW/17.1.0 /
Resource Hash
4e0705327480ad2323cb03d9c450ffcae4a98bf3a5382fa0c7882145ed620e49

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 08 Feb 2022 14:03:35 GMT
content-encoding
gzip
server
OXGW/17.1.0
vary
Accept, Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
via
1.1 google
cache-control
private, max-age=0, no-cache
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
56
expires
Mon, 26 Jul 1997 05:00:00 GMT
entity_313b.css
hostedcontent.dragonforms.com/hosted/images/dragon/generic/313/ Frame 8E4A
19 KB
19 KB
Stylesheet
General
Full URL
https://hostedcontent.dragonforms.com/hosted/images/dragon/generic/313/entity_313b.css
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
205.162.42.5 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
cdn.omeda.com
Software
Apache /
Resource Hash
a33614a196d3854d7d068b3d73dca4806956c548d1ae3163bcd8e0b7664a2ed6
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Tue, 08 Feb 2022 15:03:35 CET
X-Content-Type-Options
nosniff
Last-Modified
Fri, 22 Nov 2019 15:51:34 CET
Server
Apache
ETag
W/"19161-1574434294969"
X-Frame-Options
SAMEORIGIN
Content-Type
text/css
Access-Control-Allow-Origin
*
Access-Control-Expose-Headers
Access-Control-Allow-Origin,Access-Control-Allow-Credentials
Transfer-Encoding
chunked
Accept-Ranges
bytes
X-XSS-Protection
1; mode=block
jquery-2.2.4.min.js
code.jquery.com/ Frame 8E4A
84 KB
29 KB
Script
General
Full URL
https://code.jquery.com/jquery-2.2.4.min.js
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2001:4de0:ac18::1:a:2a , Netherlands, ASN20446 (HIGHWINDS3, US),
Reverse DNS
Software
nginx /
Resource Hash
05b85d96f41fff14d8f608dad03ab71e2c1017c2da0914d7c59291bad7a54f8e

Request headers

Referer
https://sample.dragonforms.com/
Origin
https://sample.dragonforms.com
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:35 GMT
content-encoding
gzip
last-modified
Fri, 20 Aug 2021 17:47:53 GMT
server
nginx
etag
W/"611feac9-14e4a"
vary
Accept-Encoding
x-hw
1644329015.dop201.fr8.t,1644329015.cds236.fr8.hn,1644329015.cds130.fr8.c
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=315360000, public
accept-ranges
bytes
content-length
29811
conditional.js
sample.dragonforms.com/js/ Frame 8E4A
31 KB
32 KB
Script
General
Full URL
https://sample.dragonforms.com/js/conditional.js
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.190 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
Software
Apache /
Resource Hash
d7993cf613408050b47ca5417eac7f90986d57213211a6b27f7579894e306389
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Tue, 08 Feb 2022 14:03:34 GMT
X-Content-Type-Options
nosniff
Last-Modified
Fri, 03 Sep 2021 16:11:38 GMT
Server
Apache
ETag
W/"31881-1630685498000"
Transfer-Encoding
chunked
Content-Type
application/javascript
Access-Control-Allow-Origin
*
Accept-Ranges
bytes
X-XSS-Protection
1; mode=block
dragonCampaign.js
sample.dragonforms.com/js/ Frame 8E4A
13 KB
13 KB
Script
General
Full URL
https://sample.dragonforms.com/js/dragonCampaign.js
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.190 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
Software
Apache /
Resource Hash
0dbc0190864fe5c6e0bd63e7b5233f94265ee535dc3c3e2031f27a251bbb2f60
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Tue, 08 Feb 2022 14:03:34 GMT
X-Content-Type-Options
nosniff
Last-Modified
Mon, 30 Aug 2021 17:56:04 GMT
Server
Apache
ETag
W/"13235-1630346164000"
Transfer-Encoding
chunked
Content-Type
application/javascript
Access-Control-Allow-Origin
*
Accept-Ranges
bytes
X-XSS-Protection
1; mode=block
generic.css
sample.dragonforms.com/style/ Frame 8E4A
2 KB
1 KB
Stylesheet
General
Full URL
https://sample.dragonforms.com/style/generic.css
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.190 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
Software
Apache /
Resource Hash
a75268aabd3efca2333dda30048a44d566fca0fa0c70f87249784d6c4dbaaa50
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Tue, 08 Feb 2022 14:03:34 GMT
Content-Encoding
gzip
X-Content-Type-Options
nosniff
Last-Modified
Thu, 10 Jun 2021 15:35:48 GMT
Server
Apache
ETag
W/"2478-1623339348000"
Vary
Accept-Encoding
Content-Type
text/css;charset=UTF-8
Access-Control-Allow-Origin
*
Transfer-Encoding
chunked
Accept-Ranges
bytes
X-XSS-Protection
1; mode=block
962.css
hostedcontent.dragonforms.com/hosted/images/dragon/12247/ Frame 8E4A
3 KB
3 KB
Stylesheet
General
Full URL
https://hostedcontent.dragonforms.com/hosted/images/dragon/12247/962.css
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
205.162.42.5 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
cdn.omeda.com
Software
Apache /
Resource Hash
9b7e5dca586aec7050576b4dad559ab2688067149e60467be5ca505970455229
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Tue, 08 Feb 2022 15:03:35 CET
X-Content-Type-Options
nosniff
Last-Modified
Mon, 04 Oct 2021 19:31:31 CEST
Server
Apache
ETag
W/"2856-1633368691606"
X-Frame-Options
SAMEORIGIN
Content-Type
text/css
Access-Control-Allow-Origin
*
Access-Control-Expose-Headers
Access-Control-Allow-Origin,Access-Control-Allow-Credentials
Transfer-Encoding
chunked
Accept-Ranges
bytes
X-XSS-Protection
1; mode=block
363.js
hostedcontent.dragonforms.com/hosted/images/dragon/12247/ Frame 8E4A
5 KB
6 KB
Script
General
Full URL
https://hostedcontent.dragonforms.com/hosted/images/dragon/12247/363.js
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
205.162.42.5 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
cdn.omeda.com
Software
Apache /
Resource Hash
3f680ec1d9f173ca064c4fc16850d78e3b0bd291f4e0908f203245011861567d
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Tue, 08 Feb 2022 15:03:35 CET
X-Content-Type-Options
nosniff
Last-Modified
Fri, 28 May 2021 16:35:55 CEST
Server
Apache
ETag
W/"5462-1622212555637"
X-Frame-Options
SAMEORIGIN
Content-Type
application/javascript
Access-Control-Allow-Origin
*
Access-Control-Expose-Headers
Access-Control-Allow-Origin,Access-Control-Allow-Credentials
Transfer-Encoding
chunked
Accept-Ranges
bytes
X-XSS-Protection
1; mode=block
olyticsLinkAssistance.js
sample.dragonforms.com/js/ Frame 8E4A
4 KB
4 KB
Script
General
Full URL
https://sample.dragonforms.com/js/olyticsLinkAssistance.js
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.190 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
Software
Apache /
Resource Hash
f88e771cd7aeeb1241c61b165090b9d197534d937e2bd53a62631a738439a2e6
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Tue, 08 Feb 2022 14:03:34 GMT
X-Content-Type-Options
nosniff
Last-Modified
Fri, 16 Nov 2018 20:46:06 GMT
Server
Apache
ETag
W/"3961-1542401166000"
Transfer-Encoding
chunked
Content-Type
application/javascript
Access-Control-Allow-Origin
*
Accept-Ranges
bytes
X-XSS-Protection
1; mode=block
p
olytics.omeda.com/olytics/segments/
4 KB
4 KB
XHR
General
Full URL
https://olytics.omeda.com/olytics/segments/p
Requested by
Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash
7b2b374ce8411a9f72ad8a653ccc664539713019af44251db340600d0d90e80a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
application/json

Response headers

Date
Tue, 08 Feb 2022 14:03:40 GMT
X-Content-Type-Options
nosniff
Server
Apache
X-Frame-Options
SAMEORIGIN
Content-Type
application/json
Access-Control-Allow-Origin
*
Cache-Control
no-cache
Transfer-Encoding
chunked
X-XSS-Protection
1; mode=block
/
olytics.omeda.com/olytics/segments/form/check/
20 B
313 B
XHR
General
Full URL
https://olytics.omeda.com/olytics/segments/form/check/
Requested by
Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash
a8e427db11a8744bebbcdfd050f7b9d0a84b5a1754d086f1787c40db21955264
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
application/json

Response headers

Date
Tue, 08 Feb 2022 14:03:36 GMT
X-Content-Type-Options
nosniff
Server
Apache
X-Frame-Options
SAMEORIGIN
Content-Type
application/json
Access-Control-Allow-Origin
*
Cache-Control
no-cache
Transfer-Encoding
chunked
X-XSS-Protection
1; mode=block
cswitch
olytics.omeda.com/olytics/segments/
88 B
381 B
XHR
General
Full URL
https://olytics.omeda.com/olytics/segments/cswitch
Requested by
Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash
4b16ddf00cd9cdaa8a4cb691e7fcc2ca860dee5ba2fe2a1a05c85678f48dd4da
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
application/json

Response headers

Date
Tue, 08 Feb 2022 14:03:36 GMT
X-Content-Type-Options
nosniff
Server
Apache
X-Frame-Options
SAMEORIGIN
Content-Type
application/json
Access-Control-Allow-Origin
*
Cache-Control
no-cache
Transfer-Encoding
chunked
X-XSS-Protection
1; mode=block
report
creative.spotible.com/creative/GxHs/
43 B
113 B
Image
General
Full URL
https://creative.spotible.com/creative/GxHs/report?,1644329014,595001;UNIQUE_USER_GLOBAL!0,1,0;UNIQUE_USER_DAILY!0,1,0;UNIQUE_USER_HOURLY!0,1,0;IMPRESSION!0,1,0!18,1,0!55,1,0!69,1,0!113,1,0!120,1,0;IN_VIEW!0,1,1!18,1,1!55,1,1!69,1,1!113,1,1!120,1,1&referrer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
54.144.118.149 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-144-118-149.compute-1.amazonaws.com
Software
/
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:35 GMT
cache-control
no-store
content-length
43
content-type
image/gif
view
securepubads.g.doubleclick.net/pcs/
0
23 B
Image
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsu1jP8SjAE_Y5QLtDbkL7oxJ93EtE_PBg4Fn4p5UHnvjxb65IC-mCpVDSlA9RJYEFDjX5TESr_8ovOrDCUj52-22XBT_8LrQvrIp34NzXf1LFPTzJRCTrI3qrDHM9Hk0wV6BZ9N2l8hc9D8n1BMQYRt0gHTZYrn7lhuH0K0QtupLI9pT_G_Q1YueqQ_Mcpevb9E11F9DD2m9FWIpwsjw8rRjHr-HdYaD1oPMzLUIhj8fFtVfW837J3E-Cd_Kx4A7OQzZLWZIG1mhK-ItB9lrwgrTv5KmmdOJPDch8vyno-Jwpbun6e3UxwVKe9JbWXMi81jze4ytF27VSQk_8bDaLoQJwnqY22AS-LZvjKxQl-Gufjbsap53cRChdo0uCRaPyRJGLUY6emKUqG5gaVtsA&sai=AMfl-YQrzgZ_M__aeR9HPV5vD28VyI2mwlND1ZyEdI7mJ9991kXoslbTLivvMmqv2lxM2h_FgpSJBhSr1HS7NjrLL2ImxsNY440xySLpJFZokWlhYWuFAko9VfoX2Uua6t0z&sig=Cg0ArKJSzHE5OjXfPtxGEAE&uach_m=[UACH]&urlfix=1&adurl=
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.184.226 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s12-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 08 Feb 2022 14:03:35 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-Arch, Sec-CH-UA-Model, Sec-CH-UA-Full-Version
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
server
cafe
p
olytics.omeda.com/olytics/segments/ Frame
0
0
Preflight
General
Full URL
https://olytics.omeda.com/olytics/segments/p
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Method
POST
Access-Control-Request-Headers
content-type
Origin
https://www.fiercepharma.com
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

Access-Control-Allow-Origin
*
vary
Access-Control-Request-Headers,Access-Control-Request-Headers,access-control-request-method
Access-Control-Max-Age
1800
Access-Control-Allow-Methods
HEAD,DELETE,POST,GET,OPTIONS,PUT
Access-Control-Allow-Headers
access-control-max-age,accept-language,origin,x-requested-with,access-control-request-headers,host,content-type,access-control-request-method,accept-encoding,accept,user-agent
Content-Length
0
Date
Tue, 08 Feb 2022 14:03:36 GMT
Server
Apache
/
olytics.omeda.com/olytics/segments/form/check/ Frame
0
0
Preflight
General
Full URL
https://olytics.omeda.com/olytics/segments/form/check/
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Method
POST
Access-Control-Request-Headers
content-type
Origin
https://www.fiercepharma.com
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

Access-Control-Allow-Origin
*
vary
Access-Control-Request-Headers,Access-Control-Request-Headers,access-control-request-method
Access-Control-Max-Age
1800
Access-Control-Allow-Methods
HEAD,DELETE,POST,GET,OPTIONS,PUT
Access-Control-Allow-Headers
access-control-max-age,accept-language,origin,x-requested-with,access-control-request-headers,host,content-type,access-control-request-method,accept-encoding,accept,user-agent
Content-Length
0
Date
Tue, 08 Feb 2022 14:03:35 GMT
Server
Apache
cswitch
olytics.omeda.com/olytics/segments/ Frame
0
0
Preflight
General
Full URL
https://olytics.omeda.com/olytics/segments/cswitch
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Method
POST
Access-Control-Request-Headers
content-type
Origin
https://www.fiercepharma.com
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

Access-Control-Allow-Origin
*
vary
Access-Control-Request-Headers,Access-Control-Request-Headers,access-control-request-method
Access-Control-Max-Age
1800
Access-Control-Allow-Methods
HEAD,DELETE,POST,GET,OPTIONS,PUT
Access-Control-Allow-Headers
access-control-max-age,accept-language,origin,x-requested-with,access-control-request-headers,host,content-type,access-control-request-method,accept-encoding,accept,user-agent
Content-Length
0
Date
Tue, 08 Feb 2022 14:03:36 GMT
Server
Apache
index.php
a.dpmsrv.com/dpmpxl/
5 B
1 KB
Script
General
Full URL
https://a.dpmsrv.com/dpmpxl/index.php?q=xSeg&v=1.x&ep%5Bids%5D=29315642%2C29315652%2C29028703%2C16013439%2C16671093&cl=913&pixelIndex=0&r=471413&tzOffset=0&url=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&id=5611407578940007418&_=1644329013517
Requested by
Host: s.dpmsrv.com
URL: https://s.dpmsrv.com/dpm_fa5b7e293127b3837c39f7fbd05598f32c8ce1c9.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.226.203.17 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-226-203-17.compute-1.amazonaws.com
Software
/
Resource Hash
fbc45fe018830de401f0cf801177a57d0039bc72d922b8ff2c82af7af05dd32b

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Pragma
no-cache
content-encoding
gzip
Access-Control-Max-Age
10
Access-Control-Allow-Methods
GET, POST, PUT, DELETE, OPTIONS
P3P
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
Access-Control-Allow-Origin
*
Cache-Control
no-cache, no-store, must-revalidate
Connection
keep-alive
Content-Type
text/javascript
Access-Control-Allow-Headers
content-type, accept
Content-Length
31
Expires
0
seg
ib.adnxs.com/
43 B
1021 B
Image
General
Full URL
https://ib.adnxs.com/seg?member=827&add=29315642,29315652,29028703,16013439,16671093
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
37.252.172.37 Frankfurt am Main, Germany, ASN29990 (ASN-APPNEX, US),
Reverse DNS
691.bm-nginx-loadbalancer.mgmt.fra1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
4b5b6b15c6255109e06720cce42a06d3aead8b7874423d9c52cb0303212c25ef
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 08 Feb 2022 14:03:35 GMT
X-Proxy-Origin
84.19.175.183; 84.19.175.183; 691.bm-nginx-loadbalancer.mgmt.fra1; adnxs.com
AN-X-Request-Uuid
d4012bcb-e37a-4313-bfab-072c520baeae
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
*
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
integrator.js
adservice.google.de/adsid/
107 B
122 B
Script
General
Full URL
https://adservice.google.de/adsid/integrator.js?domain=www.fiercepharma.com
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022020301.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:82a::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
a4a1824defec1084ca81d496ee77891684c26196924bdc4fc21dd3482ce15e14
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 08 Feb 2022 14:03:35 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
cache-control
private, no-cache, no-store
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
h3="googleads.g.doubleclick.net:443"; ma=2592000,h3=":443"; ma=2592000,h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
100
x-xss-protection
0
integrator.js
adservice.google.com/adsid/
107 B
122 B
Script
General
Full URL
https://adservice.google.com/adsid/integrator.js?domain=www.fiercepharma.com
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022020301.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80f::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
a4a1824defec1084ca81d496ee77891684c26196924bdc4fc21dd3482ce15e14
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 08 Feb 2022 14:03:35 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
cache-control
private, no-cache, no-store
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
100
x-xss-protection
0
ads
securepubads.g.doubleclick.net/gampad/
2 KB
311 B
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=3715860651702850&correlator=3696035797536368&output=ldjh&impl=fifs&vrg=2022020301&ptt=17&sc=1&sfv=1-0-38&ecs=20220208&iu_parts=298443%2Cquestex.lifesciences%2Cfiercepharma%2Cspecialreports&enc_prev_ius=%2F0%2F1%2F2%2F3%2C%2F0%2F1%2F2%2F3%2C%2F0%2F1%2F2%2F3%2C%2F0%2F1%2F2%2F3%2C%2F0%2F1%2F2%2F3&prev_iu_szs=970x90%7C970x250%7C970x415%2C300x600%7C300x250%2C300x600%7C300x250%2C300x600%7C300x250%2C1600x1000&prev_scp=pos%3D0%26hb_rfBid%3D0%26excl_cat%3DPREPOST%7Cpos%3D1%26hb_rfBid%3D0%26excl_cat%3DPREPOST%7Cpos%3D2%26hb_rfBid%3D0%26excl_cat%3DPREPOST%7Cpos%3D3%26hb_rfBid%3D0%26excl_cat%3DPREPOST%7Cpos%3D5%26hb_rfBid%3D0%26excl_cat%3DPREPOST&eri=1&cust_params=section%3DSpecial%2520Reports%26homefront%3D0%26sectionfront%3D0%26article%3D1%26nodeid%3D518261%26fm-tester%3Dundefined%26topic%3Dpsoriasis%252C%2520JAK%2520inhibitor%252C%2520drug%2520launch%252C%2520megamergers%26keyword%3DBristol%2520Myers%2520Squibb%252C%2520Deucravacitinib%252C%2520Otezla%252C%2520Celgene%252C%2520Amgen%252C%2520Novartis%252C%2520Cosentyx%252C%2520Eli%2520Lilly%252C%2520Taltz%252C%2520AbbVie%252C%2520Skyrizi%26tag%3DBristol%2520Myers%2520Squibb%252C%2520Deucravacitinib%252C%2520Otezla%252C%2520Celgene%252C%2520Amgen%252C%2520Novartis%252C%2520Cosentyx%252C%2520Eli%2520Lilly%252C%2520Taltz%252C%2520AbbVie%252C%2520Skyrizi%252Cpsoriasis%252C%2520JAK%2520inhibitor%252C%2520drug%2520launch%252C%2520megamergers%252CSpecial%2520Reports%26path%3D%252Fspecial-report%252F10-most-anticipated-drug-launches-2022-4-deucravacitinib%26browserLargerThan1460%3D1&cookie=ID%3Da10b70ecd31ee878-226e80d238cd00b6%3AT%3D1644329013%3AS%3DALNI_MbrV_GTIfaNb9Zl-5yagvuFtFGsWA&bc=31&abxe=1&dt=1644329015866&lmt=1644329012&dlt=1644329013005&idt=591&frm=20&biw=1600&bih=1200&oid=2&adxs=200%2C1100%2C1100%2C1100%2C-12245933&adys=988%2C1196%2C1658%2C1658%2C-12245933&adks=313090359%2C2965285993%2C3032192005%2C3032192004%2C3031910803&ucis=5%7C6%7C7%7C8%7C9&ifi=5&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&dmc=8&url=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&vis=1&scr_x=0&scr_y=0&psz=1200x0%7C300x0%7C300x0%7C300x0%7C1200x0&msz=1200x0%7C300x0%7C300x0%7C300x0%7C1600x0&psts=AGkb-H-wQ_RHzdFIx_stTghXhihM2LECFPUQCWqCwEzfOYqRlZ9aHporyagUDUyVIiGjq8mFnW9UxVxqFFxghqFt%2CAGkb-H80_Q_89g_JffIaAGB9oTASVyzNc2y9bKFMNaq9lGZg5mu-xTH_q0llOe2mNR9VSxTCzu5Aw0Ozw_qXrw0T%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk&ga_vid=800578055.1644329014&ga_sid=1644329014&ga_hid=2005409921&ga_fc=true&fws=4%2C4%2C4%2C4%2C132&ohw=1600%2C1600%2C1600%2C1600%2C1600&btvi=0%7C0%7C2%7C3%7C-1&uach=WyIiLCIiLCIiLCIiLCIiLFtdLG51bGwsbnVsbCwiIixbXV0.&nvt=1
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022020301.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.184.226 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s12-in-f2.1e100.net
Software
cafe /
Resource Hash
349cecd2f73253633d5a2b6276457c3f79d79efae59888bf75af0849407558a9
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:35 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2,-2,-2,-2,-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
282
x-xss-protection
0
google-lineitem-id
-2,-2,-2,-2,-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2,-2,-2,-2,-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
publishertag.prebid.117.js
static.criteo.net/js/ld/
87 KB
28 KB
Script
General
Full URL
https://static.criteo.net/js/ld/publishertag.prebid.117.js
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:2638::3 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
Software
nginx /
Resource Hash
90c9017a8a6447588520f38cd94ba14cdb9839c92626aa06bb8a4a1052c2ab7e
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:36 GMT
content-encoding
gzip
last-modified
Wed, 29 Dec 2021 12:30:46 GMT
server
nginx
etag
W/"61cc54f6-15c19"
strict-transport-security
max-age=31536000; preload;
content-type
text/javascript
access-control-allow-origin
*
cache-control
max-age=86400, public
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
expires
Wed, 09 Feb 2022 14:03:36 GMT
async_usersync.html
acdn.adnxs.com/ib/static/usersync/v3/ Frame 4A1D
995 B
1 KB
Document
General
Full URL
https://acdn.adnxs.com/ib/static/usersync/v3/async_usersync.html
Requested by
Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
151.101.1.108 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx/1.13.10 /
Resource Hash
8730c26defc411dd8a51f1da47e5ae3804fab6868f7914a26b09d8e0791bbe39

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://p.nodserving.com/

Response headers

Connection
keep-alive
Content-Length
506
Server
nginx/1.13.10
Content-Type
text/html
Last-Modified
Fri, 20 May 2016 02:07:09 GMT
ETag
W/"573e714d-3e3"
Expires
Thu, 06 May 2021 05:24:22 GMT
Cache-Control
max-age=31536000
Access-Control-Allow-Origin
*
Content-Encoding
gzip
Via
1.1 varnish, 1.1 varnish
Accept-Ranges
bytes
Date
Tue, 08 Feb 2022 14:03:36 GMT
Age
24050350
X-Served-By
cache-lga21980-LGA, cache-hhn4034-HHN
X-Cache
HIT, HIT
X-Cache-Hits
194520, 531902
X-Timer
S1644329016.035647,VS0,VE0
Vary
Accept-Encoding
/
onetag-sys.com/usync/ Frame 7C76
2 KB
814 B
Document
General
Full URL
https://onetag-sys.com/usync/?cb=1644329015956
Requested by
Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
51.38.120.206 , France, ASN16276 (OVH, FR),
Reverse DNS
ip206.ip-51-38-120.eu
Software
/
Resource Hash
37a31642af0a7fe695ed0fd68a06a55af44e854d083dc7f5d0e70535f0189ae0
Security Headers
Name Value
Strict-Transport-Security max-age=15552000

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://p.nodserving.com/

Response headers

content-type
text/html
cache-control
no-transform, no-cache
content-encoding
gzip
content-length
731
strict-transport-security
max-age=15552000
/
onetag-sys.com/usync/ Frame C0BB
2 KB
814 B
Document
General
Full URL
https://onetag-sys.com/usync/?cb=1644329015958
Requested by
Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
51.38.120.206 , France, ASN16276 (OVH, FR),
Reverse DNS
ip206.ip-51-38-120.eu
Software
/
Resource Hash
37a31642af0a7fe695ed0fd68a06a55af44e854d083dc7f5d0e70535f0189ae0
Security Headers
Name Value
Strict-Transport-Security max-age=15552000

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://p.nodserving.com/

Response headers

content-type
text/html
cache-control
no-transform, no-cache
content-encoding
gzip
content-length
731
strict-transport-security
max-age=15552000
/
onetag-sys.com/usync/ Frame 6B8E
2 KB
814 B
Document
General
Full URL
https://onetag-sys.com/usync/?cb=1644329015960
Requested by
Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
51.38.120.206 , France, ASN16276 (OVH, FR),
Reverse DNS
ip206.ip-51-38-120.eu
Software
/
Resource Hash
37a31642af0a7fe695ed0fd68a06a55af44e854d083dc7f5d0e70535f0189ae0
Security Headers
Name Value
Strict-Transport-Security max-age=15552000

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://p.nodserving.com/

Response headers

content-type
text/html
cache-control
no-transform, no-cache
content-encoding
gzip
content-length
731
strict-transport-security
max-age=15552000
/
onetag-sys.com/usync/ Frame 717D
2 KB
814 B
Document
General
Full URL
https://onetag-sys.com/usync/?cb=1644329015961
Requested by
Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
51.38.120.206 , France, ASN16276 (OVH, FR),
Reverse DNS
ip206.ip-51-38-120.eu
Software
/
Resource Hash
37a31642af0a7fe695ed0fd68a06a55af44e854d083dc7f5d0e70535f0189ae0
Security Headers
Name Value
Strict-Transport-Security max-age=15552000

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://p.nodserving.com/

Response headers

content-type
text/html
cache-control
no-transform, no-cache
content-encoding
gzip
content-length
731
strict-transport-security
max-age=15552000
/
onetag-sys.com/usync/ Frame 19DD
2 KB
814 B
Document
General
Full URL
https://onetag-sys.com/usync/?cb=1644329015963
Requested by
Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
51.38.120.206 , France, ASN16276 (OVH, FR),
Reverse DNS
ip206.ip-51-38-120.eu
Software
/
Resource Hash
37a31642af0a7fe695ed0fd68a06a55af44e854d083dc7f5d0e70535f0189ae0
Security Headers
Name Value
Strict-Transport-Security max-age=15552000

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://p.nodserving.com/

Response headers

content-type
text/html
cache-control
no-transform, no-cache
content-encoding
gzip
content-length
731
strict-transport-security
max-age=15552000
async_usersync
secure.adnxs.com/ Frame 4A1D
0
731 B
Script
General
Full URL
https://secure.adnxs.com/async_usersync?cbfn=AN_async_load
Requested by
Host: acdn.adnxs.com
URL: https://acdn.adnxs.com/ib/static/usersync/v3/async_usersync.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.221.91 Amsterdam, Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
721.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://acdn.adnxs.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 08 Feb 2022 14:03:36 GMT
X-Proxy-Origin
84.19.175.183; 84.19.175.183; 721.bm-nginx-loadbalancer.mgmt.ams1; adnxs.com
AN-X-Request-Uuid
69d710b0-9912-475c-a94a-c78de724b2bc
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Cache-Control
no-store, no-cache, private
Connection
keep-alive
Content-Type
text/html; charset=utf-8
Content-Length
0
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
gtm.js
www.googletagmanager.com/ Frame 8E4A
95 KB
37 KB
Script
General
Full URL
https://www.googletagmanager.com/gtm.js?id=GTM-MV5SCJ
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:808::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
7a14b326f560d86d6470ec65457774646164c34a19fe70a474ca43e88e9fd812
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:36 GMT
content-encoding
br
vary
Accept-Encoding
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
37945
x-xss-protection
0
last-modified
Tue, 08 Feb 2022 12:00:00 GMT
server
Google Tag Manager
strict-transport-security
max-age=31536000; includeSubDomains
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
access-control-allow-headers
Cache-Control
expires
Tue, 08 Feb 2022 14:03:36 GMT
olytics.min.js
olytics.omeda.com/olytics/js/v3/p/ Frame 8E4A
271 KB
73 KB
Script
General
Full URL
https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash
a054aa97d11e81c0b049b5eeb2bda656aece2bf407995fd19e4a459ce60cec28
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Tue, 08 Feb 2022 14:03:36 GMT
Content-Encoding
gzip
X-Content-Type-Options
nosniff
Last-Modified
Tue, 18 Jan 2022 16:42:56 GMT
Server
Apache
ETag
W/"277838-1642524176000"
X-Frame-Options
SAMEORIGIN
Content-Type
application/javascript
Access-Control-Allow-Origin
*
Cache-Control
max-age=21600
Transfer-Encoding
chunked
Accept-Ranges
bytes
vary
accept-encoding
X-XSS-Protection
1; mode=block
Expires
Tue, 08 Feb 2022 20:03:36 GMT
956.svg
hostedcontent.dragonforms.com/hosted/images/dragon/12247/ Frame 8E4A
2 KB
2 KB
Image
General
Full URL
https://hostedcontent.dragonforms.com/hosted/images/dragon/12247/956.svg
Requested by
Host: hostedcontent.dragonforms.com
URL: https://hostedcontent.dragonforms.com/hosted/images/dragon/12247/962.css
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
205.162.42.5 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
cdn.omeda.com
Software
Apache /
Resource Hash
576f1c20a3f2469e8fc92810450d9d4f25642aa38c0777307cc47ce8c59c6cef
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://hostedcontent.dragonforms.com/hosted/images/dragon/12247/962.css
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Tue, 08 Feb 2022 15:03:36 CET
X-Content-Type-Options
nosniff
Last-Modified
Mon, 04 Oct 2021 19:02:01 CEST
Server
Apache
ETag
W/"1609-1633366921496"
X-Frame-Options
SAMEORIGIN
Content-Type
image/svg+xml
Access-Control-Allow-Origin
*
Access-Control-Expose-Headers
Access-Control-Allow-Origin,Access-Control-Allow-Credentials
Transfer-Encoding
chunked
Accept-Ranges
bytes
X-XSS-Protection
1; mode=block
evaluateConditionalContent.do;jsessionid=2E77801E27CA7D0047C0ADB1A335285D
sample.dragonforms.com/ Frame 8E4A
277 B
468 B
XHR
General
Full URL
https://sample.dragonforms.com/evaluateConditionalContent.do;jsessionid=2E77801E27CA7D0047C0ADB1A335285D?demo147906=short&demo147907=&demo147908=&opt147912=1&demo147915=LS-FP-FORM-NSL-FPShort&dragon_pagenumber=1&jsessionid=2E77801E27CA7D0047C0ADB1A335285D&timestemp=1644329016183
Requested by
Host: code.jquery.com
URL: https://code.jquery.com/jquery-2.2.4.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.190 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
Software
Apache /
Resource Hash
de7fb728cb39a5400c73eba1a03035da14f877e20e474fc60c7c6bd68a735acb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Accept
application/json, text/javascript, */*; q=0.01
Referer
https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
X-Requested-With
XMLHttpRequest
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Tue, 08 Feb 2022 14:03:35 GMT
Content-Encoding
gzip
X-Content-Type-Options
nosniff
Server
Apache
Vary
Accept-Encoding
Content-Type
text/x-json;charset=UTF-8
Access-Control-Allow-Origin
*
Transfer-Encoding
chunked
X-XSS-Protection
1; mode=block
evaluateConditionalContent.do;jsessionid=2E77801E27CA7D0047C0ADB1A335285D
sample.dragonforms.com/ Frame 8E4A
277 B
468 B
XHR
General
Full URL
https://sample.dragonforms.com/evaluateConditionalContent.do;jsessionid=2E77801E27CA7D0047C0ADB1A335285D?demo147906=short&demo147907=&demo147908=&opt147912=1&demo147915=LS-FP-FORM-NSL-FPShort&dragon_pagenumber=1&jsessionid=2E77801E27CA7D0047C0ADB1A335285D&timestemp=1644329016190
Requested by
Host: code.jquery.com
URL: https://code.jquery.com/jquery-2.2.4.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.190 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
Software
Apache /
Resource Hash
de7fb728cb39a5400c73eba1a03035da14f877e20e474fc60c7c6bd68a735acb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Accept
application/json, text/javascript, */*; q=0.01
Referer
https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
X-Requested-With
XMLHttpRequest
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Tue, 08 Feb 2022 14:03:35 GMT
Content-Encoding
gzip
X-Content-Type-Options
nosniff
Server
Apache
Vary
Accept-Encoding
Content-Type
text/x-json;charset=UTF-8
Access-Control-Allow-Origin
*
Transfer-Encoding
chunked
X-XSS-Protection
1; mode=block
analytics.js
www.google-analytics.com/ Frame 8E4A
49 KB
20 KB
Script
General
Full URL
https://www.google-analytics.com/analytics.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-MV5SCJ
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:810::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
a1925038db769477ab74b4df34350c35688a795bb718727b0f4292a4a78a6210
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

strict-transport-security
max-age=10886400; includeSubDomains; preload
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Tue, 02 Nov 2021 17:39:06 GMT
server
Golfe2
age
1722
date
Tue, 08 Feb 2022 13:34:54 GMT
vary
Accept-Encoding
content-type
text/javascript
cache-control
public, max-age=7200
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
20006
expires
Tue, 08 Feb 2022 15:34:54 GMT
publishertag.prebid.js
static.criteo.net/js/ld/
90 KB
28 KB
XHR
General
Full URL
https://static.criteo.net/js/ld/publishertag.prebid.js
Requested by
Host: static.criteo.net
URL: https://static.criteo.net/js/ld/publishertag.prebid.117.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:2638::3 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
Software
nginx /
Resource Hash
2c8ae0c883c62c03c5800ca91a31d1f0e00088683fb5f4131667c0504ce99e64
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:36 GMT
content-encoding
gzip
last-modified
Mon, 31 Jan 2022 09:04:35 GMT
server
nginx
etag
W/"61f7a623-16685"
strict-transport-security
max-age=31536000; preload;
content-type
text/javascript
access-control-allow-origin
*
cache-control
max-age=86400, public
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
expires
Wed, 09 Feb 2022 14:03:36 GMT
evaluateConditionalContent.do;jsessionid=2E77801E27CA7D0047C0ADB1A335285D
sample.dragonforms.com/ Frame 8E4A
277 B
468 B
XHR
General
Full URL
https://sample.dragonforms.com/evaluateConditionalContent.do;jsessionid=2E77801E27CA7D0047C0ADB1A335285D?demo147906=short&demo147907=&demo147908=&opt147912=1&demo147915=LS-FP-FORM-NSL-FPShort&dragon_pagenumber=1&jsessionid=2E77801E27CA7D0047C0ADB1A335285D&timestemp=1644329016435
Requested by
Host: code.jquery.com
URL: https://code.jquery.com/jquery-2.2.4.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.190 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
Software
Apache /
Resource Hash
de7fb728cb39a5400c73eba1a03035da14f877e20e474fc60c7c6bd68a735acb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Accept
application/json, text/javascript, */*; q=0.01
Referer
https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
X-Requested-With
XMLHttpRequest
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

Date
Tue, 08 Feb 2022 14:03:35 GMT
Content-Encoding
gzip
X-Content-Type-Options
nosniff
Server
Apache
Vary
Accept-Encoding
Content-Type
text/x-json;charset=UTF-8
Access-Control-Allow-Origin
*
Transfer-Encoding
chunked
X-XSS-Protection
1; mode=block
adsbygoogle.js
pagead2.googlesyndication.com/pagead/js/ Frame 8E4A
0
0
Fetch
General
Full URL
https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js
Requested by
Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:827::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:36 GMT
content-encoding
gzip
x-content-type-options
nosniff
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
53839
x-xss-protection
0
server
cafe
etag
3720849935734544028
vary
Accept-Encoding, Origin
content-type
text/javascript; charset=UTF-8
cache-control
private, max-age=3600
timing-allow-origin
*
expires
Tue, 08 Feb 2022 14:03:36 GMT
gpt.js
www.googletagservices.com/tag/js/ Frame 8E4A
0
0
Fetch
General
Full URL
https://www.googletagservices.com/tag/js/gpt.js
Requested by
Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:812::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:36 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
27199
x-xss-protection
0
server
sffe
etag
"1125 / 395 of 1000 / last-modified: 1644322105"
vary
Accept-Encoding
report-to
{"group":"ads-gpt-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-gpt-scs"}]}
content-type
text/javascript
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="ads-gpt-scs"
expires
Tue, 08 Feb 2022 14:03:36 GMT
multitracking
ghb.hbmp.mediafuse.com/adunit/
0
211 B
XHR
General
Full URL
https://ghb.hbmp.mediafuse.com/adunit/multitracking
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/456758/hbw_master_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
2a0c:5c81:5142::2 London, United Kingdom, ASN55081 (24SHELLS, US),
Reverse DNS
Software
VertaMedia 1.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Access-Control-Allow-Origin
https://www.fiercepharma.com
Date
Tue, 08 Feb 2022 14:03:36 GMT
Access-Control-Allow-Credentials
true
Server
VertaMedia 1.0
Connection
Keep-Alive
mut
ghb.adtelligent.com/adunit/ Frame 447C
0
207 B
XHR
General
Full URL
https://ghb.adtelligent.com/adunit/mut
Requested by
Host: p.nodserving.com
URL: https://p.nodserving.com/prebidlink/19031/pbm_307825_11600.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
2a0c:5c81:5142::2 London, United Kingdom, ASN55081 (24SHELLS, US),
Reverse DNS
Software
VertaMedia 1.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://p.nodserving.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Access-Control-Allow-Origin
https://p.nodserving.com
Date
Tue, 08 Feb 2022 14:03:36 GMT
Access-Control-Allow-Credentials
true
Server
VertaMedia 1.0
Connection
Keep-Alive
p
olytics.omeda.com/olytics/segments/ Frame
0
0
Preflight
General
Full URL
https://olytics.omeda.com/olytics/segments/p
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Method
POST
Access-Control-Request-Headers
content-type
Origin
https://sample.dragonforms.com
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

Access-Control-Allow-Origin
*
vary
Access-Control-Request-Headers,Access-Control-Request-Headers,access-control-request-method
Access-Control-Max-Age
1800
Access-Control-Allow-Methods
HEAD,DELETE,POST,GET,OPTIONS,PUT
Access-Control-Allow-Headers
access-control-max-age,accept-language,origin,x-requested-with,access-control-request-headers,host,content-type,access-control-request-method,accept-encoding,accept,user-agent
Content-Length
0
Date
Tue, 08 Feb 2022 14:03:37 GMT
Server
Apache
p
olytics.omeda.com/olytics/segments/ Frame 8E4A
0
197 B
XHR
General
Full URL
https://olytics.omeda.com/olytics/segments/p
Requested by
Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://sample.dragonforms.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
application/json

Response headers

Access-Control-Allow-Origin
*
Date
Tue, 08 Feb 2022 14:03:37 GMT
X-Content-Type-Options
nosniff
Server
Apache
X-XSS-Protection
1; mode=block
X-Frame-Options
SAMEORIGIN
cswitch
olytics.omeda.com/olytics/segments/ Frame 8E4A
94 B
387 B
XHR
General
Full URL
https://olytics.omeda.com/olytics/segments/cswitch
Requested by
Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash
3dfa79f74fa390a90f9d1806c6c64f3cf789b1be61749662de88aca1ab9139a3
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://sample.dragonforms.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
application/json

Response headers

Date
Tue, 08 Feb 2022 14:03:37 GMT
X-Content-Type-Options
nosniff
Server
Apache
X-Frame-Options
SAMEORIGIN
Content-Type
application/json
Access-Control-Allow-Origin
*
Cache-Control
no-cache
Transfer-Encoding
chunked
X-XSS-Protection
1; mode=block
cswitch
olytics.omeda.com/olytics/segments/ Frame
0
0
Preflight
General
Full URL
https://olytics.omeda.com/olytics/segments/cswitch
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Method
POST
Access-Control-Request-Headers
content-type
Origin
https://sample.dragonforms.com
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

Access-Control-Allow-Origin
*
vary
Access-Control-Request-Headers,Access-Control-Request-Headers,access-control-request-method
Access-Control-Max-Age
1800
Access-Control-Allow-Methods
HEAD,DELETE,POST,GET,OPTIONS,PUT
Access-Control-Allow-Headers
access-control-max-age,accept-language,origin,x-requested-with,access-control-request-headers,host,content-type,access-control-request-method,accept-encoding,accept,user-agent
Content-Length
0
Date
Tue, 08 Feb 2022 14:03:37 GMT
Server
Apache
report
creative.spotible.com/creative/GxHs/
43 B
98 B
Image
General
Full URL
https://creative.spotible.com/creative/GxHs/report?,1644329014,595003;IN_VIEW_TIME!0,4,0!18,4,0!55,4,0!69,4,0!113,4,0!120,4,0&referrer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
54.144.118.149 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-144-118-149.compute-1.amazonaws.com
Software
/
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 14:03:38 GMT
cache-control
no-store
content-length
43
content-type
image/gif
sid
mug.criteo.com/
Redirect Chain
  • https://gum.criteo.com/sid/json?origin=prebid&topUrl=https%3A%2F%2Fwww.fiercepharma.com%2F&domain=www.fiercepharma.com&cw=1&pbt=1&lsw=1
  • https://mug.criteo.com/sid?cpp=DvZvzHwzWWNyRS9zbCtmQWFwQVBoT1BxeS9yMlhVc0pYbG9GZTczMWFZS3VVbE9OKzZBb0dWejV4ZHAyVjJwcmY4QUJGemFRdkg2Mmk4WWtXMmlUYVU0N2Rab04vUzBlNTJJR1d5SHRCelBJaStLeGhwZjdGZVdYWXlJTF...
339 B
611 B
XHR
General
Full URL
https://mug.criteo.com/sid?cpp=DvZvzHwzWWNyRS9zbCtmQWFwQVBoT1BxeS9yMlhVc0pYbG9GZTczMWFZS3VVbE9OKzZBb0dWejV4ZHAyVjJwcmY4QUJGemFRdkg2Mmk4WWtXMmlUYVU0N2Rab04vUzBlNTJJR1d5SHRCelBJaStLeGhwZjdGZVdYWXlJTFhQZDFPc25DdmtueStDU29SUjlWNy83bnlhY09UOVRJOXMzd2h5RGlWdFhrNTAwRmc0RGw1d3VyeFVSdVNxbzR3TStYWmFScVhkTGdOOURZWnN4L1dlNW9GcHdnNlN1UkpiQmt3THFuNDVUNFNwYjU3RWhHN0d2Y2xlVXNIT2JJZTMyakRoMzlwfA&cppv=2
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Protocol
H2
Server
178.250.2.146 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
Software
/
Resource Hash
1f6a83834d6b0a2b528773f7ea5cfe1a42d5b6cd68d6a4f837e86fa55e24f80a
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 08 Feb 2022 14:03:38 GMT
content-encoding
gzip
vary
Accept-Encoding
access-control-allow-methods
GET
content-type
application/json; charset=utf-8
access-control-allow-origin
null
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
server-processing-duration-in-ticks
3119
strict-transport-security
max-age=31536000; preload;
expires
0

Redirect headers

pragma
no-cache
date
Tue, 08 Feb 2022 14:03:38 GMT
location
https://mug.criteo.com/sid?cpp=DvZvzHwzWWNyRS9zbCtmQWFwQVBoT1BxeS9yMlhVc0pYbG9GZTczMWFZS3VVbE9OKzZBb0dWejV4ZHAyVjJwcmY4QUJGemFRdkg2Mmk4WWtXMmlUYVU0N2Rab04vUzBlNTJJR1d5SHRCelBJaStLeGhwZjdGZVdYWXlJTFhQZDFPc25DdmtueStDU29SUjlWNy83bnlhY09UOVRJOXMzd2h5RGlWdFhrNTAwRmc0RGw1d3VyeFVSdVNxbzR3TStYWmFScVhkTGdOOURZWnN4L1dlNW9GcHdnNlN1UkpiQmt3THFuNDVUNFNwYjU3RWhHN0d2Y2xlVXNIT2JJZTMyakRoMzlwfA&cppv=2
strict-transport-security
max-age=31536000; preload;
access-control-allow-methods
GET
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
server-processing-duration-in-ticks
1931
content-length
509
expires
0
692.json
id5-sync.com/g/v2/
213 B
538 B
XHR
General
Full URL
https://id5-sync.com/g/v2/692.json
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456758/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
51.89.7.110 London, United Kingdom, ASN16276 (OVH, FR),
Reverse DNS
p23.id5-sync.com
Software
/
Resource Hash
a3a01e6d4d86e74c95101f4abf4061a84f9729b1e2b82a75da7b8f32066af3f0
Security Headers
Name Value
Strict-Transport-Security max-age=63072000; includeSubDomains; preload

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Content-Type
text/plain

Response headers

Access-Control-Allow-Origin
https://www.fiercepharma.com
Date
Tue, 08 Feb 2022 14:03:38 GMT
Access-Control-Allow-Credentials
true
Vary
Origin
Transfer-Encoding
chunked
Strict-Transport-Security
max-age=63072000; includeSubDomains; preload
Content-Type
application/json;charset=UTF-8
json
gum.criteo.com/sid/ Frame
0
0
Preflight
General
Full URL
https://gum.criteo.com/sid/json?origin=prebid&topUrl=https%3A%2F%2Fwww.fiercepharma.com%2F&domain=www.fiercepharma.com&cw=1&pbt=1&lsw=1
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:2638::1c , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
Software
/
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Accept
*/*
Access-Control-Request-Method
GET
Access-Control-Request-Headers
content-type
Origin
https://www.fiercepharma.com
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

cache-control
no-cache, no-store, must-revalidate
pragma
no-cache
content-type
application/json; charset=utf-8
expires
0
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-headers
content-type
access-control-allow-credentials
true
access-control-allow-methods
GET
server-processing-duration-in-ticks
1596
date
Tue, 08 Feb 2022 14:03:38 GMT
strict-transport-security
max-age=31536000; preload;
content-encoding
gzip
vary
Accept-Encoding
sid
mug.criteo.com/ Frame
0
0
Preflight
General
Full URL
https://mug.criteo.com/sid?cpp=DvZvzHwzWWNyRS9zbCtmQWFwQVBoT1BxeS9yMlhVc0pYbG9GZTczMWFZS3VVbE9OKzZBb0dWejV4ZHAyVjJwcmY4QUJGemFRdkg2Mmk4WWtXMmlUYVU0N2Rab04vUzBlNTJJR1d5SHRCelBJaStLeGhwZjdGZVdYWXlJTFhQZDFPc25DdmtueStDU29SUjlWNy83bnlhY09UOVRJOXMzd2h5RGlWdFhrNTAwRmc0RGw1d3VyeFVSdVNxbzR3TStYWmFScVhkTGdOOURZWnN4L1dlNW9GcHdnNlN1UkpiQmt3THFuNDVUNFNwYjU3RWhHN0d2Y2xlVXNIT2JJZTMyakRoMzlwfA&cppv=2
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
178.250.2.146 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
Software
/
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Accept
*/*
Access-Control-Request-Method
GET
Access-Control-Request-Headers
content-type
Origin
null
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/97.0.4692.71 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

cache-control
no-cache, no-store, must-revalidate
pragma
no-cache
content-type
application/json; charset=utf-8
expires
0
access-control-allow-origin
null
access-control-allow-headers
content-type
access-control-allow-credentials
true
access-control-allow-methods
GET
server-processing-duration-in-ticks
992
date
Tue, 08 Feb 2022 14:03:38 GMT
strict-transport-security
max-age=31536000; preload;
content-encoding
gzip
vary
Accept-Encoding

Failed requests

These URLs were requested, but there was no response received. You will also see them in the list above.

Domain
c405.fiercepharma.com
URL
https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/794?referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-08T14%3A03%3A33%2B00%3A00&ts=1644329013468
Domain
rtb.adxpremium.services
URL
https://rtb.adxpremium.services/openrtb2/auction
Domain
rtb.adxpremium.services
URL
https://rtb.adxpremium.services/openrtb2/auction
Domain
rtb.adxpremium.services
URL
https://rtb.adxpremium.services/openrtb2/auction
Domain
rtb.adxpremium.services
URL
https://rtb.adxpremium.services/openrtb2/auction
Domain
rtb.adxpremium.services
URL
https://rtb.adxpremium.services/openrtb2/auction
Domain
ads.spotible.com
URL
https://ads.spotible.com/tag/universal-tag.js

Verdicts & Comments Add Verdict or Comment

103 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

object| 0 object| 1 object| 2 object| 3 object| 4 object| 5 object| 6 object| 7 object| event object| NREUM object| newrelic function| __nr_require function| mobileCheck object| dataLayerValues object| dataLayer object| googletag object| vmpbjs object| vpb object| a2a_config object| Modernizr object| blueConicPreListeners function| BCClass object| blueConicClient function| bc_json795 string| ssaUrl undefined| $ function| jQuery object| drupalSettings object| Drupal object| picturefillCFG function| picturefill function| _toConsumableArray function| disablePurgingButton object| WebFont object| a2a function| a2a_show_dropdown function| a2a_miniLeaveDelay function| a2a_init number| a2apage_init object| google_tag_manager object| google_tag_data string| GoogleAnalyticsObject function| ga string| method string| bid string| oid object| olytics object| a string| qtxSection function| vmpbjsChunk object| _pbjsGlobals object| mnet string| nobidVersion object| nobid object| ggeac object| google_js_reporting_queue object| PARSELY function| mktoMunchkinFunction object| Munchkin function| mktoMunchkin object| gaplugins object| gaGlobal object| gaData function| Dpxl object| dpmPixels object| jQuery111107257027583721554 object| MktoForms2 function| mktoFormSubmitCallback boolean| CE_USER_SCRIPT object| CE2 string| CE_USER_DATA_URL object| _ml function| readCookie function| profileIdExecute string| queryString boolean| disableBcMarketoIntegration object| MunchkinTracker undefined| google_measure_js_timing function| _typeof string| CE_USER_COMMON_SCRIPT_URL string| CE_USER_THIRDPARTY_SCRIPT_URL object| CE2BH function| CE_URL_FINGERPRINT object| Criteo object| googleToken object| googleIMState function| processGoogleToken number| google_unique_id function| bc_json796 function| __$PP function| bc_json797 object| spotible function| setImmediate function| clearImmediate function| normalize object| auvars object| w7eDOMEvents object| au function| docReady object| autag object| criteo_pubtag object| criteo_pubtag_prebid_117 object| Criteo_prebid_117

79 Cookies

Domain/Path Name / Value
www.fiercepharma.com/special-report Name: hasLiveRampMatch
Value: true
www.fiercepharma.com/ Name: last_visit_bc
Value: 1644329013128
.app-sj10.marketo.com/ Name: __cf_bm
Value: g5Lx5V6dxbfnzrsU5o_5Cx8OsstB_gpPww1I8lmJ60c-1644329013-0-Aeiz2unaZ1FKixzMNgKjbVCSXCVI3zpPDuSIWXC1/WEu/mtQXaWK7TeGgjk2fgjvNbw3qUgYMoYPhstYDm6lp4k=
.fiercepharma.com/ Name: _ga
Value: GA1.2.800578055.1644329014
.fiercepharma.com/ Name: _gid
Value: GA1.2.421591499.1644329014
.fiercepharma.com/ Name: _gat_UA-336524-28
Value: 1
www.fiercepharma.com/ Name: dpm_url_count
Value: 1
.fiercepharma.com/ Name: _mkto_trk
Value: id:294-MQF-056&token:_mch-fiercepharma.com-1644329013575-25283
.adnxs.com/ Name: uuid2
Value: 5611407578940007418
.fiercepharma.com/ Name: _parsely_session
Value: {%22sid%22:1%2C%22surl%22:%22https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib%22%2C%22sref%22:%22%22%2C%22sts%22:1644329013617%2C%22slts%22:0}
.fiercepharma.com/ Name: _parsely_visitor
Value: {%22id%22:%22pid=7c909c60890d123c6bb653f8bb6696b3%22%2C%22session_count%22:1%2C%22last_session_ts%22:1644329013617}
.ws.zoominfo.com/ Name: visitorId
Value: d2f3e0c2bed1c3e83568062f7e22b5e79495d293784b40d3be92de746223ff87
.hbmp.mediafuse.com/ Name: vmuid
Value: a588dd692d2223c1
www.fiercepharma.com/ Name: _pbjs_userid_consent_data
Value: 3524755945110770
.fiercepharma.com/ Name: _pubcid
Value: b3acf975-6694-4970-9538-76bd2b008d42
.adtelligent.com/ Name: vmuid
Value: dee7590cecd5b9a6
.lijit.com/ Name: ljtrtb
Value: eJyrrgUAAXUA%2BQ%3D%3D
.admixer.net/ Name: am-uid
Value: a8d164efc01546ef85842406b01a90a4
.go.sonobi.com/ Name: __uih
Value: 1
.go.sonobi.com/ Name: HAPLB5A
Value: s56128|YgJ4O
sample.dragonforms.com/ Name: JSESSIONID
Value: 2E77801E27CA7D0047C0ADB1A335285D
.dpmsrv.com/ Name: dpm_pxl
Value: 55f4c5a04a9bcdfda03ed1afef3377e0eb46b049
.dpmsrv.com/ Name: dpm_pxl_aid
Value: 5611407578940007418
.betweendigital.com/ Name: dc
Value: mow1
.betweendigital.com/ Name: tuuid
Value: ba90f581-3f66-5127-a6b9-6233c4bb1a05
.betweendigital.com/ Name: ut
Value: YgJ4NgABU9iZ0l4JeSNz-prHbRFfHYRkj8diPA==
.betweendigital.com/ Name: ss
Value: 1
.betweendigital.com/ Name: unm
Value: 1
.doubleclick.net/ Name: IDE
Value: AHWqTUk-oOPV5mn-0Qi2JeV9LQNK-S91VIlB9IRHXbqcPIHRAgCUm2Qc7CXXJVOfsL4
.rubiconproject.com/ Name: khaos
Value: KZE71FF7-1F-MBLT
.rubiconproject.com/ Name: audit
Value: 1|SDziDG3X/EjOCL5oZInRXebASkO6QPb7E03ikE5KqM12wHsFnqwQFFQuMMdx5ksT2Viil87TsQADU4L+VXaOPcBQn6AvuCLFQXFQM5ICNxAdOKW1qRBjyg==
.contextweb.com/ Name: V
Value: Tw2CeqoIXBHo
prebid.a-mo.net/ Name: __amc
Value: 1_1644329014_1644329014
.ad.gt/ Name: au_id
Value: 71ea94e0-0093-44cb-b4dd-d08066fc43e4
.ad.gt/ Name: au_idmatch
Value: {"apn": "2022-02-08", "ttd": "2022-02-08", "pub": "2022-02-08", "adx": "2022-02-08", "halo": "2022-02-08", "goo": "2022-02-08", "impr": "2022-02-08", "bees": "2022-02-08", "rub": "2022-02-08"}
.fiercepharma.com/ Name: oly_enc_id
Value: null
.fiercepharma.com/ Name: oly_anon_id
Value: %226682244b-7143-4ba5-82f6-a1f8c72d7e4e%22
.pubmatic.com/ Name: KTPCACOOKIE
Value: true
.pubmatic.com/ Name: KADUSERCOOKIE
Value: BBFBF67E-52FE-430F-93B6-E6A55E905C12
.360yield.com/ Name: tuuid
Value: bcc9beb1-8e48-4422-8855-3bd127e27e5e
.360yield.com/ Name: tuuid_lu
Value: 1644329014
.adsrvr.org/ Name: TDID
Value: 5f6d2359-c211-4f10-9b58-14dbad0adcf8
.adsrvr.org/ Name: TDCPM
Value: CAEYBSABKAIyCwjg7vPv0MW1OhAFOAE.
.bidr.io/ Name: bito
Value: AAFhKk7EBPAAAAJ4odOVww
.bidr.io/ Name: bitoIsSecure
Value: ok
c405.fiercepharma.com/ Name: AWSALB
Value: H1vrA8dDz+QnBDshHI9y35PDb0IFKADU/qDBWjVDSDfnx8YxeFwhkjvMd3qlRRmXljpv+BsDrhU3rCOZeenfHeZdup2SpR6tCpc0INtjz6wee0gXGZXIJz6O7M5W
c405.fiercepharma.com/ Name: AWSALBCORS
Value: H1vrA8dDz+QnBDshHI9y35PDb0IFKADU/qDBWjVDSDfnx8YxeFwhkjvMd3qlRRmXljpv+BsDrhU3rCOZeenfHeZdup2SpR6tCpc0INtjz6wee0gXGZXIJz6O7M5W
.ad.gt/ Name: last_seeng_hosted
Value: 1644329015026
.ad.gt/ Name: g_hosted
Value:
.ad.gt/ Name: last_seenadnxs
Value: 1644329015037
.ad.gt/ Name: adnxs_id
Value: 5611407578940007418
.ad.gt/ Name: first_seenadnxs
Value: 1644329015037
.ad.gt/ Name: last_seentd
Value: 1644329015037
.ad.gt/ Name: tdid
Value: 5f6d2359-c211-4f10-9b58-14dbad0adcf8
.ad.gt/ Name: first_seentd
Value: 1644329015038
.ad.gt/ Name: last_seenimprove
Value: 1644329015039
.ad.gt/ Name: impr_uid
Value: bcc9beb1-8e48-4422-8855-3bd127e27e5e
.ad.gt/ Name: last_seenadx
Value: 1644329015039
.ad.gt/ Name: google_gid
Value: CAESEK46dYDDn1ptvDyhgNKmnDA
.ad.gt/ Name: first_seenadx
Value: 1644329015039
.ad.gt/ Name: last_seenpbm
Value: 1644329015042
.ad.gt/ Name: pbm
Value: BBFBF67E-52FE-430F-93B6-E6A55E905C12
.ad.gt/ Name: first_seenpbm
Value: 1644329015042
.ad.gt/ Name: last_seenrub
Value: 1644329015044
.ad.gt/ Name: rub
Value:
.ad.gt/ Name: last_seenbeeswax
Value: 1644329015051
.ad.gt/ Name: beeswax_id
Value: AAFhKk7EBPAAAAJ4odOVww
.ad.gt/ Name: last_seenhaloid
Value: 1644329015235
.ad.gt/ Name: halo_id
Value: 0201tlxlfd07jv2yg08xizqr0bwpa1w0evvljv1k7cm961o8b5po0ntek210qskvk40trr7270wqxik90zq3u2c12pa5j31k0gxf118nmsj90fzd0bt1elzfjf1hl5r1i1kkc2jl
.ad.gt/ Name: first_seenhaloid
Value: 1644329015235
.adnxs.com/ Name: anj
Value: dTM7k!M4/8CxrEQF']wIg2In@d?pgc!]tbP6j2F-XstGt!@Dd]$l-/M
.dpmsrv.com/ Name: xdpm_segsid_913
Value: 16013439%2C16671093%2C29315652%2C29315642%2C29028703
.dpmsrv.com/ Name: xdpm_segs_913
Value:
.fiercepharma.com/ Name: __gads
Value: ID=a10b70ecd31ee878:T=1644329013:S=ALNI_MZsm7Wnc7_eQhKrhueLNPLik0Vgww
.dragonforms.com/ Name: oly_enc_id
Value: null
.dragonforms.com/ Name: oly_anon_id
Value: %22bcd030a0-6b5c-4fff-8bb4-6bcfafbc13b3%22
.fiercepharma.com/ Name: cto_bundle
Value: TUZ0zF9jSFJ2ODRlZE83Y0xrUEVDOU83aDB4a21EdWRjUGpJNnNWNSUyRjNCSzBYOHglMkJlYmpreGhsMWRqYUtNRmJ1M3J1SXBST0k1M01mSDRyeHlIV2ZURmpJcDh5eVZJVENGQm12RDA1dHkyQnl0M2hvYmNXR01FblgxTVlGb3ZhZzVROWU
.fiercepharma.com/ Name: cto_bidid
Value: pb4bzl96VVpLMjNZVFZmUjhnVHN6T3g5V2JTdWNZRHdzdE5GUUlPcW9jWVdhTXVRWXdyYWpyWXo5Tm01Y3Q0dzF5WmJkRFVMQWxaVU4lMkI2bk1PR1k2WTZub0h3JTNEJTNE
www.fiercepharma.com/ Name: dpm_time_site
Value: 6.006

7 Console Messages

Source Level URL
Text
network error URL: https://questex.blueconic.net/DG/DEFAULT/cs?&callback=bc_json795
Message:
Failed to load resource: the server responded with a status of 404 ()
network error URL: https://prebid.adnxs.com/pbs/v1/openrtb2/auction
Message:
Failed to load resource: the server responded with a status of 400 (Bad Request)
javascript error URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-4-deucravacitinib
Message:
Access to XMLHttpRequest at 'https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/794?referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-08T14%3A03%3A33%2B00%3A00&ts=1644329013468' from origin 'https://www.fiercepharma.com' has been blocked by CORS policy: No 'Access-Control-Allow-Origin' header is present on the requested resource.
network error URL: https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/794?referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-08T14%3A03%3A33%2B00%3A00&ts=1644329013468
Message:
Failed to load resource: net::ERR_FAILED
network error URL: https://idsync.rlcdn.com/423396.gif?partner_uid=5611407578940007418
Message:
Failed to load resource: the server responded with a status of 451 ()
network error URL: https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22getProfile%22%2C%22params%22%3A%22null%22%2C%22id%22%3A%221644329013130%22%7D%2C%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22language%5C%22%3A%5B%5C%22en%5C%22%5D%2C%5C%22currentscreenwidth%5C%22%3A%5B1600%5D%2C%5C%22currentscreenheight%5C%22%3A%5B1200%5D%2C%5C%22currentresolution%5C%22%3A%5B%5C%221600x1200%5C%22%5D%2C%5C%22entrypage%5C%22%3A%5B%5C%22https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib%5C%22%5D%2C%5C%22new_visit_bc%5C%22%3A%5B%5C%22true%5C%22%5D%7D%2C%5C%22sources%5C%22%3A%7B%5C%22listenerinteractiontype%5C%22%3A%5B%5C%22language%5C%22%2C%5C%22currentscreenwidth%5C%22%2C%5C%22currentscreenheight%5C%22%2C%5C%22currentresolution%5C%22%2C%5C%22entrypage%5C%22%5D%2C%5C%22newvisitlistener%5C%22%3A%5B%5C%22new_visit_bc%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644329013132%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22resolution%5C%22%3A%5B%5C%221600x1200%5C%22%5D%7D%2C%5C%22sources%5C%22%3A%7B%5C%22listenerinteractiontype%5C%22%3A%5B%5C%22resolution%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644329013133%22%7D%2C%7B%22method%22%3A%22createEvent%22%2C%22params%22%3A%22%7B%5C%22type%5C%22%3A%5B%5C%22PAGEVIEW%5C%22%5D%2C%5C%22referrer%5C%22%3A%5B%5C%22%5C%22%5D%2C%5C%22profile%5C%22%3A%5B%5D%7D%22%2C%22id%22%3A%221644329013134%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-08T14%3A03%3A33%2B00%3A00&callback=bc_json796
Message:
Failed to load resource: the server responded with a status of 404 ()
network error URL: https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22getProfile%22%2C%22params%22%3A%22null%22%2C%22id%22%3A%221644329013130%22%7D%2C%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22language%5C%22%3A%5B%5C%22en%5C%22%5D%2C%5C%22currentscreenwidth%5C%22%3A%5B1600%5D%2C%5C%22currentscreenheight%5C%22%3A%5B1200%5D%2C%5C%22currentresolution%5C%22%3A%5B%5C%221600x1200%5C%22%5D%2C%5C%22entrypage%5C%22%3A%5B%5C%22https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib%5C%22%5D%2C%5C%22new_visit_bc%5C%22%3A%5B%5C%22true%5C%22%5D%7D%2C%5C%22sources%5C%22%3A%7B%5C%22listenerinteractiontype%5C%22%3A%5B%5C%22language%5C%22%2C%5C%22currentscreenwidth%5C%22%2C%5C%22currentscreenheight%5C%22%2C%5C%22currentresolution%5C%22%2C%5C%22entrypage%5C%22%5D%2C%5C%22newvisitlistener%5C%22%3A%5B%5C%22new_visit_bc%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644329013132%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22resolution%5C%22%3A%5B%5C%221600x1200%5C%22%5D%7D%2C%5C%22sources%5C%22%3A%7B%5C%22listenerinteractiontype%5C%22%3A%5B%5C%22resolution%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644329013133%22%7D%2C%7B%22method%22%3A%22createEvent%22%2C%22params%22%3A%22%7B%5C%22type%5C%22%3A%5B%5C%22PAGEVIEW%5C%22%5D%2C%5C%22referrer%5C%22%3A%5B%5C%22%5C%22%5D%2C%5C%22profile%5C%22%3A%5B%5D%7D%22%2C%22id%22%3A%221644329013134%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-4-deucravacitinib&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-08T14%3A03%3A34%2B00%3A00&callback=bc_json797
Message:
Failed to load resource: the server responded with a status of 404 ()

Security Headers

This page lists any security headers set by the main page. If you want to understand what these mean and how to use them, head on over to this page

Header Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

294-mqf-056.mktoresp.com
88de716fcdb80ed5cefd22d492c50498.safeframe.googlesyndication.com
a.ad.gt
a.dpmsrv.com
acdn.adnxs.com
ad.360yield.com
ads.betweendigital.com
ads.servenobid.com
ads.spotible.com
ads.yieldmo.com
adservice.google.com
adservice.google.de
adtelligent-d.openx.net
ajax.googleapis.com
ap.lijit.com
apex.go.sonobi.com
api-54-185-136-237.b2c.com
api.fouanalytics.com
app-sj10.marketo.com
assets-tracking.crazyegg.com
aufp.io
bid.contextweb.com
bidder.criteo.com
c2shb.ssp.yahoo.com
c405.fiercepharma.com
cdn.blueconic.net
cdn.omeda.com
cdn.parsely.com
cdn.spotible.com
cm.g.doubleclick.net
code.jquery.com
colossusssp.com
creative.spotible.com
d1z2jf7jlzjs58.cloudfront.net
dm.hybrid.ai
fastlane.rubiconproject.com
fonts.googleapis.com
fonts.gstatic.com
ghb.adtelligent.com
ghb.hbmp.mediafuse.com
gum.criteo.com
hbopenbid.pubmatic.com
hostedcontent.dragonforms.com
htlb.casalemedia.com
ib.adnxs.com
id5-sync.com
ids.ad.gt
idsync.rlcdn.com
image2.pubmatic.com
in.ml314.com
inv-nets.admixer.net
match.adsrvr.org
match.prod.bidr.io
ml314.com
mug.criteo.com
munchkin.marketo.net
olytics.omeda.com
onetag-sys.com
oqs.omeda.com
p.ad.gt
p.nodserving.com
p1.parsely.com
pagead2.googlesyndication.com
pagestates-tracking.crazyegg.com
pbjs.e-planning.net
pixel-a.basis.net
pixel.sitescout.com
pixels.ad.gt
player.adtelligent.com
player.hbmp.mediafuse.com
player.mediafuse.com
prebid-eu.creativecdn.com
prebid-us.creativecdn.com
prebid.a-mo.net
prebid.adnxs.com
prebid.deepintent.com
prebid.media.net
qtxasset.com
questex.blueconic.net
rtb.adxpremium.services
s.dpmsrv.com
sample.dragonforms.com
script.crazyegg.com
secure.adnxs.com
securepubads.g.doubleclick.net
static.addtoany.com
static.criteo.net
stats.g.doubleclick.net
sync.adtelligent.com
sync.medidexs.com
t.trafmag.com
tag.1rx.io
token.rubiconproject.com
tracking.crazyegg.com
u.openx.net
v4-api-54-185-136-237.b2c.com
ws.zoominfo.com
www.fiercepharma.com
www.google-analytics.com
www.googletagmanager.com
www.googletagservices.com
ads.spotible.com
c405.fiercepharma.com
rtb.adxpremium.services
104.111.234.67
104.16.92.165
104.16.94.80
104.18.14.141
142.250.184.226
142.250.185.66
143.204.215.21
146.0.227.109
147.75.38.124
151.101.1.108
169.197.150.8
178.162.133.150
178.250.0.165
178.250.2.146
18.156.195.47
18.66.248.91
185.184.10.30
185.184.8.65
185.33.221.91
185.64.189.112
185.64.190.80
192.28.147.68
193.200.65.5
198.148.27.133
2001:4de0:ac18::1:a:2a
204.180.130.159
204.180.130.165
204.180.130.190
205.162.42.5
213.19.147.42
216.52.2.48
23.37.38.181
2602:803:c003:200::41
2606:4700:10::6816:47c5
2606:4700:20::681a:723
2606:4700:3033::6815:3a2a
2606:4700::6810:a852
2606:4700::6813:9308
2a00:1450:4001:808::2008
2a00:1450:4001:80f::2002
2a00:1450:4001:810::2001
2a00:1450:4001:810::2003
2a00:1450:4001:810::200e
2a00:1450:4001:812::2002
2a00:1450:4001:813::2002
2a00:1450:4001:827::2002
2a00:1450:4001:827::200a
2a00:1450:4001:82a::2002
2a00:1450:4001:82b::200a
2a00:1450:400c:c08::9c
2a02:2638::1c
2a02:2638::3
2a0c:5c81:5142::2
3.226.203.17
3.251.21.8
34.107.148.139
34.194.161.83
34.200.182.42
34.249.212.247
34.251.249.129
35.244.159.8
35.244.174.68
35.83.23.20
37.18.16.16
37.252.161.190
37.252.172.37
44.230.193.23
45.133.44.3
45.133.44.4
5.178.65.246
51.38.120.206
51.89.7.110
52.208.138.90
52.223.40.198
52.35.70.100
52.43.149.174
52.50.101.149
54.144.118.149
54.149.174.3
54.185.136.237
54.72.7.92
62.149.0.72
63.32.247.12
65.9.58.62
65.9.61.60
65.9.63.73
66.155.71.150
69.173.144.165
8.2.111.126
88.212.252.22
99.86.3.109
99.86.3.25
99.86.3.4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